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ABSTRACT 
Coronary vascular disease (CVD) is the number one cause of death worldwide. 
According to a WHO report and global and regional projections of mortality and 
burden of disease, by 2030, the number of people dying from heart disease and 
stroke will increase to reach 23.3 million. Non-HDL cholesterol, determined by 
subtracting the high density lipoprotein cholesterol (HDL-C) concentration from the 
total cholesterol (TC) content, has been recommended as a target for preliminary 
CVD prevention. In recent times, single-step homogeneous assays have been 
developed which allow simple and selective measurement of cholesterol fractions. 
Electrochemical sensors have also been developed which are based on the 
electrocatalysis of hydrogen peroxide using low cost printed sensor methodologies 
and such platforms would have the potential to be used as the basis of fabricating 
cholesterol biosensors for point of care use. 
Here, the development of electrochemical biosensors for the selective 
measurement of HDL-C, TC, and by subtraction non-HDL-C was explored. A 
spectrophotometric assay for use at room temperature and with minimal sample 
dilution was first established in order to optimise the assay reagent components for 
the development of selective cholesterol assays. Assay chemistries based on 
polyoxyethylene tribenzylphenyl ethers (Emulgen B-66) and Triton X-100 for the 
selective measurement of HDL-C and TC, respectively, were developed. The 
impact of these reagents on the electrocatalytic reduction of hydrogen peroxide at 
silver paste screen printed electrodes was also evaluated and optimised. 
Electrochemical biosensors for HDL-C and TC using externally added assay 
reagents were developed by combining the homogeneous assay methodologies 
with the printed electrocatalytic electrodes. The effects of assay reagents such as 
surfactants, enzymes, HDL-C sample and delipidated serum on the electrode 
behaviour were assessed amperometrically in the presence of hydrogen peroxide 
solutions. The electrodes showed increases in their catalytic activity toward 
hydrogen peroxide in the presence of both selective and non-selective surfactant 
and decreases in the presence of cholesterol oxidase and HDL-C samples. Despite 
the negative effects of cholesterol oxidase and sample matrix on electrode 
behaviour, the electrode response was linear within the clinically relevant ranges of 
HDL-C and TC. The modified electrodes were evaluated for their ability to 
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selectively measure HDL-C and TC in clinical serum samples. The resulting HDL-C 
biosensor yielded a sensitivity of 3.3210-8 A/mM with a linear range of 0 to 4 mM 
(r2=0.999), LOD of 0.5 mM and average RSD of 9.5% (n=5) while the TC biosensor 
had a sensitivity of 2.2410-8 A/mM and a linear range of 0 to 10 mM r2=0.984), 
LOD of 2 mM and average RSD of 10.8% (n=3). The correlation between the HDL-
C sensor and a commercial laboratory assay in clinical serum samples had a slope 
of 0.87 and a Pearson correlation coefficient of 0.76 (n=13) while the correlation for 
TC measurement had a slope of 1.07 and a Pearson correlation coefficient of 0.87. 
Finally, in order to develop a disposable biosensor suitable for point of care testing, 
integrated biosensors for HDL-C and TC were fabricated by inkjet-print deposition 
of assay reagents on the electrode surface. Integrated biosensors for the 
measurement of HDL-C were optimised and yielded a sensitivity of 4.5510-8 A/mM 
with a linear range of 0 to 4 mM (r2=0.993) with an LOD of 0.25 mM and average 
RSD of 6.6% (n=3). The integrated TC biosensor had a sensitivity of 9.3810-9 
A/mM and linear range of 0 to 9 mM (r2=0.982), LOD of 0.5 mM and average RSD 
of 9.5% (n=3).  
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Chapter 1  
Introduction 
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1.1 Cholesterol and vascular disease 
Coronary artery disease (CAD) is the number one cause of death in all developed 
countries (Heron, 2012). In the 1980s, public concern over the risks of high blood 
cholesterol levels began to rise. Since then, several studies have demonstrated the 
increased possibility of cardiovascular diseases including arteriosclerosis in relation 
to high cholesterol levels. Atherosclerosis is a condition in which the arteries 
become blocked partly due to the accumulation of cholesterol. When cholesterol 
deposits on the walls of arteries, plaques form which may lead to blockages and 
interruption of the circulation, causing angina and myocardial infarction, with their 
associated morbidity and mortality. Some plaques can burst and release fat into the 
bloodstream, which can lead to a thromboembolism (Campbell et al., 2006). As a 
result, cholesterol has become one of the main parameters which are measured in 
routine clinical laboratory testing, accounting for an increase in demand for 
cholesterol testing technology in the last few years (Marazuela et al., 1997). 
Treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in 
adults was emphasised and considered as the goal of American College of 
Cardiology (ACC) and the American Heart Association (AHA) in 2013 (Stone et al., 
2014). While the new guideline did not introduce any recommendation for or 
against specific LDL-C or non-HDL-C targets for the primary and secondary 
prevention of atherosclerotic cardiovascular disease (ASCVD), primary prevention 
of heart disease by lowering cholesterol levels using statins in individuals with 
diabetes, or without diabetes with LDL-C between 70 to 189 mg/dL and individuals 
over 21 years of age with LDL-C more than 190 mg/dL was recommended (Stone 
et al., 2014).  
Cholesterol (including esterified cholesterol), phospholipids (PLs), and triglycerides 
(TGs) are three major types of lipid present in the plasma. Cholesterol [(3β)-
cholest-5-en-3-ol] is by far the most abundant member of a family of polycyclic 
compounds known as sterols. It occurs in the free form, esterified to long-chain 
fatty acids (cholesterol esters), and in other covalent and non-covalent linkages in 
animal tissues, including the plasma lipoproteins (Christie, 2012). The chemical 
structures of cholesterol and cholesterol ester are shown in Fig.  1.1. 
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Fig. ‎1.1. Chemical structure of (a) cholesterol, and (b) cholesteryl ester. 
Since lipids are not readily soluble in water, only a small amount is present as free 
cholesterol (FC). To allow adequate transport of cholesterol and other lipids, 
lipoproteins form a coat around the lipids in order to suspend them in the plasma. 
The function of the lipoprotein particle is to transport lipids such as cholesterol or 
TGs around the body via the blood stream. Based on the relative densities of these 
species, the four major categories of lipoprotein are chylomicron (CM), very low-
density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density 
lipoprotein (HDL) (Christie, 2012). Lipoproteins have unique physical and chemical 
characteristics, particularly with respect to the types and ratios of lipids and proteins 
present. These characteristics are used to achieve their separation and 
identification. Since lipoproteins vary in size and density, ultracentrifugation 
techniques have been used to separate them from each other (Table  1.1).  
Table ‎1.1. Classification of lipoproteins.a 
Classb 
Density 
(kg/L) 
Diameter 
(nm) 
Protein 
(%) 
FC 
(%) 
Cholesteryl 
ester (%) 
HDL 1.063-1.21 5–15 33 7 40 
LDL 1.019–1.063 18–28 25 11 50 
VLDL 0.95–1.006 30–80 10 7 18 
CM <0.95 100-1000 <2 2 3 
a
This table was adapted from (Christie, 2012; Garrett and Grisham, 1995; Rifai, Warnick 
and Dominiczak, 2001). 
b 
HDL - high density lipoprotein; LDL - low density lipoprotein; VLDL 
- very low density lipoprotein; CM - chylomicron. 
LDL and HDL are the two major lipoproteins found in humans, and are responsible 
for carrying cholesterol in the blood. The lipid core of HDL and LDL contains 
cholesteryl esters and TGs surrounded by PLs and specialized proteins known as 
apolipoproteins (Fig.  1.2). The cholesteryl esters are enriched in linoleate, reflecting 
their biosynthetic origin. Apolipoproteins are a group of proteins which are 
specialized to facilitate several biochemical steps associated with plasma lipid 
metabolism. Lipoproteins have unique physical and chemical characteristics which 
relate to their relative amounts of lipids, protein/lipid ratios and specific protein 
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species present (Table  1.1). Since lipoproteins vary in size and density, 
centrifugation techniques have been used to separate them and distinguish them 
from each other. Apolipoproteins are amphipathic in nature which can interact with 
lipid moieties of lipoproteins and the aqueous environment and are specialized to 
facilitate several biochemical steps associated with plasma lipid metabolism 
(Segrest et al., 2001). Plasma apolipoproteins can be classified as the non-
exchangeable apolipoproteins (e.g., apo B-100) and the exchangeable 
apolipoproteins (eg. apo A-I, apo A-II). 
Exchangeable 
apoprotein
Phospholipid
Free cholesterol
Cholesteryl ester
Core of mainly 
nonpolar lipid
Monolayer of mainly 
amphipathic lipids
Nonexchangeable
Apoprotein
Triacylglycerol  
Fig. ‎1.2. General structure of lipoproteins. Adapted from Griffin (2009).  
LDL particles with a density range between 1.019 and 1.063 kg/L carry 60–70% of 
the total serum cholesterol. LDL is the major atherogenic lipoprotein and has long 
been identified by the National Cholesterol Education Program (NCEP) as the 
primary target of cholesterol lowering therapy. The importance of reducing the risk 
of coronary heart disease (CHD) by lowering LDL-C has been shown by clinical 
trials (Adult Treatment Panel III (ATP III), 2002; Eleni, Bairaktari and Seferiadis, 
2005). However, in recent years, both LDL-C and non-HDL-C (cholesterol 
contained in lipoproteins other than HDL) have been considered as a target for 
preliminary and secondary prevention of ASCVD (Stone et al., 2014; Talwalkar et 
al., 2013). Fig.  1.3 is a schematic of the LDL consensus model summarizing the 
proposed organization of lipids: Hydrophobic core lipid including cholesterol ester 
and TGs, hydrophilic shell of phospholipid and unesterified cholesterol (Segrest et 
al., 2001). 
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Fig. ‎1.3. LDL consensus model. 
Intermediate-density lipoproteins (IDLs) have a hydrated density between LDL and 
VLDL of 1.006-1.019 and have a very similar structure and functionality to LDL. 
LDL, ILDL and VLDL with apolipoprotein B-100 (apo B-100) as their single 
apolipoprotein are classified as non-HDL-C.  
HDL-C is known as the ‘good’ cholesterol, capable of removing cholesterol from 
atherosclerotic plaques and transporting it back to the liver for excretion or re-
utilization. HDL is the smallest lipoprotein, which normally carries 20–30% of the 
total serum cholesterol known as HDL-C. Apo A-I and apo A-II are the two major 
apolipoproteins of HDL. They are both classified as exchangeable amphipathic 
apolipoproteins and are soluble in aqueous solutions. Apo A-I is the main protein 
component of HDL, which is synthesized within the liver (70%) and intestine (30%) 
(Christie, 2012). It has been shown that a 1 mg/dL increase in HDL-C concentration 
decreases the risk of CHD by 2-3% (Chapman et al., 2004). However, recent 
studies have shown that while HDL-C is an important factor in cardiovascular risk, 
the relationship between HDL-C and ASCVD is not yet fully understood. HDL 
consists of two major subclasses known as HDL2 and HDL3. HDL2 – with a hydrated 
density between 1.063 and 1.125 kg/L – is the larger particle and is enriched with 
apolipoprotein E (apo E), while HDL3 – with a hydrated density between 1.125 and 
1.210 kg/L – is the smaller particle and more important in predicting cardiovascular 
disease. The metabolic origin of HDL-C has been discussed by Rye et al. (2012). 
While some studies reported the importance of the measurement of HDL-C 
subfractions as a better option which reflect CHD risk compared to total HDL-C 
(Ashmaig et al., 2013; Ito et al., 2014; Okada et al., 2001), this differentiation has 
not yet been reported for general clinical use. Although HDL-C levels are inversely 
correlated with the risk of CHD, the value of treating low HDL-C is not as well 
established as treating high LDL-C. Most treatment options for lowering high LDL-C 
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levels such as physical exercise, weight loss and even some of the cholesterol 
lowering drugs such as statins, have demonstrated a beneficial effect on HDL-C 
concentration (Adult Treatment Panel III (ATP III), 2002; Warnick, Nauck and Rifai, 
2001). Levels of HDL-C above 60 mg/dL (1.55 mM) are considered to have a 
positive protective role in heart disease, while low HDL-C levels (less than 
40 mg/dL or about 1 mM) are linked to an increase in heart attack risk. For this 
reason, the importance of measurement of HDL-C has been emphasized by NCEP 
since the late 1980s (Bethesda, 1995; Warnick, 1995).  
The measurement of HDL-C is also important for two other purposes (Adult 
Treatment Panel III (ATP III), 2002; Contois, Warnick and Sniderman, 2011; Rifai, 
Warnick and Dominiczak, 2001): 
 The calculation of (low density lipoprotein cholesterol) LDL-C using the 
Friedewald formula: LDL-C = Total cholesterol (TC) - (HDL-C + TG/5) 
 The calculation of non-HDL cholesterol, determined by subtracting the HDL 
cholesterol concentration from the TC content. Non-HDL-C has been 
recommended as a target for preliminary ASCVD prevention.  
1.2 Importance of standardisation of cholesterol measurement  
Since low HDL-C and high LDL-C levels are linked to an increase in heart attack 
risk, the importance of accurate measurement of both HDL-C and LDL-C has been 
emphasized by NCEP (Bethesda, 1995; Caudill et al., 1998; Warnick, 1995). NCEP 
is a program managed by the US National Heart, Lung and Blood Institute which 
established the laboratory standardisation panel on blood cholesterol 
measurement. (Rifai, Warnick and Dominiczak, 2001). The main reason for 
standardisation is to ensure the agreement of reported results across measurement 
systems, laboratories and over time (Warnick et al., 2009). Table  1.2 shows the 
classification of serum TC, LDL-C and HDL-C as summarised in the third report of 
the expert panel on detection, evaluation, and treatment of high blood cholesterol in 
adults (Adult Treatment Panel III, or ATP III) presenting the NCEP’s updated 
recommendations for cholesterol testing and management (ATP III, Adult treatment 
panel III, 2001). 30 mg/dL above the LDL-C treatment target is considered as the 
treatment goal for non-HDL-C. Based on the clinical need to reliably categorise 
patients, NCEP established analytical performance goals for measurement of the 
TC, HDL-C and LDL-C (Table  1.3) (Bachorik, 1995; Warnick, 1995). 
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Table ‎1.2. ATP III Classification of TC, LDL-C and HDL-C. 
Analyte 
Concentration 
Classification 
(mM) 
TC 
5.2 Desirable 
5.2-6.2 Borderline high 
6.2 High 
LDL-C 
2.6 Optimal 
2.6-3.3 
Near or above 
optimal 
3.3-4.1 Borderline high 
4.1-4.9 High 
4.9 Very high 
HDL-C 
1.0 Low 
1.6 High 
 
 
Table ‎1.3. NCEP criteria for TC, HDL-C and LDL-C testing. 
Analyte Inaccuracy Imprecision Total error 
TC  3%RM CV<3% 8.9% 
HDL-C  5%RM 
SD1.7 at (<1.1 mM) 
13% 
CV4.0% at (1.1 mM) 
LDL-C  4%RM CV4% 12% 
 
RM=reference value assigned by CDC reference measurement procedure 
CV= coefficient of variation 
SD= standard deviation  
Reference methods for measuring HDLC and LDL-C are based on separation using 
ultracentrifugation which is not practical to be used in clinical laboratories (Adult 
Treatment Panel III (ATP III), 2002; Nauck, Warnick and Rifai, 2002; Rifai, Warnick 
and Dominiczak, 2001; Warnick, Nauck and Rifai, 2001). This is due to the fact that 
ultracentrifugation methods are very tedious, time consuming and very difficult to 
achieve complete and reproducible recovery.  
The most common approach to determining LDL-C in the clinical laboratory is using 
the Friedewald calculation (Eleni, Bairaktari and Seferiadis, 2005; Friedewald, 
1972). The principle of the Friedewald calculation is as follows:  
1. TC is distributed among the three major lipoprotein classes (HDL, LDL and 
VLDL). 
2. VLDL carries most of the circulating TGs and therefore VLDL-cholesterol (VLDL-
C) can be estimated reasonably well from measured total TGs (TG/5 for mg/L or 
TG/2.2 for mM units).  
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3. LDL-C is then calculated as: LDL-C=TC-1/2.22 TG (mM). 
This is the most commonly used method in the clinical laboratory and in large scale 
studies.  Although the Friedewald method is widely used, the well-known limitation 
of this method (Bairaktari et al., 2001; Tanno et al., 2010; Tighe et al., 2006; Timón-
Zapata, 2011; Turkalp, 2005) increases the interest in improving the accuracy of 
LDL-C estimated by this equation (Rostami, 2011). The US Centres for Disease 
Control and Prevention (CDC) uses a reference method based on the Lipid 
Research Clinic’s (LRC) beta-quantification procedure (BQ) for measuring LDL-C 
(Rifai, Warnick and Dominiczak, 2001; Tremblay et al., 2004). In this method an 
aliquot of plasma is ultracentrifugated at a density 1.006 kg/L for at least 18 h at 
105,000 g to accumulate the VLDL as a floating layer. The amount of LDL-C is then 
calculated by separating the HDL-C from the lower fraction after ultracentrifugation 
(Eleni, Bairaktari and Seferiadis, 2005; Nauck, Warnick and Rifai, 2002; Rifai, 
Warnick and Dominiczak, 2001).  
Accuracy in HDL-C measurement has also been important for the calculation of 
LDL-C using the Friedewald formula and also non-HDL-C. As recommended by 
NCEP, the CDC method is the current secondary reference method for HDL-C 
measurement (Warnick et al., 2009; Warnick, 1995). There are three key steps to 
this method:  
1. Ultracentrifugation at a density of 1.006 kg/L to isolate HDL and LDL from 
other lipoproteins 
2. Selective precipitation of LDL with heparin/MnCl2 
3. Analysis of cholesterol in the HDL (supernatant) using the Abell-Kendall 
assay. Abell-Kendall assay is used as a standard assay for TC 
measurement (Rifai, Warnick and Dominiczak, 2001). 
Since there are only a few laboratories capable of performing the ultracentrifugation 
steps necessary in the CDC method, and due to the high volume (greater than 5.0 
mL) of sample required, the Cholesterol Reference Method Laboratory Network 
(CRMLN) also developed the Designated Comparison Method (DCM) based on a 
modified dextran sulphate procedure (Kimberly et al., 1999). This method uses 50 
kDa dextran sulphate with MnCl2 for the precipitation of non-HDL, followed by 
measurement of the cholesterol in the supernatant by the CDC reference method.  
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1.3 Evolution of methods for the measurement HDL-C and LDL-C 
Other than reference methods based on ultracentrifugation, laboratory based tests 
using electrophoresis, chromatography and spectrophotometry have been 
developed. Due to the differences in the size and charge of various lipoproteins, 
isolation can be also achieved using electrophoretic techniques, with visualization 
achieved using lipophilic dyes (Warnick, Nauck and Rifai, 2001). However, due to 
the fact that the lipophilic dyes are not specific for a class of lipid such as 
cholesterol, TGs or PLs, these techniques cannot be used for quantitative analysis, 
but can be used for qualitative analysis of lipoproteins (Contois, 1999; Nauck, 1995; 
Rifai, Warnick and Dominiczak, 2001). Visual presentation is a distinct advantage 
of the electrophoretic methods, facilitating observation of atypical lipoproteins. For 
the routine clinical laboratory, both ultracentrifugation and electrophoresis have 
disadvantages especially when the workload is high.  
A variety of HPLC methods have been used to separate lipoproteins such as HDL, 
LDL, VLDL and CM, but this has been impeded by the poor stability of the columns 
used for separation. Even improved HPLC techniques which separate serum 
lipoproteins based on their size using two connected columns with subsequent 
determination of cholesterol concentration using an online enzymatic reaction 
cannot be used in the routine clinical laboratory (Nauck, Warnick and Rifai, 2002; 
Okazaki, 1997; Okazaki et al., 2008; Osman and Yap, 2006; Usui, 2000; Usui et al., 
2000; Usui et al., 2000; Warnick, Nauck and Rifai, 2001).  
Many spectrophotometric methods have been developed to measure HDL-C and 
LDL-C due to its widespread adoption and simple methodology. Initially, cholesterol 
was measured using non-enzymatic spectrophotometry in the form of the 
Liebermann-Burchard (L-B) and Killani-Zak assays (Burke, Diamondstone and 
Velapoldi, 1974). The L-B reaction is performed in an acetic acid-sulphuric acid-
acetic anhydride medium based on the fact that cholesterol reacts with various 
strong acids of the Brønsted and Lewis types to yield coloured products. The 
Killani-Zak assay was based on direct treatment of the serum with a reagent 
composed of ferric chloride dissolved in a glacial acetic acid-sulphuric acid mixture 
(Zlatkis, Zak and Boyle, 1953). However, poor specificity, instability of the 
colorimetric reagent, and standardization difficulties were some of the 
disadvantages of this method (Richmond, 1973). The selectivity of 
spectrophotometric methods was improved significantly by using enzymes such as 
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cholesterol esterase (ChEs), cholesterol oxidase (ChOx) and horseradish 
peroxidise (HRP) (Allain et al., 1974). The spectrophotometric measurement of 
esterified cholesterol requires three enzymatic reaction steps, as shown in Fig.  1.4, 
where 4AAP is 4-aminoantipyrine and Trinder’s dye such as phenol is an enhancer. 
As can be seen, cholesterol esters released from lipoproteins (in the presence of 
non-specific surfactants such as Triton X-100) are hydrolysed to non-esterified 
cholesterol (FC) in the presence of ChEs. In the next step, the –OH group of non-
esterified cholesterol produced in the presence of ChOx and oxygen is oxidized to 
a ketone (cholest-4-en-3-one) and H2O2. For a complete reaction with ChEs, each 
molecule of cholesterol ester present in the lipoprotein will yield one molecule of 
cholesterol. The cholesterol will then produce one molecule of H2O2 in the presence 
of cholesterol oxidase and one molecule O2 their concentration being proportional 
to the concentration of cholesterol ester.  
Measuring the amounts of O2 consumed or the H2O2 produced are the preferred 
methods of quantifying cholesterol spectrophotometrically. Due to the consumption 
of oxygen by other substances in clinical samples such as ascorbic acid, any 
method measuring the amount of oxygen consumed in Fig.  1.4 is not accurate 
(Marazuela et al., 1997). Therefore, measuring the amount of H2O2 produced was 
found to be a more accurate method of quantifying blood TC (Allain et al., 1974; 
Salè et al., 1984). In the presence of a reducing compound, HRP catalyses the 
reduction of H2O2 and produces a coloured product which can be measured 
spectrophotometrically. Trinder (1969) developed an assay strategy for H2O2 
measurement employing HRP catalytic oxidation of phenol in the presence of 4-
AAP to form a quinoneimine dye (Fig. 1.4). In the final step, a highly coloured 
quinoneimine is produced in the presence of 4-AAP, a Trinder’s dye such as phenol 
and HRP, the optical density of which can be measured at 500 nm when phenol is 
used as the Trinder’s dye. (Vojinovi´c et al., 2004; Trinder, 1969). 4-AAP is 
accepted as a sensitive reagent for detection of phenols (Emerson, 1943). The 
concentration of cholesterol ester and cholesterol are proportional to the 
concentration of H2O2 formed. 
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Fig. ‎1.4. Spectrophotometric measurement of cholesteryl ester and 
cholesterol using cholesterol esterase (ChEs) and cholesterol oxidase 
(ChOx). The generation of H2O2 is detected using horseradish peroxidase 
(HRP) in the presence of 4-aminoantipyrine (4-APP) and Trinder’s‎ dye‎
(phenol), generating a quinoneimine dye, the optical density of which is 
measured at 500 nm (Allain et al., 1974). 
There are several assay methodologies for measuring cholesterol in specific 
lipoproteins. All of these are based on the colorimetric measurement of the H2O2 
produced after the enzymatic reaction of cholesterol when measured 
spectrophotometrically following the formation of a dye complex. For the selective 
spectrophotometric measurement of HDL-C, two additional aspects of the assay 
need to be employed. Firstly, the enzymes must gain effective access to the 
cholesterol associated with the lipoprotein fraction. Secondly, the enzymes must 
also only gain access to the cholesterol from the specific lipoprotein fraction to be 
measured and be prevented from catalysing cholesterol present in other fractions. 
In the following sections, some of the approaches that have been used for 
measuring HDL-C and adapted by clinical laboratories will be reviewed. 
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1.3.1 Chemical precipitation methods for HDL-C measurement 
In chemical precipitation methods, lipoproteins other than the target, e.g., HDL-C 
are aggregated and rendered insoluble using polyanions in combination with 
divalent cations which can then be sedimented by low-speed centrifugation, while 
HDL remains soluble (Rifai, Warnick and Dominiczak, 2001). The supernatant 
containing HDL-C can then be recovered for cholesterol analysis. The larger and 
lipid-rich lipoprotein such as VLDL and LDL, form insoluble complexes more readily 
than the smaller and protein-rich HDL. The insoluble complexes may either remain 
suspended in the solution or float to the surface in the presence of high 
concentrations of TG-rich lipoproteins. Heparin-Mn2+ has been a popular 
polyanion/divalent ion combination which has been used to assign target values to 
reference materials (Warnick, 1978). Due to some inconsistency in commercial 
heparin properties to be used routinely, other polyanion/divalent ion combination 
such as dextran sulphate-Mg2+ (50 kDa) (Warnick, Benderson and Albers, 1982), 
phosphotungstic acid-Mg2+ (Lopes-Virella, 1977)
 and polyethylene glycol 
(PEG)(Briggs, 1981) have been used as alternatives. 
The actual mechanism of non-HDL-C precipitation in the presence of polyanions 
and divalent cations such as Mg2+ has not yet been fully elucidated.  However, 
based on the fact that that all non-HDLs have one molecule of apo-B100 containing 
a cluster of positively charged residues (Fernández-Higuero et al., 2014), these 
may interact with negatively charged groups on the polyanions such as dextran 
sulphate. Divalent metal cations such as Mg2+ may interact with the negatively 
charged polar phosphate headgroup of phospholipids on the lipoproteins which, in 
combination with polyanions can facilitate formation of insoluble complexes of non-
HDL (Kim and Nishida, 1979; Warnick, Benderson and Albers, 1982).   
1.3.2 Homogeneous methods 
Homogeneous assays were a major step forward in improving the precision of 
earlier precipitation methods. Full automation eliminated manual pipetting, off-line 
pre-treatment, centrifugation and separation steps and improved assay precision, in 
line with recommended NCEP criteria. The development of such assays has been 
an area of intense commercial research and development dominated by several 
Japanese companies including Kyowa Medex, Seikisui Medical (formerly Daiichi 
Pure Chemicals Company), Deneka Seiken Co., Sysmex International Reagents 
(formerly International Reagents Corporation, IRC), Wako Chemicals, UMA and 
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Serotec (Miller et al., 2010). However, the precise mechanisms involved in the 
interaction between the lipoproteins and the assay reagents used in these assays 
remain unclear (Kondo, 1999). In their review, Warnick et al. (2001) described 
some of these homogeneous assay methodologies for HDL-C in detail and 
compared them with conventional assay methods. The authors reported that all five 
methods demonstrated acceptable accuracy, precision and total error by meeting 
the NCEP criteria, making them suitable for clinical application. A brief description 
of the principles of each of the assays is given below. 
IRC was the first to publish a report of a HDL-C fully automatable homogeneous 
assay based on an immunological separation method in 1996. Based on this 
method, CM, VLDL and LDL were first aggregated using a reagent containing PEG 
and then protected with antibodies to apo B and apo C. In the next step, 
unprotected HDL-C underwent enzymatic reaction as described in Fig.  1.4. In the 
final step, guanidine salts were used to stop the enzymatic reaction and clear the 
reaction mixture. The final absorbance was measured at 600 and 700 nm (Rifai, 
Warnick and Dominiczak, 2001; Warnick, Nauck and Rifai, 2001). In spite of the 
fact that this assay showed reasonable precision, accuracy and specificity, the 
addition of four different reagents limited its application to a small number of 
automated analyzers (Kakuyama, Kimura and Hasiguchi, 1994). 
In 1995, Kyowa Medex reported a homogeneous assay for HDL-C which its 
selectivity was based on a combination of PEG-modified enzymes with α-
cyclodextrin sulphate in the presence of a small amount of dextran sulphate with no 
need for precipitation of lipoprotein aggregates. PEG-modified ChEs and ChOx 
showed selective catalytic activity towards lipoprotein fractions. The reactivity 
increased in the order LDL < VLDL ≈ CM < HDL (Sugiuchi et al., 1995). Although 
the mechanism for the selectivity of the modified enzymes towards the lipoprotein 
fractions is not clear, it is suggested that the modified enzymes may be able to 
recognize differences in hydrated density, net charge, or size of the various 
lipoprotein fractions. Size-exclusion chromatography revealed that PEG-modified 
ChEs breaks up the lipoprotein particles more effectively than the native enzyme, 
probably because of the amphiphilic properties of the attached PEG molecules 
(Sugiuchi et al., 1995). Therefore, HDL should be more susceptible to the modified 
enzyme than non-HDL-C, explaining the observed differences in reactivities of 
cholesterol moieties of the lipoprotein fractions. H2O2 generated from the enzymatic 
reaction is then measured spectrophotometrically (Arranz-Peña, 1998; Sugiuchi et 
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al., 1995; Warnick, Nauck and Rifai, 2001). This method was evaluated in several 
studies including comparison with RM and DCM methods, which showed 
correlations of 0.993 and 0.996, respectively. The dynamic range reported for this 
method was 30 to 150 mg/L (Warnick, Nauck and Rifai, 2001). 
Daiichi developed a homogeneous assay for HDL-C which employed a synthetic 
polymer together with a polyanion to block the non-HDL lipoproteins. Cholesterol in 
HDL was then exposed to the enzymes in the presence of a selective detergent 
which gives specificity for HDL-C. Kondo et al. (1999) visualized the formation of 
HDL-polymer complexes after the addition of polymer and polyanionin (the first 
reaction) using electron microscopy. This showed that this complex breaks down in 
the presence of a detergent in the second reaction. It also showed that the 
polyanion in reagent 1 (phosphotungstate) caused the aggregation of almost all 
lipoprotein. However, the exact roles of the polyanion and synthetic polymer remain 
unknown (Kondo, 1999). The detection limit of the method was 0.1–0.1 mM with 
linearity to at least 5.2 mM (Harris et al., 1997; Kondo, 1999; Lin, 1998; Naucka, 
März and Wieland, 1998). Commercial reagent sets included two reagent additions; 
the first with the polyanion and polymer blocking agents and the second with 
detergent and enzymes. A disposable assay strip for measuring HDL-C was also 
reported by Daiichi group consisting of a reagent layer which formed on a support 
made of polyethylene terephthalate (PET). The reagent layer included the sample 
supply layer containing ChOx and ChEs and specific surfactants and the detecting 
layer was contained of colorimetric reagent. A polyoxyethylene alylene tribenzyl 
phenyl ether (Emulgen B-66) that increases the solubility of the HDL-C fraction over 
other lipoproteins is contained in the lower sample supply layer and a 
polyoxyethylene-polyoxypropylene condensation product (Pluronic F-88) that 
inhibits the non-HDL from dissolving was contained in upper sample supply layer. 
The correlation coefficient between the measured value obtained by the test piece 
and that obtained by direct Daiichi method and the aggregation method were 0.962 
and 0.974, respectively (Tamura et al., 2009).  
Fig.  1.5 illustrates a generalised approach to the selective detection of HDL-C in 
the presence of other lipoproteins using the homogeneous principle based on  a 
blocking reagent which selectively prevents access of a HDL-C selective surfactant 
to the non-HDL lipoproteins. Addition of the surfactant selectively solubilises the 
HDL, allowing access to ChEs and ChOx. The generated H2O2 can then be 
measured in the conventional manner as described in Fig.  1.4. 
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Fig. ‎1.5. Generalised homogeneous assay methodology for the selective 
determination of HDL-C. A blocking reagent selectively prevents access of a 
specific surfactant to the non-HDL lipoproteins. Addition of the surfactant 
selectively solubilises the HDL, allowing access to ChEs and ChOx. The 
generated H2O2 can then be measured in the conventional manner. 
According to the homogeneous method for LDL-C, lipoproteins other than LDL 
such as VLDL, HDL and CM are removed in the first step using the first reagent 
described by each method. In the second stage, LDL-cholesterol undergoes an 
enzymatic reaction to produce H2O2which is measured colorimetrically (Bairaktari et 
al., 2001; Nauck, Warnick and Rifai, 2002). Although the mechanism that confers 
selectivity to LDL-C from a specific surfactant is also not well understood, the same 
general mechanism is thought to apply as for HDL-C in that the surfactant may be 
able to distinguish differences in hydrated density, net charge, or size of the various 
lipoprotein fractions (Pembouong et al., 2011; Sugiuchi, 1998). Several authors 
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have reviewed homogeneous assay methodologies for LDL-C measurement and 
compared them with conventional assay methods (Bayer et al., 2005).  
A comparison of homogeneous assay kits for the measurement of HDL-C clinical 
samples showed a maximum coefficient of variation (CV) of 14.5% for 990 heath 
check-up samples with almost all of the assay kits except Serotec partially reacting 
with apo E-rich HDL (Iizuka et al., 2012). The CV of 26.9% was observed for LDL-C 
measurement using different LDL-C assay kit with IDL ratio and high serum 
bilirubin levels affecting the final value using all the kits. The study was performed 
by dividing the patients samples into 6 groups based according to their lipid profile 
and bilirubin levels. However a good correlation was observed between LDL-C 
measured using Sekisui assay kit and that calculated using Friedewald equation 
showing some differences for LDL-C value in the presence of different 
concentrations of TG (Iizuka et al., 2012). 
1.4 Enzyme kinetics 
In an enzyme-catalyzed reaction, the enzyme binds to the substrate to form an 
enzyme-substrate complex transition-state species, which leads to the formation of 
a product. Michaelis and Menten introduced a useful model for the kinetics of 
enzyme-catalyzed reactions in 1913 based on a typical reaction of the conversion 
of a single substrate to a product. As can be seen in  Fig.  1.6A, for the 
measurement of reaction rates, at different substrate concentrations, the initial rate 
of the reaction is measured. At lower substrate concentrations, the reaction is first 
order and the rate of the enzymatic reaction is dependent on substrate 
concentration. At higher substrate concentrations, the rate of the enzymatic 
reaction reaches a maximum value called Vmax. At Vmax, enzymes are completely 
saturated with substrate. The substrate concentration at one-half of its Vmax is used 
as a measure of the enzyme’s affinity for the substrate and is known as the 
Michaelis-Menten constant (KM). A small Km is indicative of a higher affinity.  
Enzymes with multiple substrates such as ChEs and ChOx have more complex 
kinetic properties and can also vary according to their source (Polleqioni, et al,. 
1999; Srisawasdi, Prasertsincharoen and Kroll, 2012). However, these can often be 
approximated by Michaelis-Menten kinetics. 
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Fig. ‎1.6. Kinetics of enzyme-catalysed reactions with respect to substrate 
concentration, A: Relationship between initial reaction rate and substrate 
concentration.  B: Relationship between reaction velocity and substrate 
concentration. (Adapted from Campbell and Farrell, 2006).  
The assay in this study contains the enzymes ChEs and ChOx which are coupled 
together to produce H2O2. Assays using more than one enzyme show unusual 
features such as having a very long lag phase which may affect the next step of the 
enzymatic reaction. Depending on the activity of the enzymes (ChEs and ChOx) 
and the lag phase of the coupled enzymatic reaction, the rate of H2O2 production 
may vary but not exceed the rate of production of esterified cholesterol. Looking at 
the first and second steps, this shows that cholesterol ester in the presence of 
ChEs produces non-esterified cholesterol. Non-esterified cholesterol then, in the 
presence of the second enzyme ChOx produces H2O2. In this coupled assay, the 
concentration of non-esterified cholesterol depends on its rate of formation by ChEs 
and rate of removal by ChOx. If the concentration of cholesterol ester is greater 
than its KM for ChEs, the first reaction may approach zero order. The concentration 
of cholesterol ester reduces overtime and the concentration of non-esterified 
cholesterol increases to reach a steady-state concentration which is high enough 
that the rate of ChOx becomes almost equal to the rate of ChEs. The rate at which 
non-esterified cholesterol reaches its steady-state concentration very much 
depends on the KM for ChOx and the concentration of ChOx present. The time 
during which the non-esterified cholesterol is building up results in a lag phase in 
the enzymatic reaction. In this work, it took about a minute until final product forms, 
which is directly dependent on the time taken for the intermediate product – which 
is a substrate for the second reaction – to build up. This is the phenomenon of the 
lag phase which will affect the rate of the formation of the final product, H2O2. It is 
important to optimise the conditions in a way so as to minimise this lag phase. All 
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the absorbance measurements to quantify substrate concentrations should be 
performed during the steady state phase (Copeland, 2000, Tipton, 1992). 
1.5 Non-HDL-C or LDL-C 
The term ‘non-HDL-C’ is used for cholesterol associated with apo-B-containing 
lipoproteins which is reported as an alternative for CVD risk score. It has been 
found that for the majority of patients with TG less than 200 mg/dL it is better to 
employ a calculation method for LDL-C measurement rather than the 
homogeneous method (Deventer et al., 2011; Liu et al., 2006). It has also been 
shown that VLDL which is enriched with cholesterol could be the main source of the 
bias observed with many homogeneous LDL-C assay kits (Bayer et al., 2005). A 
comparison between homogeneous LDL-C, calculated LDL-C and non-HDL-C as a 
coronary vascular disease (CVD) risk factor was performed by Deventer et al., 
(2011) showing in general better correlation of non-HDL-C as CVD risk predictor for 
patients with TG between 200 and 400 mg/dL when compared to the CDC 
reference method, while homogeneous LDL-C showed a better correlation when 
compared to Friedewald calculation. Compared to the Friedewald calculation, the 
non-HDL-C result is free from errors related to VLDL estimation as well as errors 
related to LDL-C specificity (Deventer et al., 2011). In addition, non-HDL-C is 
calculated from TC - which is normally very precise - and HDL-C measurement, 
introducing no extra expense and is also capable of assessing risk in patients with 
elevated TG. Only bias related to HDL-C measurement may impact the clinical 
accuracy of non-HDL-C (Contois, Warnick and Sniderman, 2011). Compared to 
LDL-C, non-HDL-C was shown to be a better risk factor for ischaemic stroke 
among the Chinese population (Wu et al., 2013). Even among statin-treated 
patients, association between CVD and non-HDL-C was found to be greater than 
LDL-C and apoB (Boekholdt et al., 2012). Non-HDL-C (apoB) or the TC to HDL-C 
ratio has also found to be stronger ASCVD risk predictors than LDL-C for men with 
type 2 diabetes (Pischon et al., 2013). However, apoB was shown to be a better 
risk predictor for CHD in men than the cholesterol carried by lipoproteins containing 
apoB proteins (Pischon et al., 2013).  
1.6 Point of care testing for HDL-C and TC 
In order to remove sample transport requirements, reduce processing and assay 
times and facilitate near patient testing, point of care devices that measure HDL-C 
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and LDL-C directly are very attractive in biomedical diagnostics. In general, point of 
care testing needs relatively small volumes of whole blood directly from a 
fingerstick and test results are available soon after sampling, which is highly 
advantageous in self-management of hypercholesterolaemia. There is no 
requirement for transportation of samples to a central laboratory which helps to 
reduce result turnaround time and transport costs. Earlier diagnosis and disease 
management as well as potential for improving patient satisfaction and cost-
effectiveness are some other advantages offered by POCT (Gubala et al., 2012; 
Lee et al., 2011).  
A number of both professional use and consumer point of care devices for 
measurement of cholesterol are commercially available. The CardioCheck PA and 
Cholestech LDX are two systems that support the UK NHS health check vascular 
risk assessment. Cardiocheck PA is based on a spectrophotometric method and 
the measurement of the light reflected off a disposable test strip that has changed 
colour after applying blood sample. The analyzer converts this reading into an HDL 
result and displays it (Méndez-González, Bonet-Marqués and Ordóñez-Llanos, 
2010; Panz et al., 2005). The Cholestech LDX system combines the enzymatic 
methodology with ‘solid-phase’ technology to measure the quantity of TC, HDL-C, 
TGs, glucose, and others in the blood (capillary or venous), serum or plasma. The 
sample is applied to a Cholestech LDX cassette. The cassette is then placed into 
the Cholestech LDX analyzer that can measure the resultant colour by reflectance 
photometry (The Medical Services Advisory Committee (MSAC), 2001). The LDX 
uses the Friedewald equation to calculate LDL-C while the Cardiocheck PA 
measures LDL-C directly. A comparison between Cholestech LDX POC and 
hospital reference laboratory validates the use of the Cholestech LDX analyser for 
point of care lipid measurements in clinical practice under the use of a well-trained 
operator (Carey et al., 2006). A comparison between the performance of these two 
point-of-care analyzers and clinical diagnostic laboratory methods for the 
measurement of TC, HDL-C and LDL-C has been reported (Dale, Jensen and 
Krantz, 2008; Panz et al., 2005). Both of them were found to have acceptable 
performance, which offers healthcare professionals a rapid POC method for the 
measurement of cholesterol in specific lipoproteins. Moreover, determination of the 
accuracy and precision of TC, TG and HDL cholesterol measures by a nurse on 
capillary blood using the Cardiochek system suggested that this approach was 
appropriate for predicting CHD risk and provided reliable fractionated lipid 
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information which was consistent with traditional clinical chemistry platforms (Patel 
et al., 2011).  
1.7 Biosensors 
The evolution of point of care tests from central laboratory testing towards low cost, 
consumer diagnostics based on biosensors has been exemplified by the 
development of glucose biosensors (Turner, 2013). The progression from optical to 
electrochemical measurement methods is a natural evolution for many diagnostic 
devices as they progress from laboratory tests typically based on 
spectrophotometry, to electrochemical devices which allow lower cost 
instrumentation and system simplification. Cholesterol testing is also going through 
this evolution (Belluzo, Ribone and Lagier, 2008; Kimmel et al., 2012). Biosensors 
not only could revolutionise point-of-care testing but have also been successfully 
used in the food industry, environmental monitoring and pharmaceutical industries 
through their ability to convert complex bioanalytical measurements into simple and 
easy to perform techniques.  
A biosensor is an integrated analytical device consisting of a bio-receptor which is a 
biomolecule capable of recognizing the target analyte and a transducer which 
converts a biological response into a measurable signal enabling the measurement 
of target analyte without using any reagent. Therefore, the selection of 
biomolecules, immobilisation matrix, immobilisation method and transducer are 
important steps in the fabrication of a biosensor. For electrochemical detection, 
electrodes such as platinum, gold, carbon based materials such as graphite; 
carbon black and carbon fiber are suitable (Arya, Datta and Malhotra, 2008). For 
the purpose of this work, ChOx and ChEs are normally employed as the bio-
receptors capable of recognizing esterified and non-esterified cholesterols. 
There is a wide variety of deposition and immobilisation techniques as well as 
transducers that have been applied to the development of cholesterol biosensors 
(Arya, et al., 2008). The following section is a general review of the techniques 
most relevant to the current work.    
1.7.1 Immobilisation techniques 
There is no general method available which is capable of being applied to the 
immobilisation of all enzymes. However, the most commonly used immobilisation 
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techniques could be classified into five categories (Hanefeld et al., 2008): non-
covalent adsorption and deposition, immobilisation using ionic interactions, 
covalent attachment, cross-linking of an enzymes and finally entrapment in a 
polymeric gel or capsule. In general, enzymes can be attached to a support using 
reversible techniques such as physical adsorption and ionic linkages or using 
irreversible techniques such as covalent bonds (Brena and Batista-Viera, 2006). 
Covalent bonding is normally strong and formed between functional groups present 
on the enzymes surface and reactive groups present on the solid support, while 
physical bonds such as hydrophobic interactions, van der Waals binding or ionic 
interactions are generally not very strong and enzymes may leach readily from the 
carrier (Cantone et al., 2013).   
Although covalent binding of enzymes to the carrier has the advantage of the 
enzyme being attached to the carrier tightly, non-covalent binding was chosen as 
the method employed in this work. Depending on the deposition technique used, an 
aqueous solution of enzyme is deposited on a solid support, followed by 
evaporation of the aqueous phase. This typically requires an optimised enzyme 
formulation to improve the rate of re-solubilisation as well as enzyme activity 
following deposition. Immobilisation via ionic interactions is based on the fact that 
enzymes may possess a net positive or negative charge depending on their 
isoelectric point and the pH of the solution. For the purpose of ionic interaction, 
based on the predominant charge on the enzyme, an oppositely charged ion 
exchanger may be introduced.  
The properties of enzymes such as size, conformational flexibility, isoelectric point, 
surface functional groups/charge density, stability under immobilisation conditions 
and hydrophilic or hydrophobic regions are important factors when choosing an 
immobilisation technique. Factors relating to the reaction system itself such as 
diffusion limitations, enzyme inhibition, viscosity of the mixture, etc., are also 
important parameters which should be taken into account when considering an 
immobilisation technique. 
Despite the many enzyme immobilisation techniques described in the patent and 
research literature, only a few techniques have been found to be suitable for mass 
production and commercialisation (DiCosimo et al., 2013).   
Printing technologies such as screen printing and inkjet printing have been found to 
be amenable towards industrial scale-up of biosensors. Screen printing was first 
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used in the 1980’s for the production of enzyme electrodes and currently half of the 
disposable glucose electrodes are screen printed using curable polymer inks 
(Turner, 2013). While screen printing is capable of forming a biosensor with thick 
films, inkjet printing is capable of using very small quantities of enzyme reagents 
required for the fabrication of disposable biosensors with minimum waste and high 
reproducibility which lends itself well attractive in mass production of disposable 
biosensors (Delaney, Smith and Schubert, 2009). Drop-on-demand which is based 
on producing droplets when required, and continuous inkjet in which droplets are 
formed from a continuous stream to the substrate when needed, are two types of 
inkjet printing techniques. Droplets can be generated using piezoelectric, thermal 
and electrostatic techniques (Hutchings and Martin, 2013). Among them, drop-on-
demand techniques capable of deposition of pico-litre to nano-litre size reagent 
containing proteins precisely to a designated sensor area with minimum waste 
were found to be more suitable for fabrication of disposable biosensors and point of 
care diagnostic products (Delaney, Smith and Schubert, 2009).  
1.7.2 Transducer 
The final essential component of the biosensor configuration is the transducer 
which is the component of the biosensor capable of converting the biochemical 
response into a measurable electrical signal. Electrochemical and optical are the 
two major modes of transduction which have been mostly applied to cholesterol 
biosensor fabrication. Electrochemical sensors are devices that provide information 
about a sample from the measurement of some electrochemical parameter such as 
potential, current or resistance (Grieshaber, MacKenzie and Reimhul, 2008; 
Kimmel et al., 2012; Wang et al., 2008). Therefore, different groups of 
electrochemical sensors such as potentiometric, voltammetric, conductometric etc. 
have been developed. Among these, voltammetric sensors are arguably the most 
common, especially in research laboratories. Voltammetric sensors are based on 
the measurement of current response as a function of applied potential.  A special 
case of voltammetric sensor is the amperometric sensor where a fixed potential is 
applied and the current response is measured. The current response is directly 
proportional to the number of electrons transferred, and therefore, to the 
concentration of the electroactive species (Brett and Brett, 1998): 
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                (1) 
where O (oxidised spices) receives n electrons in order to transform into R 
(reduced species). When certain chemical species are oxidized or reduced (redox 
reactions) at inert metal electrodes, electrons are transferred between the 
electroactive species and the working electrode. The direction is based on the 
properties of the electroactive species and can be controlled by applying a constant 
potential to the working electrode (Brett and Brett, 1998; Kissinger and Heineman, 
1996). The relationship between the moles, N, of electroactive species reacted 
(either oxidised or reduced) and charge passed through the sensor, Q, is known as 
Faraday’s law: 
                    (2) 
where F is the Faraday constant. The application of a defined potential and 
measurement of the transfer of current is normally measured in an electrochemical 
cell connected to a potentiostat. Electrochemical cells composed of either two or 
three electrodes are necessary. These consist of a reference electrode, a working 
electrode and a counter electrode or combined reference and counter electrode.  
The working electrode is typically constructed from an inert conductor such as a 
precious metal (Pt, Au) or carbon. A reference electrode such as Ag/AgCl, provides 
a fixed potential against which the potential applied to the working electrode is 
measured and controlled. A third electrode, the counter (or auxiliary) electrode is 
employed to allow current to flow between the working and auxiliary electrodes 
while the potential is measured between the working and reference electrodes 
(Brett and Brett, 1998; Wang et al., 2008). 
Cyclic voltammetry (CV) and chronoamperometry are two common 
electroanalytical techniques used to measure electron transfer processes. CV is 
useful to obtain information about the redox potential and electrochemical kinetics 
of these processes. Fig.  1.7 (left) illustrates a potential waveform (plot of potential 
vs. time) and Fig.  1.7 (right) depicts a typical CV (plot of the current vs. potential) 
for a fully reversible one electron transfer reaction.  
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Fig. ‎1.7: Potential waveform (left) and Cyclic voltammogram (right) for a 
reversible one electron transfer process. 
 
As can be seen, the voltage is swept between two values (V1 to V2) at a fixed rate. 
When the voltage reaches V2 the scan is reversed and the voltage is swept back to 
V1. According to Fig.  1.7 (right), by scanning the potential negatively, the reduction 
occurs from V1 (the initial potential) to V2 which is the point the potential switches. 
The resulting current is called the cathodic current (ic). The peak of which (Ip,
c) 
occurs at the peak cathodic potential, Ep
c. Initially, only non-Faradic currents flow 
for potentials <V2, until the potential approaches Ep
c. As Ep
c is approached, the 
surface concentration of substrate decreases, while the flux to the surface and 
therefore the current increases. When the potential passes Ep
c, the surface 
concentration becomes zero and mass transfer of substrate to the surface reaches 
its maximum rate. Current then decreases due to mass transport limitation (Bard 
and Faulkner, 2001). Theoretical analysis of the CV leads to the Randles-Sevcik 
equation for the peak current in linear sweep voltammetry:  
 
      (3) 
where the ip is peak current (in A), n  is the number of electrons, A is the area of the 
electrode (in cm2), R is the concentration (in mM), D is the diffusion coefficient (in 
cm2s-1) and v is the scan rate (in Vs-1). The peak separation between the two 
potentials for a reversible system and the number of electrons involved in the 
reaction is governed by the Nernst equation: 
 Δ                (4) 
 where Epa and Epc are the maximum anodic and cathodic potentials, respectively 
and n is the number of electrons transferred. According to the Nernst equation, a 
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fast one electron process has ΔEp of 59 mV and the peak potentials are 
independent of the scan rate. 
As with glucose, cholesterol lends itself effectively to electrochemical measurement 
as many of the transduction principles employed are transferrable, such as the use 
of electron transfer mediators or H2O2 to measure the oxidation of cholesterol 
(Aravind et al., 2011; Dey and Raj, 2014; Fang, 2011; Fang, 2011; Huang, Juan 
and Guilabult, 1977; I. Karube, Hara and Mastsuoka, 1982; Kumar, Pandey and 
Brantley, 2006; Manjunatha et al., 2012; Pundir, 2008; Ruecha et al., 2014; Shih, 
Yang and Lin, 2009; Shin and Kameoka, 2012; Shin and Kameoka, 2012; Yang, 
Shen-Ming Chen and Lin, 2011; Yang, Shen-Ming Chen and Lin, 2011; Özer et al., 
2007). However, despite the growing importance of the selective determination of 
HDL-C for monitoring and managing hypercholesterolaemia, coupled with the 
suitability of electrochemical assay methodologies to translate well to cholesterol 
testing, there are only a few reports of the measurement of H2O2 generated from 
the enzymatic reaction of HDL-C using electrochemical methods (Kinoshita et al., 
1998; Murphy et al., 2009). 
1.8 Electrochemical determination of H2O2  
H2O2 has been widely studied and is readily amenable to measurement using 
electrochemical methods. As already discussed, there are several optical assay 
methodologies for measuring cholesterol, and more specifically HDL-C. All of these 
methods determine the amount of H2O2 produced after the enzymatic reaction of 
cholesterol when measured spectrophotometrically following the formation of a dye 
complex. Given that electrochemical techniques lend themselves very well to the 
fabrication of low cost point of care and disposable diagnostic devices, it would 
seem a common sense approach to develop electrochemical biosensor 
methodologies that are capable of measuring cholesterol using a similar principle, 
with the measurement of H2O2 performed electrochemically. Most of the H2O2 
sensing used as a platform for development of electrochemical biosensors for total 
cholesterol were fabricated by ChEs, ChOx and HRP immobilized onto various 
membrane or matrix containing a redox mediator such as biosensors based on 
peroxidase oxidation of potassium ferrocyanide by H2O2 (Foster, Cassidy and 
O'Donoghue, 2000), HRP-hydroxymethyl ferrocene (HMF)-carbon paste electrode  
(hydroxymethyl ferrocene as mediator) (Charpentier and El Murr, 1995), Chox, 
ChEs, HRP and potassium ferrocyanide immobilized on the screen-printed carbon 
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electrodes (Li et al., 2005), Chox, ChEs, HRP co-immobilised on 3-aminopropyl-
modified controlled-pore glass (APCEG)/rotating disk using a soluble-redox 
mediator of 4-tert-butylcatechol (Salinas et al., 2006). Fang, et al., (2011) reported 
a disposable screen printed TC biosensor using ink formula containing ChEs and 
cholesterol dehydrogenase as enzymes, a nicotinamide adenine dinucleotide 
(NAD) as the coenzyme, and a 1,10-phenanthroline-5,6-dione (PD) as the electron 
mediator.  However, some enzyme-less H2O2 sensors capable of direct oxidation or 
reduction of H2O2 were fabricated which were employed as a platform for 
cholesterol measurement. Multiwall carbon nanotubes (MWCNTs) (Yang, Shen-
Ming Chen and Lin, 2011), reduced graphene oxide–dendritic Pd nanoparticle 
(rGO–nPd) hybrid material (Dey and Raj, 2014), a gold (Au) electrode modified with 
MWCNTs uniformly dispersed in nafion matrix (Urmila et al., 2011), graphene, 
polyvinylpyrrolidone (PVP) and polyaniline (PANI)-modified electrodes with a 3-fold 
increase in the current signal compared to an unmodified electrode exhibiting 
electrocatalytic activity towards the oxidation of H2O2 (Ruecha et al., 2014) are 
some of the examples of the non-enzymatic electrochemical determination of H2O2. 
Due to the biocompatibility of nanoparticles, their ability to provide a large surface 
area and their excellent conductivities, nanoparticles were employed to improve the 
sensitivity of H2O2 sensors (Lian et al., 2009). Lian, et al., (2009) reported a silver 
electrode which was roughened by electrochemical oxidation-reduction cycle in a 
KCl solution with an excellent electrocatalytic activity for the reduction of H2O2. 
Later on, in 2011, a fully printed electrocatalyst for H2O2 reduction using a screen-
printed silver electrode as a platform was introduced by Killard and coworkers 
(2012). Screen printed silver paste electrodes dip-coated in solution containing 
3.310-2 M dodecylbenzenesulfonic acid (DBSA) in 0.1 M KCl (DBSA/KCl) solution 
showed an 80-fold enhancement in electrocatalytic reduction of H2O2 at -0.1V vs 
Ag/AgCl compared to un-modified silver electrodes. This increase in catalysis was 
reported to be due to the fact that surfactant at lower concentration may form a 
spheroidal micelles aggregate in aqueous solutions which can convert to lamellar 
structures on the surface of the electrode. The presence of chloride salt such as 
NaCl was also found to be important in catalysis as the modification was significant 
above certain concentrations of salt. This aggregation may have occurred due to 
hydrophobic interactions between the long hydrocarbon chains which is not a 
favour interaction with water and the hydrophilic head group with a favour 
interaction with water (Gonzalez-Macia, Smyth and Killard, 2011). The 
electrocatalytic layer was also inkjet printed (Gonzalez-Macia, Smyth and Killard, 
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2012b) and used as a platform for glucose sensing (Gonzalez-Macia, Smyth and 
Killard, 2012a). The following is a possible electrocatalytic mechanism for H2O2 
reduction at a silver electrode as reported by Honda et al., (1983 & 1986) and 
adapted by Welch et al (2005): 
               (5) 
              (6) 
              (7) 
Since Eq. (5) is the rate-determining step, it is believed that lamellar structures 
formed in the presence of the surfactant/salt may stabilize OHads which favours this 
reaction. 
1.9 Conclusion  
While near patient testing and point of care testing are becoming very important, a 
major challenge continues to be the development of sensitive and accurate 
methods capable of performing rapid analysis by untrained users. Biosensors 
based on electrochemical techniques are ideally suited to this due to their high 
sensitivity and selectivity, rapid response time and low-cost (Grieshaber, 
MacKenzie and Reimhul, 2008; Kimmel et al., 2012; Wang et al., 2008).  
These days, the movement of many routine blood tests away from the central 
laboratory, to the point-of-care is a major trend in healthcare provision. This is also 
the case for cholesterol. Moving away from free cholesterol testing and focusing on 
measuring HDL-C, non-HDL-C and HDL-C/TC ratios as major risk factors for heart 
disease has been recommended by the NCEP. Homogeneous methods which can 
be fully automated are found to be a good answer to the need of clinical 
laboratories to cope with increasing workload. Using biosensors and point of care 
devices could be even more effective for the monitoring patient health. Given the 
effective development of homogeneous methodologies based on 
spectrophotometric measurement, it seems inevitable that such methodologies will 
soon migrate onto electrochemical biosensor platforms suitable for consumer use. 
Electrochemical sensors based on the electrocatalysis of H2O2 are particularly 
suited to the development of cholesterol biosensors. 
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Screen printing and, more recently inkjet-printing have been applied to the 
fabrication of sensors and biosensors. Combining the benefits of both techniques 
for the fabrication of distinct components of the biosensor which are most suited to 
the particular printing method may provide a viable means of low cost, high 
throughput mass production of such sensors. 
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1.10 Aims and objectives 
The purpose of this research was to develop low cost electrochemical biosensors 
for the direct, selective measurement of HDL-C and TC using screen printed silver 
electrodes with enhanced electrocatalytic reduction of H2O2 at a silver paste 
electrode. This was achieved through the following objectives: 
 Development of single step assay methodologies for the selective 
measurement of HDL-C and TC using the homogeneous enzyme assay 
principle (Chapter 3): A room temperature spectrophotometric assay with 
minimum sample dilution factor based on an assay methodology using a 
HDL-C or TC selective surfactants designed to assist the development and 
optimization of the assay properties required for the development of the 
HDL-C and TC biosensors (e.g., buffers, surfactants, enzymes, 
concentrations and incubation times) 
 Adaptation of the assay reagent formulation to the screen printed 
silver paste H2O2 electrocatalyst (Chapter 4): Investigation of the effects 
of assay reagents such as buffer, surfactant, samples, delipidated serum 
and enzymes on electrochemical behaviour of H2O2 at DBSA/KCl modified 
SPEs and establishment of an optimised HDL-C assay formulation to 
measure H2O2 in delipidated serum. 
 Evaluate the ability of the sensors to measure cholesterol in clinical 
samples (Chapter 5): Development of HDL-C and TC biosensors by 
employing external addition of assay reagents using the DBSA/KCl modified 
electrodes and also exploring the potential for using surfactant/salt 
combinations used in HDL-C and TC assays. 
 Integrate the assay reagent formulation into the sensor using inkjet 
printing (Chapter 6): Formulation and analytical characterisation of an 
assay reagent ink suitable for inkjet-printing designed to improve sensor 
stability, limit of detection, analytical range and reproducibility of the assay.  
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2.1 Materials 
Dodecylbenzenesulphonic acid (DBSA-D0989) was purchased from TCI Europe. 
Polyoxyethylene octyl phenyl ether (Triton X-100), sodium chloride (KCl), 
potassium chloride (KCl), potassium dihydrogen phosphate (KH2PO4), disodium 
hydrogen phosphate (Na2HPO), N,N-dimethyl-m-toluidine, 3-(N-morpholino) 
propanesulfonic acid (MOPS), Tris-HCl, NaOH, MgCl2, 
Poly(diallyldimethylammonium chloride) solution (PDA) 20% (w/v) in H2O were 
purchased from Sigma-Aldrich (UK). 4-Aminoantipyrine HCl was from BDH (Dorset, 
UK).  Cholesterol oxidase (ChOx, CO5F; 19.4 U/mg), Cholesterol esterase (ChEs, 
CE4F; 130.5 U/mg) and Horseradish peroxidise (HRP, HRP4C; 295 U/mg) were 
purchased from BBI Enzymes (Gwent, UK). LDL-C (P232-8), HDL-C (P233-8) 
isolated from human serum and delipidated serum (S139) all from human plasma 
were purchased from Scipac Ltd (Kent, UK). Clinical serum samples were kindly 
donated by Alere (San Diego). 
Other materials were obtained as follows: 30% (v/v) hydrogen peroxide solution 
(Merck, UK), Polyoxyethylene derivatives (Emulgen B-66, Kao Corporation (Japan), 
HDL and LDL/VLDL cholesterol assay kit (Abcam, UK). Silver (PF-410), carbon 
(Electrodag 6017SS), and Ag/AgCl (Electrodag 6038SS) screen printing inks were 
from Henkel (Netherlands). 16 nozzles print cartridge (Fujifilm, USA), Costar 96-
Well microplates (VWR, UK), Pluronic F-68 (POE-POP) (Sigma, UK) and 
Polyvinylpyrrolidone K30 (PVP) from Fluka. Poly (ethylene) terephthalate (PET) 
substrates (film type: SU320/175 mic) obtained from HiFi Industrial Film Ltd. 
(Stevenage/UK)) and 25 µm polyester pressure sensitive adhesive (PSA) spacer 
layer and hydrophilic cyclic polyolefin (Zeonor) lid. 
2.2 Buffers and solutions 
2.2.1 Phosphate buffered saline solution (PBS) 
Unless otherwise stated, all electrochemical measurements were carried out in 
phosphate buffered saline solution (PBS) which contained 0.1 M phosphate, 137 
mM NaCl and 2.7 mM KCl. This was prepared by mixing solution containing 0.1 M 
Na2HPO4, 137 mM NaCl and 2.7 mM KCl with a solution containing 0.1 M KH2PO4, 
137 mM NaCl and 2.7 mM KCl to a pH of 6.8.  
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2.2.2 MOPS buffer  
50 mM MOPS was prepared in deionised water and pH adjusted to 7.3 using 1 M 
NaOH.    
2.2.3 Tris-HCl buffer  
0.1 M Tris-HCl was prepared in dionised water and pH was adjusted with 1 M HCl. 
2.2.4 DBSA/KCl modification solution 
A solution of 33 mM DBSA/0.1 M KCl was prepared by mixing 2.35 mL water, 1.25 
mL 0.1 M DBSA and 0.15 mL 2.5 mM KCl (Gonzalez-Macia, Smyth and Killard, 
2012). 
2.2.6 Cholesteryl acetate stock solution  
Cholesteryl acetate (50 mg) was dissolved on 1.0 mL of Triton X-100 by slowly 
heating and stirring until solution was clear. 0.1 M PBS (pH 6.8) was added to get a 
final concentration of 500 mg/dL. The solution was stored at 4°C. 
2.3 Instrumentation  
Screen-printing was performed using an automated DEK 248 machine (Weymouth, 
UK). Scanning electron microscopy (SEM) using secondary electron (SE) detection 
was carried out with a Philips XLS0 ESEM with acceleration voltage of 20 keV. 
Both Gaseous Secondary Electron (GSE) and Back-scattered Secondary Electron 
(BSE) were used. A GRAPHTEC Craft Robo ProS (Model No. CE50000-40-CRP) 
cutting plotter and a Robo Master-Pro software were used to prepare the PSA and 
Zeonor patterns for encapsulation of the biosensor to provide a thin layer cell. 
Electrode patterns were drawn using AutoCAD and uploaded into the Robo Master 
software. All spectrophotometric measurements were performed using 96 well 
microplates with a FLUOstar Optima plate reader (BMG Labtech, UK) with Optima 
software (version: 2.1). Inkjet-printing was performed using a Dimatix Materials 
Printer DMP-2831 with Dimatix Drop manager DMP-2800 series software (Fujifilm 
Dimatix, Inc., US). The MEMS-based Dimatix cartridge with 16 nozzles (20 µm 
diameter) spaced at 254 µm was used. Most of the electrochemical measurements 
were carried out using a PGSTAT128N potentiostat with NOVA 1.6 software 
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(Metrohm, UK) and some of them performed using SP-200 potentiostat with EC-lb 
V10.19 software. Unless otherwise stated, all measurements were performed at a 
room temperature of 25±3°C. All potentials were referred to the Ag/AgCl reference 
electrode unless otherwise stated.   
2.4 Methods 
2.4.1 Screen printing of electrodes and silver modification 
Screen-printed electrodes (SPEs) (Ag working, Ag/AgCl reference and carbon 
counter with silver connector) were fabricated using an automated DEK 248 
machine (Weymouth, UK) according to the design shown in Fig. 2.1. Briefly, a layer 
of silver paste was deposited onto PET substrate and cured in a convection oven at 
120°C for 5 minutes. A single layer of Ag/AgCl was then screen printed and cured 
in a convection oven at the same temperature for 5 min, followed by two layers of 
carbon over-printed on silver and cured for 5 min at 120°C. 
Carbon counter with 
silver connector
Ag working electrode
33 mm
Ag/AgCl reference electrode
 
Fig. ‎2.1. Image of the dual electrode system fabricated using screen printing. 
In the three-electrode system, a 3 3 mm Ag screen printed electrode (PF-410) and 
an Ag/AgCl screen printed electrode (6038SS) were used as a working electrode 
and reference electrode, respectively. The counter electrode was composed of a 
screen printed silver conductor (PF-410) overprinted with carbon (Electrodag 
6017SS) to ensure minimal resistance and electrochemical interference. The area 
of each working electrode was 9 mm2. Electrodes were either used in single or dual 
electrode mode, either in open batch experiments, or following encapsulation with a 
25 µm pressure sensitive adhesive (PSA) spacer layer and hydrophilic cyclic 
polyolefin (Zeonor) lid, yielding a sample volume of 8 µL (Fig.  2.2).  
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Lid layer 
(hydrophilic Zeonor)
PSA 
 
Fig. ‎2.2. Design layout of the encapsulated electrodes 
Different techniques such as dip-coating, drop-coating and inkjet-printing were 
employed to modify silver screen printed electrodes. For dip-coating, the entire 
electrode was dipped in modification solution, while for drop-coating, defined 
volumes of modification solution were pipetted onto the silver electrode surface and 
left for a minimum 10 min. Where appropriate, modification solutions  of DBSA/KCl, 
6% (w/v) Emulgen B-66/PBS or 0.5% Triton X-100/PBS were inkjet-printed at a 
nozzle voltage of 26 V using a 16-nozzle head cartridge without filtration on silver 
screen printed electrodes with 20 μm dot spacing. Modification was typically 
performed with 5 to 15 layers of modification solution. Electrodes were then left to 
dry for at least 10 min and then rinsed using deionised water to remove the excess 
of modification solution that did not interact with the electrode surface just before 
use. 
2.4.2 Spectrophotometric assay development 
Spectrophotometric measurement of HDL-C was performed according to the 
literature as summarised in Table  2.1 (Nakamura et al., 2009, Hino et al., 1998, 
Tamura et al., 2009), and was used as the initial platform for assay development. 
300 μL of a reagent 1 was mixed with 3 μL of serum sample and heated at 37 °C 
for 5 min. the absorbance was measured at 545 nM. The 100μL of reagent 2 was 
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added to the mixture and the difference between absorbance was measured at 545 
nM at 37 °C. 
Table ‎2.1. Spectrophotometric methodology for HDL-C measurement at 37°C 
according to the literature.   
 
Reagent 1 Reagent 2 Buffer 
ChOx (1-5 U/mL) Emulgen B-66 (0.1%w/v) Tris-HCl (0.1 M, pH 7.0) 
MOPS (50 mM, pH 7.3) 
HRP (5 U/mL) ChEs (1.2 U/mL) 
4-AAP (0.05 % (w/v)) DMT (0.02-0.04% (w/v)) 
Fig.  2.3 shows a flow diagram for spectrophotometric assay methodology 
developed at room temperature for this work using 96 well microtitre plates. The 
final volume of reaction solution in each well was 100 µL. A final concentration of 
each assay component was: 6.1% (w/v) Emulgen B-66/PBS, 0.075 % (w/v) 4-AAP, 
14 U/mL HRP and 0.06 % (v/v) DMT, 23 U/mL ChOx and 39 U/mL ChEs. Unless 
otherwise stated, incubation was at 25 ±3°C (Hino, Nakamura and Manabe, 1998; 
Nakamura et al., 2009; Tamura et al., 2009; Yamamoto, Yamamoto and Nakanishi, 
2011). 
24 µl of substrate 
61 µL of 10% (w/v) 
Emulgen B-66/0.1 M PBS 
pH 6.8 
5 µL of colour substrate
(1.5% (w/v) 4-AAP, 280
U/mL HRP and 1.2 % (v/v)
DMT)
5 µL of 460 U/mL ChOx 
5 µL of 780 U/mL ChEs
The resulting colour was measured
spectrophotometrically at 545 nm
after incubation for 180 s at room
temperature.
 
Fig. ‎2.3. Flow diagram for spectrophotometric assay methodology developed 
at room temperature for this work using 96 well microtitre plates 
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2.4.3 Electrochemical measurements using the three electrode system 
All electrochemical measurements were carried out on the Ag SPEs in either an 
open stirred batch system or an enclosed (encapsulated) electrode sample 
chamber with a volume of 8 µL. In the stirred batch system, all the measurements 
were performed in 4 mL 0.1M PBS pH 6.8 unless otherwise stated. In the case of 
the encapsulated sample chamber, the modified SPEs were enclosed within a 
chamber of volume encapsulated using PSA and Zenor (Fig.  2.1 and Fig.  2.2). 
Encapsulation was performed by enclosing each electrode using a 25 µm pressure 
sensitive adhesive (PSA) spacer layer and hydrophilic cyclic polyolefin (Zeonor) lid 
to yield a sample volume of 8 µL. 20 µL of the reaction solution were placed on a 
PET sheet and the sample chamber was filled by capillary action. 
Cyclic voltammetric measurement was perfumed using a narrow potential window 
of -0.25 to 0 V (vs Ag/AgCl) where the scan started and finished at -0.25 V vs. 
Ag/AgCl, with a scan rate of 100 mV/s. Chronoamperometric measurement was 
performed either in stirred batch solution using three electrode system at 150 rpm 
using stirring plate and at -0.1 V vs (Ag/AgCl) when the steady state current 
obtained or using encapsulated electrodes at -0.1 V vs Ag/AgCl with the current 
response measured at 420 s following 240 s incubation. 
2.4.4 Measurement of HDL and TC using biosensors with externally added 
assay reagents 
The general approach to the measurement of HDL-C and TC using the developed 
biosensors is shown in Fig.  2.4. Typically in the case of the measurement of HDL-
C, a HDL-C selective surfactant, or in the case of TC a non-selective surfactant 
was mixed with ChEs and ChOx and allowed to incubate for a period of time before 
application to the electrode. In the next step, cholesterol esters released from HDL 
were hydrolyzed to FC in the presence of ChEs. The FC produced was oxidized by 
ChOx to cholest-4-en-3-one. ChEs was reduced to the active oxidised state by 
transferring electrons to molecular oxygen, resulting in the production of H2O2. 
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Fig. ‎2.4. General approach to the amperometric measurement of HDL-C using 
externally added reagents. Step 1 and 2: externally addition of assay reagent 
containing HDL-C selective surfactant solubilises the HDL which allows 
access to cholesterol esterase (ChEs) and cholesterol oxidase (ChOx) 
presents in the reagent at room temperature. Step 3: The generated H2O2 can 
then be measured using modified electrodes at -0.1 V vs. Ag/AgCl which is 
measured at 420 s.  
Assay reagents were externally added to known concentrations of substrate as 
shown in Fig.  2.5. The amperometric measurement of H2O2 released after 
enzymatic reaction was then performed at -0.1 V vs Ag/AgCl and the current was 
typically measured at 420 s. Assay reagent parameters were studied including 
surfactants (Triton X-100 and Emulgen B-66), buffers (PBS, MOPS or Tris-HCl), 
enzyme concentrations (20 to 156 U/mL) and incubation times (180 and 240 s). 
The optimised HDL-C biosensor was based on a final concentration of 6% (w/v) 
Emulgen B-66/PBS, 39 U/mL ChEs and 23 U/mL ChOx while the optimised TC 
biosensor was based on 0.5% (v/v) Triton X-100/PBS, 156 U/mL ChEs and 60 
U/mL ChOx.  
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Fig. ‎2.5. Schematic of assay reagent addition for amperometric measurement 
of HDL-C using external addition of reagents.  
2.4.5 Analysis of clinical samples 
Two sets of samples were provided by Alere and were stored at -80°C. One set 
was spiked human serum samples and the other set was composed of donor 
samples which were un-manipulated ‘off the clot’ serum samples from a donor 
population in San Diego, USA (Table  2.2).  
Table ‎2.2. Composition of the clinical serum samples as per certificate of 
analysis provided by Alere. 
  
Samples 
ID 
TG 
(mg/dL) 
TC  
(mM) 
GLU 
(mg/dL) 
HDL-C(mM) 
1 39.5 1.47 26 0.3 
2 138 3.57 48 0.72 
3 163.5 4.23 70 0.95 
4 183.5 4.93 92 1.2 
5 127.5 4.89 113 1.39 
6 127 4.17 136 1.7 
7 126.5 3.63 183 2.175 
8 160.5 5.56 231 0.699 
9 211 6.34 267 1.24 
10 174 7.5 316 0.44 
11 205 8.96 360 0.62 
1085S 104.1 5.5 73 2.33 
1087S 94.1 4.11 128.8 1.2 
1106s 289.9 3.7 120.7 0.74 
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Each of the samples was analysed using the Abcam cholesterol assay kit for HDL-
C and FC while TC was taken as reported in the certificate of analysis. Some of the 
spiked human serum samples were used as calibrators and the rest were used as 
clinical samples for HDL-C and TC measurement. For analysis of the clinical 
samples using the developed biosensors, optimised assay reagent was externally 
added to the samples and amperometric measurement was performed after 240 s 
incubation at room temperature using modified electrodes.  
2.4.6 Measurement of HDL and LDL/VLDL using the Abcam cholesterol 
assay kit  
Measurement of FC and HDL-C present in clinical samples was performed using 
the Abcam cholesterol assay kit (ab65390), according to manufacturer’s 
instructions. 100 µL of serum samples were mixed with 100 µL of 2X precipitation 
buffer in microcentrifuge tubes and incubated for 10 min at room temperature, 
followed by centrifugation at 5,000 rpm for 10 min. The supernatant containing the 
HDL-C fraction was incubated for 60 min at 37 °C in the presence of the reaction 
mix containing 44 µL cholesterol assay buffer, 2 µL cholesterol probe, 2 µL 
cholesterol enzyme and 2 µL ChEs. For FC measurement, 2 µL cholesterol assay 
buffer was added instead of ChEs (ab65390 assay protocol). The absorbance of 
the final solution was then measured at 570 nm. A calibration curve was prepared 
by measuring the absorbance of cholesterol standards (0 to 5 µg/well).  
2.4.7 Development of integrated HDL-C and TC biosensors 
Integrated HDL-C and TC biosensors were fabricated using either modified or 
unmodified electrodes followed by the deposition of assay reagent formulations 
directly onto the electrode surface using inkjet printing. The average deposited 
droplet volume of 9.210-6 µL which was experimentally obtained using the drop 
volume calibration feature. Parameters such as the number of printed layers and 
the print design were evaluated. Each printed layer was either on a single silver 
electrode (Fig.  2.6A), or both silver electrodes (Fig.  2.6B) using a 3.2  3.2 mm 
pattern each with 25,921 droplets, equivalent to a total volume of 0.238 µL per 
layer, or on  the whole cells area including working, reference and counter 
electrodes (Fig.  2.6C) of 15  8 mm at a final total volume of 2.77 µL and a drop 
count of 301,151.  
51 
 
The printed assay reagent formulation was optimised in terms of enzyme 
concentrations, number of printed layers, incubation time and stabilisers such as 
PVP and PDA. The final optimised integrated HDL-C biosensor employed four 
printed layers of assay reagent, of which each layer  was composed of a 2.77 µL 
reagent solution containing ChOx (218 U/mL) and ChEs (633 U/mL) in 6% (w/v) 
Emulgen B-66/PBS in the presence of 0.2% (w/v) PVP and PDA  deposited onto 
unmodified electrodes on an area of 15  8 mm. Optimised TC biosensors were 
based on ChEs (1044 U/mL) and ChOx (388 U/mL) in 0.25% (v/v) Triton X-
100/PBS in the presence of 0.2% (w/v) PVP and PDA . Sensors were then 
encapsulated as described in Section  2.4.1. 
158 mm3.23.2 mm 2 (3.23.2 mm)
A CB
 
Fig. ‎2.6. Schematic showing patterns of printing used for the deposition of 
assay reagent formulation. A: 3.2  3.2 mm single silver working electrode, B: 
3.2  3.2 mm on two working electrodes and C: 15  8 mm across dual three-
electrode cells. 
Fig.  2.7 illustrates the general approach for amperometric measurement of 
cholesterol using the integrated biosensors. Application of both modified and un-
modified silver electrodes were assessed for the development of the integrated 
biosensors. Typically, 20 µL of sample was directly placed on a clean, flat 
hydrophobic surface and introduced to the integrated biosensor by capillary filling. 
The deposited assay reagent containing surfactant and enzymes on the electrode 
surface was then re-solubilised upon contact to the sample. Some of the main 
challenges in development of the integrated biosensor are discussed in Chapter 6.  
The sensor was allowed to incubate for 240 s with cholesterol sample in order to 
release H2O2 following enzymatic reaction and the current was measured using 
chronapmerometry at -0.1 V vs. Ag/AgCl after 420 s.  
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Fig. ‎2.7. General approach to the amperometric measurement of cholesterol 
in delipidated serum using integrated biosensors. Application of the sample 
to the sensor solubilises the reagent layer. H2O2 is produced following the 
reaction of surfactants with lipoproteins and enzymes with cholesterols at 
room temperature for 240 s. Electrodes, either modified or unmodified 
catalyse the reduction of H2O2 at the silver electrode surface at -0.1 V vs. 
AgCl which is measured at 420 s. 
 
2.5 Research Governance 
All of the research was carried out in accordance with UWE’s Code of Good 
Research Conduct (http://www1.uwe.ac.uk/research/researchgovernance). All 
relevant ethical and health and safety requirements were adhered to. 
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Chapter 3  
Development and optimisation of assays 
for the measurement of TC and HDL-C 
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3.1  Introduction 
As already discussed in Chapter 1, there are several assay methodologies for 
measuring cholesterol, and more specifically HDL-C. All of these methods 
determine the amount of H2O2 produced after the enzymatic reaction of cholesterol 
when measured spectrophotometrically following the formation of a dye complex. 
Although the homogeneous assay methodologies allow direct and selective 
analysis of HDL-C using automated devices, development of a spectrophotometric 
assay capable of measuring HDL-C at room temperature with minimum dilution 
factor is critical as a foundation for the development of an analogous 
electrochemical biosensor and so it is necessary to understand the mechanisms 
and kinetics of the enzymatic reaction under conditions suitable for development of 
the electrochemical biosensor.  
In this chapter, a spectrophotometric assay with minimum dilution factor was 
developed for HDL-C and TC measurement. In order to assist the development and 
optimization of the assay properties, a spectrophotometric assay was designed by 
considering several assay methodologies reported in literatures and patents (Hino, 
Nakamura and Manabe, 1998; Nakanishi, Nakamura and Hino, 1998; Tamura et 
al., 2009). An assay employing 39 U/mL ChEs, 23 U/mL ChOx, 1% (w/v) Emulgen 
B-66, 0.05% (w/v) 4-AAP, 0.04% (v/v) DMT and 5 U/mL HRP was used as the 
starting point for assay development.  
Optimisation studies were performed to assess the most suitable enzyme 
concentrations capable of measuring HDL-C in its clinically relevant range at room 
temperature which would be more suitable for subsequent room temperature 
operation of the biosensor. To ensure that the assay was optimised for the 
quantitative measurement of HDL-C, each step of the assay was studied and 
optimised to ensure that it did not constitute a rate limiting step in the assay. 
Enzyme assays can be performed either when the reaction has gone to completion, 
or kinetically, by looking at the rates of reaction during the earlier phase of the 
assay (Copeland, 2000; Tipton, 1992).  
The effect of different surfactants such as Emulgen B-66, Triton X-100, and sodium 
cholate on the selective measurement of HDL-C over LDL-C was evaluated. Triton 
X-100, and sodium cholate were used as non-selective surfactants for the 
measurement of TC present in HDL-C and LDL-C samples for comparison with the 
TC measured in the presence of HDL-C selective surfactant. Optimisation was then 
56 
 
performed to evaluate the most suitable surfactant concentrations for 
spectrophotometric measurement of HDL-C and TC. The final optimised 
formulation was applied for the selective measurement of HDL-C in mixtures of 
HDL-C and LDL-C prepared in delipidated serum. 
3.2  Development of a spectrophotometric assay for the measurement of 
cholesterol 
In this section, the operation of an assay methodology employing 39 U/mL ChEs, 
23 U/mL ChOx, 1% (w/v) Emulgen B-66, 0.05% (w/v) 4-AAP, 0.04% (v/v) DMT and 
5 U/mL HRP for HDL-C measurement in its clinically relevant range was monitored 
spectrophotometrically for 1800 s at room temperature (RT). This was performed to 
evaluate the possibility of occuring the enzymatic reaction at room temperature 
while using 1 in 4 dilution of the sample (24 µL sample in a 100 µL total reaction 
volume). 
Fig.  3.1 shows the effect of the HDL-C concentration on the reaction kinetics of the 
assay. Under these experimental conditions, initial reaction rates were similar for all 
concentrations of HDL-C, suggesting that the reaction rate was not limited by the 
substrate concentration. The responses typically reached a plateau sooner for 
lower concentrations of HDL-C. Most reactions had reached completion by approx. 
800 s. The inset shows a plot of absorbance vs. H2O2 concentration at 400 and 800 
s (6.6 and 13.3 min) showing linearity only up to approx. 1.2 or 1.6 mM. This could 
be due to enzyme limitation due to the reduced rate of reaction for these coupled 
enzyme reactions at RT in which a lag phase can result. This lag phase can result 
from a delay in the formation of the final product which occurs as a result of the 
build up in concentration of the intermediate product which is a substrate for the 
second reaction (Fig.  3.2) (Copeland, 2000). Alternatively, the delay could also be 
due to the time required for the dissolution of HDL-C to make the esterified 
cholesterol available for enzymatic catalysis. 
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Fig. ‎3.1. The effect of HDL-C concentration on the kinetics of the 
spectrophotometric assay. Inset: Plot of absorbance vs. HDL-C concentration 
(t=400 and 800 s). 
 
 
Fig. ‎3.2. Kinetic response of a coupled enzyme reaction showing the lag 
phase and steady state phase [Used with permission of the publisher 
(Copeland, 2000)]. 
Therefore, the use of HDL-C as a substrate adds an additional kinetic step in the 
reaction of HDL-C. To reduce the complication introduced by the use of HDL-C in 
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this optimization study, cholesteryl acetate was then employed. Cholesteryl acetate 
has been shown to be a suitable substrate for ChEs in the electrochemical 
determination of blood TC (Fang, 2011; Hooda et al., 2009). It is soluble in water 
and easier to work with than HDL-C. Control experiments were performed with 3 
mM cholesteryl acetate as substrate at RT (Fig.  3.3).  
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Fig. ‎3.3. Use of 3 mM cholesteryl acetate as substrate for assay optimisation. 
a) No ChEs or ChOx; b) no ChOx; c) no ChEs; d and e) repeats with all assay 
components. 
These confirmed that catalysis of the cholesteryl acetate using this assay protocol 
was very effective, with no observable lag phase and reaching a final absorbance 
reading of 1.2 AU after approximately 1500 s. This demonstrated that cholesteryl 
acetate would act as an effective substrate with which to optimise the enzymatic 
steps of the assay. However, assay optimisation must be performed at a 
concentration which is within the linear range of the spectrophotometric assay. 
Assays employing this protocol typically use an effective 1 in 4 dilution of the 
sample (24 µL sample in a 100 µL total reaction volume). Given that the method 
showed linearity up to 1.2 mM HDL-C concentration, further optimisation was 
performed using 1.2 mM cholesteryl acetate concentrations. Consequently, the 
optimization of each step was carried out using cholesteryl acetate as substrate, 
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commencing with the final step. When the optimum concentration of an assay 
component was ascertained, it was fixed at that concentration for subsequent 
optimisation of the previous assay step.  
Since the colorimetric measurement of H2O2 is the final step in the enzymatic 
reaction of cholesteryl acetate, it is very important that this step is not rate limiting. 
Therefore, for the optimization of the colorimetric substrate formulation, the 
formulation developed by Hino et al. (1998) and Tamura et al. (2009) and adapted 
here was termed the ‘initial formulation’ (Table  3.1).  
To see if any increase in concentrations of this formulation would have an effect on 
the rate of the reaction, two additional colorimetric reagent formulations with 
reagents at 1.5 times and 3 times that of the initial formulation were prepared 
(Table  3.1). Concentrations of ChEs (107 U/mL) and ChOx (72 U/mL) which were 
approx. three times greater than those reported by Tamura et al. (2009)  were used 
as start points in this optimisation to ensure that neither one would be rate limiting. 
In the electrochemical sensor for cholesterol, this step will be replaced by the 
measurement of the reduction of H2O2 at the electrode. However, for assay 
development using the spectrophotometric assay, it was important to ensure that 
this assay step did not limit the performance of the assay when performed at RT. 
Table ‎3.1. Colorimetric reagent formulations employed for assay 
optimisation. 
  
Initial 
formulation 
1.5 x 
concentration 
3 x 
concentration 
4-AAP (% w/v) 0.05 0.075 0.15 
DMT (% v/v) 0.04 0.06 0.12 
HRP (U/mL) 9 14 28 
Fig.  3.4 illustrates the effect of the three different concentrations of colorimetric 
reagent on the kinetics of the assay at RT in 1.2 mM cholesteryl acetate. All curves 
in Fig.  3.4 showed a typical substrate utilization profile where the final steady state 
response was related to the total concentration of substrate. No lag phase was 
observed at the beginning of the reaction. The reaction rates for 1.5x and 3x were 
more rapid than for the initial formulation, which suggested some rate limitation 
from the colorimetric reagent in the initial formulation. However, the similarity of 
1.5x and 3x suggests no rate limitation at these concentrations. The 1.5x and 3x 
mixtures also reached saturation more rapidly at approx. 200 s, as opposed to 400 
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s for the initial formulation. Further assay optimization was performed based on a 
colorimetric reagent formula at 1.5x the initial formula concentrations. 
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Fig. ‎3.4. Effect of colorimetric reagent formulation concentration on assay 
reaction kinetics in 1.2 mM cholesteryl acetate at RT using a) Initial 
formulation; b) 1.5x and; c) 3x reagent concentrations. 
Following optimisation of the colorimetric reagent, optimisation of ChEs was 
performed using concentrations of 39, 79 and 107 U/mL, again using an elevated 
concentration of ChOx of 72 U/mL in an attempt to ensure no kinetic limitation in 
this step. Fig.  3.5 shows the effect of ChEs concentration on the overall reaction 
kinetics of the enzyme assay. As can be seen, the final absorbance value for all 
three concentrations was approx. 0.9 AU, and all had similar initial reaction rate 
kinetics. This shows that increasing the concentration of ChEs from 39 U/mL to 78 
and 107 U/mL had no effect on the rate of the process, which suggests that the 
ChEs concentration was not rate limiting at these concentrations. Therefore, 39 
U/mL ChEs was selected for further assay optimisation. 
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Fig. ‎3.5. Effect of ChEs concentration on assay reaction kinetics in 1.2 mM 
cholesteryl acetate at RT using a) Initial formula; b) 2x and; c) 3x reagent 
concentrations. 
Based on the optimised conditions for HRP and ChEs, ChOx concentration was 
next optimised using concentrations of ChOx of 23, 46 and 72 U/mL. 23 U/mL was 
the initial concentration and 46 and 72 U/mL represented concentrations that were 
approx. 2 and 3 times more than the initial formulation concentrations. Fig.  3.6 
illustrates the plot of absorbance vs. reaction time of 1.2 mM cholesteryl acetate in 
the presence of 39 U/mL ChEs, 14 U/mL HRP and different concentrations of 
ChOx. As can be seen, the final absorbance for all three concentrations of ChOx 
was approx. 0.9 AU. The initial reaction rate kinetics was also similar for all 
concentrations showing that increasing the concentration of ChOx from 23 U/mL to 
46 and 72 had no effect on the reaction rate of the process. This suggests that the 
ChEs concentration used in this experiment was not rate limiting and therefore 23 
U/mL ChOx was selected for future assay optimisation.   
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Fig. ‎3.6. Effect of ChOx concentration on assay reaction kinetics in 1.2 mM 
cholesteryl acetate and RT using a) Initial formula; b) 2x and; c) 3x reagent 
concentrations. 
A more detailed kinetic study was then performed with the re-optimised assay 
formulation detailed in Table  3.2. Cholesteryl acetate was then assayed in the 
range of 0 to 4.0 mM which is in the clinically relevant range. Fig.  3.7 shows the 
kinetics of the assay at RT.  
Table ‎3.2. Optimised spectrophotometric assay formulation. 
Ingredient Concentration 
Cholesterol esterase 39 U/mL 
Cholesterol oxidase 23 U/mL 
Horseradish peroxidase 14 U/mL 
4-AAP 0.075% (w/v) 
DMT 0.06% (v/v) 
Under these assay conditions, the initial reaction rates were related to the 
concentration of cholesteryl acetate, with rates being greater for higher 
concentrations, indicating partial, if not complete substrate (cholesteryl acetate) 
limitation at RT. The inset in Fig.  3.7 shows the relationship between the cholesteryl 
acetate concentration and absorbance at 545 nm at 180 and 420 s. As shown, the 
reaction completion time was increased from 180 to 400 s at substrate 
concentrations above 2.0 mM. The steady state absorbance value also appeared to 
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be reasonably stable over the duration of the assay (7 min). The assay showed an 
acceptable linearity at 420 s from 0 to 4.0 mM cholesteryl acetate (slope=1.54, 
r2=0.99). Since most point of care assays must be completed within a matter of 
minutes (Lee et al., 2011), therefore, a target assay time of 10 min or less for final 
amperometric measurement of cholesterol was defined.  
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Fig. ‎3.7. Reaction kinetics of the optimised spectrophotometric assay in 
cholesteryl acetate at RT. Inset: Plot of absorbance vs. concentration of 
cholesteryl acetate at t=180 and 420 s. 
To sum up, a spectrophotometric method was established at RT for the 
measurement of cholesteryl acetate following optimisation of the assay reagent 
concentrations. The method showed reasonable linearity between 0 to 4 mM with 
an assay time of 420 s. The next step was to apply this assay methodology to the 
measurement of esterified cholesterols in HDL following solubilisation using 
selective surfactants, and in TC measurement using non-selective surfactants. To 
achieve this, optimisation of the surfactants to be used was necessary.          
3.3  Evaluation of different surfactants on the selective measurement of 
HDL-cholesterol and total cholesterol 
The spectrophotometric formulation developed in section 3.2 showed an 
acceptable linearity at 420 s from 0 to 4.0 mM cholesteryl acetate (slope=1.54, 
r2=0.99). Since most point of care assays must be completed within a matter of 
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minutes (Lee et al., 2011)., a target assay time of 10 min or less for final 
amperometric measurement of cholesterol was defined. 
As discussed in the introduction, cholesterol is present in both esterified and non-
esterified forms, either free or in association with various lipoproteins. Thus, for the 
measurement of TC, all of this must be made accessible to enzymatic catalysis by 
ChEs and ChOx. The surfactant Triton X-100 (polyethylene glycol alkyl aryl ether) 
is a widely used non-ionic surfactant which has been found to be suitable for the 
total dissolution of cholesterol in blood (Allain et al., 1974; Brahim, Narinesingh and 
Guiseppi-Elie, 2001; Richmond, 1973; Richmond, 1976; Shih, Yang and Lin, 2009; 
Zoppi and Fenili, 1976). It has been shown to disrupt all types of lipoprotein 
structures and is also able to maintain the released cholesterol in micellar 
suspension. The cholesterol suspension has also been shown to be amenable to 
enzymatic reaction.  
Sodium cholate is another surfactant which has also been used for the total 
solubilisation of all blood cholesterol (TC) (Akimova and Melgunov, 1984; Allain et 
al., 1974; Mitra and Dungan, 2001; Richmond, 1976). It has been reported that 
surfactant molecules with a hydrophobic portion containing fused-ring structures 
such as sodium cholate, solubilised cholesterol significantly better than surfactants 
containing a linear hydrocarbon chain such as Triton X-100 (Mitra and Dungan, 
2001). However, sodium cholate is an ionic surfactant (Lin et al., 2007) which may 
have some impact on final amperometric measurement of H2O2 using modified 
silver electrodes.  
In contrast, for the selective measurement of HDL-C, a surfactant has been 
identified which is capable of only solubilising HDL particles, making this fraction 
selectively available for enzymatic degradation. This surfactant, Emulgen B-66, is a 
polyoxyethylene derivative with a hydrophile-lipophile balance of 13.2 which 
enables the selective breakdown of HDL particles, as opposed to other lipoproteins 
such as LDL, VLDL and CM (Nakamura et al., 2009; Okada et al., 2001; Tamura et 
al., 2009). Although the exact mechanism of HDL solubilisation remains unclear, it 
is believed that this effect might be related to the presence of different apoprotein 
types in HDL and non-HDL. Apoprotein A-I and II are the major apoproteins in HDL, 
while non-HDLs such as LDL, CM and VLDL all have just one molecule of 
apoprotein B-100. A surfactant which is selective for HDL-C can distinguish 
between these proteins and may solubilise the polar lipids via a specific interaction 
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with this apolipoprotein. This is believed to be related to the surfactant’s 
hydrophilic-lipophilic balance (HLB) (Kane, 1983; Kondo, 1999; Kurosaki and 
Ogawa, 2009; Okada et al., 2001; Okada, 2001; Segrest et al., 1992; Segrest et al., 
2001). 
The biological effects of surfactants depend on the concentration and structure of 
the chosen surfactants resulting from penetration of the membrane, its fluidization 
and solubilisation. It has also been found that there is parabolic relationship 
between membrane activity and lipophilicity of non-ionic surfactant which varies in 
lower and higher concentrations of surfactant (Florence, Tucker and Walters, 1984; 
Tucker and Florence, 1983). Therefore, these surfactants were studied for their use 
in the measurement of HDL-C and TC in the assays developed here.  
Before the surfactants associated with HDL-C (Emulgen B-66) and TC (Triton X-
100 and sodium cholate) measurement could be employed, they were first 
evaluated for any impact they might have on the behaviour of the optimised 
enzyme assay. To assess this, the assay was performed using 2.0 mM cholesteryl 
acetate as substrate in the presence of these surfactants in PBS. Previous studies 
have indicated the suitability of Emulgen B-66 at 1% (w/v) for measurement of 
HDL-C (Nakamura et al., 2009; Okada et al., 2001) and 0.5% (v/v) Triton X-100 
and 8 mM sodium cholate (Allain et al., 1974; Richmond, 1976) for TC 
measurement. So to assess the effect on the enzyme assay, these concentrations 
were employed (Fig. 3.8). The assay control in the absence of ChEs and ChOx 
gave an absorbance of 0.23 AU. The assay response in PBS was 1.38 AU, while in 
1% (w/v) Emulgen B-66, 0.5% (v/v) Triton X-100, and 8 mM sodium cholate the 
responses were 1.35, 1.39 and 1.35, respectively, showing little, if any significant 
difference in absorbance between the PBS control and the surfactants, and 
confirming that the surfactants used had no impact on the enzymatic assay. The 
next step was to then evaluate these surfactants as the basis of assays for HDL-C 
and TC. 
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Fig. ‎3.8. Spectrophotometric enzyme assay of 2.0 mM cholesteryl acetate in 
the presence of surfactants. Control contained no enzymes. 
3.3. 1  Evaluation of the efficiency and selectivity of different surfactants in 
the measurement of HDL-C and TC 
As was mentioned before, lipoproteins are a complex of lipids and apolipoproteins. 
Apolipoproteins have an amphipathic property. They surround lipids and enable 
them to be transported within blood stream. The solubility of these lipoproteins in 
the presence of surfactants might be due to the partial unfolding of their protein and 
interaction of surfactant with the lipoprotein surface layer. Higher concentrations of 
ionic and non-ionic surfactants with HLB values less than 14.6 were found to 
decrease the Stokes' radius of proteins, which might be due to delipidation of the 
lipoproteins. In the absence of surfactant, protein adsorbs at the water/fluid layer in 
a diffusion controlled manner which may result in very slow enzymatic reactions 
with ChEs and ChOx (Miller et al., 2000; Tucker and Florence, 1983). 
In the presence of surfactant, there are different types of proteins/surfactant 
interaction which lead to protein/surfactant complexes with different surface 
activities compared to pure protein. Ionic surfactants bond to proteins via 
electrostatic interactions, leading to higher surface activity, while non-ionic 
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surfactants adsorb competitively with the protein with a hydrophobic interaction 
which is less surface active than the pure proteins (Miller et al., 2000). 
Having established that the identified surfactants had no impact on the behaviour of 
the enzyme assay, the effect of these surfactants and their concentrations on the 
measurement of TC and non-esterified cholesterol within HDL-C was assessed. 
The absorbance value of non-esterified cholesterol was considered as the control 
in the presence of LDL-C due to the presence of significant levels of non-esterified 
cholesterol in LDL stock solutions.  To do this, 2.0 mM HDL-C (prepared in PBS 0.1 
M pH 6.8) was used as a substrate in the presence and absence of the selected 
surfactants. Since Emulgen B-66 is known to be capable of the solubilisation of 
HDL-C and Triton X-100 and sodium cholate are known to be capable of the 
solubilisation of all lipoproteins, all surfactants should be comparable in their ability 
to solubilise HDL-C. The enzyme assay was used to determine the amount of 
measurable cholesterol from the HDL sample (2.0 mM) following its solubilisation 
with the various surfactants. In addition, however, measurement with ChOx alone 
was used to determine the fraction of measurable non-esterified cholesterol, while 
measurement with ChEs and ChOx allowed the determination of both esterified and 
non-esterified forms, as some free cholesterol is always present in the sample. The 
kinetic assay responses are shown in Fig.  3.9, while the absorbances at 600 s are 
compiled in the inset and in Table  3.3. 
The amount of non-esterified cholesterol measured following HDL-C solubilisation 
by surfactants was only fractionally greater than that measured in PBS alone, while 
all surfactants showed similar values. This indicated that most of the non-esterified 
cholesterol was available without solubilisation. The amount of both esterified and 
non-esterified cholesterol measured was greater than the amount of non-esterified 
cholesterol in PBS, which suggested a fraction of esterified cholesterol was 
available without solubilisation of lipoprotein. However, significantly more esterified 
cholesterol could be measured in the presence of surfactants. In addition, all 
surfactants appeared to be comparably effective at solubilisation of the esterified 
cholesterol fraction present in HDL, and that HDL-C can be effectively solubilised in 
the presence of 1% (w/v) Emulgen B-66.  
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Fig. ‎3.9. Enzyme assay responses in 2.0 mM HDL-C at RT at 545 nm in 
different surfactants. Control (reagent blank) contains assay reagent without 
enzymes. Non-esterified cholesterol was determined in the absence of ChEs 
Inset: Absorbance at 600 s.  
 
Table ‎3.3. Measurement of total cholesterol and non-esterified cholesterol 
from 2.0 mM HDL-C in the presence of specific and non-specific surfactants 
(Absorbance was measured at 545 nm). 
Type of surfactant 
 
Cholesterol fraction measured 
Esterified and non-
esterified cholesterol 
(ChEs + ChOx) 
(Absorbance)  
Non-esterified 
cholesterol    
(ChOx) 
(Absorbance) 
Substrate blank                  
(no enzyme) 
0.222 0.222 
PBS (no surfactant) 0.807 0.370 
1% (w/v) Emulgen B-66 1.32 0.413 
0.5% (v/v) Triton X-100 1.31 0.406 
8 mM sodium cholate 1.42 0.392 
After assessing the effect of individual surfactants on the measurement of 
cholesterol from HDL-C, the next step was to assess the specificity of Emulgen B-
66 for HDL-C. This meant determining its ability (or rather inability) to solubilise 
non-HDL lipoproteins. Among the non-HDLs (that is LDL, VLDL and CM), LDL-C 
carries most of the cholesterol in the body. Since the surfactant Emulgen B-66 is 
believed to exhibit the same kind of effect on all lipoproteins containing apo-B, and 
since all the non-HDLs possess a single apo-B lipoprotein (Murphy et al., 2009), 
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LDL-C was used as the representative for all non-HDLs in assessing surfactant 
selectivity. Enzyme assays were again performed, this time with 2.0 mM LDL-C, 
either with ChOx or ChEs and ChOx to measure levels of non-esterified or 
esterified cholesterol, respectively (Fig.  3.10, Table  3.4).  
By comparing the results for 2.0 mM HDL-C and 2.0 mM LDL-C, the absorbances 
observed for 2.0 mM LDL-C were 1.35 and 1.44 in the presence of 0.5% (v/v) 
Triton X-100 and 8 mM sodium cholate, respectively which were almost the same 
intensity as the absorbance observed for 2.0 mM HDL-C in the presence of these 
two surfactants (1.31 and 1.42, respectively). This suggests that both of these 
surfactants could be used for TC measurement of the samples as both of them 
were able to disrupt both types of lipoproteins. 
The absorbance for measurement of esterified and non-esterified cholesterol from 
2.0 mM LDL-C in the presence of 1% (w/v) Emulgen B-66 was 0.65 compared to 
1.32 for 2.0 mM HDL-C, which constitutes a reduction of almost half. For a 
surfactant to selectively measure HDL-C, the differentiation between HDL-C and 
LDL-C is required to be around 50 to 90% (Murphy et al., 2009). The differentiation 
between HDL-C and LDL-C is calculated according to the following formula: 
Differentiation (%) = (GHDL-GLDL)*100/GHDL  
where G is the gradient of the measured response vs. known concentrations of the 
sample. The percentage differentiation between HDL-C and LDL-C using this 
formula, and after removing background absorbance from the absorbance value 
observed for each of them in the presence of 1% (w/v) Emulgen B-66, was 60% in 
this case. This was within the percentage range defined by Murphy et al. (2009).  
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Fig. ‎3.10. Enzyme assay response in 2.0 mM LDL-C at RT at 545 nm in 
different surfactants. Control (reagent blank) contains assay reagent without 
enzymes. Non-esterified cholesterol was determined in the absence of ChEs 
Inset: Absorbance at 600 s.  
 
Table ‎3.4. Total cholesterol and non-esterified cholesterol measurement of 
2.0 mM LDL-C in the presence of HDL-C specific and non-specific surfactants 
(Absorbance was measured at 545 nm). 
Type of surfactant 
Cholesterol fraction measured 
Esterified and non-
esterified cholesterol 
(ChEs + ChOx) 
(Absorbance)  
Non-esterified 
cholesterol    
(ChOx) 
(Absorbance) 
Substrate blank                 
(no enzyme) 
0.222 0.222 
PBS (no surfactant) 0.803 0.451 
1% (w/v) Emulgen B-66 0.649 0.361 
0.5% (v/v) Triton X-100 1.35 0.507 
8 mM sodium cholate 1.44 0.521 
The percentage recovery of TC and cholesterol ester present in 2.0 mM LDL-C was 
also calculated. This was achieved by assigning the measured concentration of 
cholesterol from LDL-C in the presence of 0.5% (v/v) Triton X-100 as 100%. The 
absorbance value of 0.22 AU was used as a background absorbance for the 
calculation of TC recovery of 2.0 mM LDL-C. For calculating the percentage 
recovery of cholesterol ester, the absorbance value of non-esterified cholesterol in 
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the absence of surfactant (0.45 AU) was subtracted from the value of total 
cholesterol measurement in the presence of surfactants. The percentage recovery 
of total cholesterol and cholesterol ester from 2.0 mM LDL-C in the presence of 1% 
(w/v) Emulgen B-66 were found to be approx. 38% and 21.3%, respectively, which 
demonstrated that further optimisation was required if adequate efficiency was to 
be achieved. 
Assigning 100% to the absorbance value obtained for the recovery of cholesterol 
from 2.0 mM LDL-C in the presence of 8 mM sodium cholate, this gave percentage 
recoveries of 35 and 19.4% for TC and esterified cholesterol measurement in 1% 
(w/v) Emulgen B-66, respectively. This suggests that both Triton X-100 and sodium 
cholate can be used for total cholesterol measurement. However, Triton X-100 is a 
non-ionic surfactant and may have less impact on the final amperometric 
measurement method than cholate. Therefore, Triton X-100 was used for future 
developments of TC assays. 
Given that the selectivity of 1% (w/v) Emulgen B-66 was relatively poor, alternative 
strategies were investigated to see if this could be improved. Others have used 
alternative surfactants such as Emulgen A90 (Yamamoto, Yamamoto and 
Nakanishi, 2011) and Pluronic F-68 (Tamura et al., 2009) to prevent the non-HDL 
lipoprotein from dissolving. However, it was found that Emulgen A90 demonstrated 
a decrease in selectivity towards both HDL and LDL cholesterol, while Pluronic F-
68 showed no significant improvement in bioassay selectivity towards HDL-C (data 
not shown). These methods were not studied further.  
Others have shown that the addition of di-cations such as MgCl2 improves 
selectivity (Okada et al., 2001; Okada, 1998). Therefore, the ability of Emulgen B-
66 in association with MgCl2 to solubilise LDL-C was evaluated, alongside Triton X-
100 which was used to evaluate TC (Fig.  3.11). The best percentage recovery was 
achieved in the presence of 1% (w/v) Emulgen B-66 and 20 mM MgCl2 which was 
40.6 and 17.7% for total cholesterol and esterified cholesterol in 2.0 mM LDL-C, 
respectively. Therefore, little improvement was seen across the concentration 
range studied and this approach was not considered further.  
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Fig. ‎3.11. Effect of supplementation of Emulgen B-66 with MgCl2 on selectivity 
to LDL-C. Enzyme assays in 2.0 mM LDL-C at RT. Inset: Absorbance at 600 s. 
In summary, Triton X-100 was selected for further optimisation of TC measurement, 
while Emulgen B-66 was selected for use in selective HDL-C assays. However, 
both surfactants required further individual and joint optimisation to achieve the 
most efficient measurement of both TC, HDL-C, and by subtraction, non-HDL-C.  
This optimisation is dealt with in the following sections. 
3.3. 2  Optimisation of the measurement of total cholesterol 
As was discussed earlier, Triton X-100 was able to solubilise both HDL and LDL 
cholesterols, making their cholesterol esters available for enzymatic catalysis. 
However, Triton X-100 had only been evaluated at a single concentration and so it 
was necessary to investigate the optimal conditions for recovery of TC from both 
HDL and LDL. Others have shown that higher concentrations of Triton X-100 may 
inhibit the enzymes’ activity (Shih, Yang and Lin, 2009; Tan et al., 2005; Vidal, 
Garcı́a and Castillo, 1999).  
To establish the best concentration of Triton X-100 for TC measurement, the effect 
of its concentration on the enzymatic determination of 2.0 mM LDL-C was 
assessed (Fig. 3.12).  
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Fig. ‎3.12. Effect of Triton X-100 concentration on the enzymatic determination 
of cholesterol in 2.0 mM LDL. Inset: Absorbance at 600 s. 
As shown, almost the same absorbance values of 1.20 and 1.21 AU were observed 
in the presence of 0.2 and 0.5 % (v/v) Triton X-100. This was 1.4 fold higher than 
that observed in its absence which was 0.85 AU. By increasing the concentration of 
Triton X-100 from 0.5 to 1.0 and 1.5 % (v/v), the absorbance decreased from 1.21 
to 1.14 and 1.08 AU, respectively. As mentioned, this may be due the inhibition of 
enzyme activity. Nishiya et al. (1998) reported that by increasing the concentration 
of Triton X-100, the reaction rate of ChOx decreased. Non-ionic surfactants such as 
Triton X-100 form micelles around cholesterol. Enzymes must remove the 
cholesterol from its micellar form to expedite the enzymatic reaction. Therefore the 
enzyme’s affinity for surfactant is critical in determining the rate of the enzymatic 
reaction. Higher concentrations of Triton X-100 may make very dense micelles 
around the cholesterol molecules, which might then interfere with the diffusion of 
cholesterol to the enzyme (Vidal, Garcı́a and Castillo, 1999). Further studies of 
Triton X-100 were performed at 0.5% (v/v). 
Reproducibility of the measurements in Triton X-100 was assessed by measuring 
TC and non-esterified cholesterol levels from HDL-C and LDL-C (2.0 mM) in the 
presence of 0.5% (v/v) Triton X-100. The measurement of non-esterified 
cholesterol (with ChOx) was again used to account for the free cholesterol present 
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in the sample, while TC was then measured in the presence of ChEs and ChOx 
and  Triton X-100 (n=3) (Fig.  3.13). While the kinetics of the reaction in HDL-C 
appeared to be moderately faster than for LDL-C, both assays had very 
comparable kinetics and final absorbance values. 
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Fig. ‎3.13. Enzyme assay of non-esterified (ChOx only) and total cholesterol 
(ChEs and ChOx) in 0.5% (v/v) Triton X-100 in a) 2.0 mM HDL-C and; b) 2.0 
mM LDL-C at RT. 
The average absorbance and standard deviation of each measurement are shown 
in Fig.  3.14. The average absorbance value for TC measurement of 2.0 mM HDL 
and LDL cholesterol were 1.29 ±0.02 AU (RSD=1.6%) and 1.39 ±0.01 AU 
(rsd=0.7%), respectively. Measurement of non-esterified cholesterol from 2.0 mM 
HDL and LDL yielded absorbance values of 0.403 ±0.003 (RSD= 0.7%) and 0.53 
±0.01 AU (rsd=2.0%), respectively. Therefore, under the developed assay 
conditions, the use of 0.2 or 0.5% (v/v) Triton X-100 was found to be an efficient 
and reproducible means of measuring TC in HDL and LDL using the enzyme assay 
and was used as the basis of further developments. 
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Fig. ‎3.14. Reproducibility study of enzyme assay measurements of total 
cholesterol and non-esterified cholesterol from 2.0 mM HDL-C and LDL-C in 
0.5% (v/v) Triton X-100 (absorbance at 600 s). 
3.3. 3  Optimisation of the selective measurement of HDL-C 
As was mentioned earlier (see section 3.3.1), selectivity of the spectrophotometric 
assay towards HDL-C was achieved by introducing a non-ionic surfactant such as 
Emulgen B-66 to the assay reagents detailed in Table  3.2. This surfactant was 
found to be highly selective to HDL-C over LDL-C, by making mainly the cholesterol 
bound to HDL-C available for enzymatic reaction. To further improve assay 
selectivity towards HDL-C, the effect of different concentrations of Emulgen B-66 
on the recovery of cholesterol from 2.0 mM LDL-C in PBS was assessed. The 
recovery of cholesterol from LDL-C using 0.2% (v/v) Triton X-100 was taken as 
being 100%. The kinetics of the enzyme assay was studied in the usual way over 
600 s at RT (Fig.  3.15).  
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Fig. ‎3.15. Effect of Emulgen B-66 concentration on recovery of cholesterol 
from 2.0 mM LDL-C. 0.2 % (v/v) Triton X-100 taken as 100%. Inset: 
Absorbance values measured at 600s. 
As can be seen, for 0.2% (w/v) Emulgen B-66, the absorbance value observed at 
200 s was approx. 0.66 AU, compared to 1.19 AU for 0.2% (v/v) Triton X-100. 
However, the absorbance value increased and reached 1.15 AU at 600 s. 
Therefore, 0.2% (w/v) Emulgen B-66 was able to inhibit the enzymatic reaction of 
2.0 mM LDL-C for just the first 200s. This might be due the inability of lower 
concentrations of surfactant to form a stable protein-surfactant complex by affecting 
the adsorption dynamics of apo-lipoprotein B and their surface activity. 
Hydrophobic interactions between protein and surfactant increase with increasing 
surfactant concentration, leading to less protein adsorption (Florence, Tucker and 
Walters, 1984; Miller et al., 2000).  
Florence et al. also reported different behaviours of non-ionic surfactant at lower 
and higher surfactant concentrations. Depending on the HLB of the surfactant, at 
very low surfactant concentrations, the activity of the hydrophobic region of the 
surfactant may be limited by micellisation, leading to better affinity of the hydrophilic 
region for the membrane, causing disruption and solubilisation. The slow action 
might be due to the slow saturation of its bilayers with surfactant and therefore 
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slower enzymatic reaction (Florence, Tucker and Walters, 1984; Tucker and 
Florence, 1983). 
By increasing the concentration of Emulgen B-66 from 0.2% to 6% (w/v), the 
percentage recovery of cholesterol from 2.0 mM LDL-C decreased from 89.1% to 
17.6% at 600 s. This confirmed that the protein/surfactant interaction was altered 
by changing the concentration of surfactant, showing an inhibition at higher 
concentration of Emulgen B-66 which might be due to increased hydrophobic 
interaction of apolipoprotein B with non-ionic surfactant by causing an increase in 
the Stokes radius of the LDL particles. This might be due to unfolding of 
apolipoprotein B molecules and therefore penetration of the phospholipid surface 
layer (Florence, Tucker and Walters, 1984; Miller et al., 2000).  
The percentage recovery and the absorbance values are summarised in Table  3.1. 
As was shown, the lowest percentage recovery was observed in the presence of 
6.0% (w/v) Emulgen B-66 which was 17.6%, including non-esterified cholesterol 
present in the stock sample.  
Table ‎3.5. Summary of effect of Emulgen B-66 concentration on the recovery 
of cholesterol from 2.0 mM LDL-C. Recovery in 0.2% (v/v) Triton X-100 taken 
as 100%. (t=600 s and absorbance was measured at 545 nm). 
Type of surfactant Absorbance (AU) 
Percentage 
recovery (%) 
Control 0.217 0.0 
0.2% (v/v) Triton X-100 1.27 100.0 
0.2% (w/v) Emulgen B-66 1.15 89.1 
0.5% (w/v) Emulgen B-66 0.751 51.0 
1.0% (w/v) Emulgen B-66 0.703 46.3 
1.5% (w/v) Emulgen B-66 0.638 40.1 
2.0% Emulgen B-66 0.609 37.4 
2.5% Emulgen B-66 0.534 30.2 
6.0% Emulgen B-66 0.409 17.6 
In a further experiment, Emulgen B-66 at 1%, 2.5% and 6% (w/v) was used to 
measure esterified cholesterol present in 2.0 mM LDL-C, this time in delipidated 
serum rather than in PBS to enhance the authenticity of the matrix, and taking 0.5% 
(v/v) Triton X-100 as 100% cholesterol recovery (Fig.  3.16).  
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Fig. ‎3.16. Effect of Emulgen B-66 concentration on the recovery of cholesterol 
from 2.0 mM LDL-C in delipidated serum. 0.5% (v/v) Triton X-100 taken as 
100% recovery. Absorbance in 0.1 M PBS and in the absence of ChEs and 
surfactant used as control. Inset: Average absorbance of three repeats at 600 
s. 
The absorbance in the absence of ChEs and surfactant was used as a control. As 
can be seen, in the presence of Emulgen B-66, the absorbance increased up to 
approx. 0.77 (±0.04), 0.70 (±0.03) and 0.60 (±0.01) AU for 1%, 2% and 6%, 
respectively, which were very similar to that observed for non-esterified cholesterol 
measurement (0.57 (±0.02) AU). This might be due to the presence of high 
concentrations of non-esterified cholesterol in the stock sample. The absorbance 
value observed in the presence of 0.5% (v/v) Triton X-100 was 1.67 (±0.03) AU 
which was more than twice the absorbance observed in the presence of Emulgen 
B-66. By considering the absorbance in the absence of ChEs and surfactant as a 
control and the absorbance in the presence of 0.5% (v/v) Triton X-100 as 100%, 
the percentage recoveries of esterified cholesterol in 2.0 mM LDL-C were 18.0, 
12.4 and 2.5% for 1%, 2.5%, and 6% (w/v) Emulgen B-66, respectively. Therefore 
6% (w/v) Emulgen B-66 was found to be the most suitable concentration to achieve 
approx. 97.5% rejection of LDL-C. However, it was now necessary to assess the 
recovery of cholesterol from HDL-C using this optimised concentration. 
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To evaluate the effect of 6% (w/v) Emulgen B-66 on the recovery of cholesterol 
from HDL-C, a similar experiment was performed employing 2.0 mM HDL-C in 
delipidated serum, again with 0.5% (v/v) Triton X-100 taken as 100% recovery   
(Fig.  3.17). As shown, the absorbance at 600 s for the measurement of 2.0 mM 
HDL-C in the presence of Emulgen B-66 and Triton X-100 were 1.16 (±0.03) AU 
and 1.22 (±0.03), respectively, yielding a percentage recovery in Emulgen B-66 of 
approx. 95%. 
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Fig. ‎3.17. Effect of 6% (w/v) Emulgen B-66 on the recovery of cholesterol from 
2.0 mM HDL-C in delipidated serum. 0.5% (v/v) Triton X-100 taken as 100% 
recovery. Absorbance in the absence of enzymes and surfactant was taken 
as control. Inset: Absorbance values of two repeats at 600 s. 
To sum up, for 6% (w/v) Emulgen B-66, the recovery of cholesterol from LDL-C 
relative to 0.5% (v/v) Triton X-100 was 2.5%, whereas with HDL-C, this was 95% 
with inaccuracy of minus 5%. Previously, 0.9% (w/v) Emulgen B-66 in combination 
with 15 mM MgCl2 was reported by Okada et al. (2001) as the best surfactant 
among four HDL-C selective surfactants employed in their experiment which was 
capable of measuring 95% of cholesterol content in HDL3 following 76% in HDL2 
and 10% in LDL-C (Okada et al., 2001). Later on, in 2008, Matsui and Ohta 
reported that Emulgen 911, Emulgen B-66 and the combination of Emulgen B-66 
and Emulgen A-90 with concentrations ranging from 0 to 3 %(w/v) were suitable as 
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surfactants which specifically act on HDL-C (Matsui and Ohta, 2008). Recently, Ito 
et al. (2014) developed a method for measurement of HDL subclasses, again by 
employing a surfactant from the polyoxyethyene derivatives with an HLB of 13.6 
which was capable of the selective decomposition of HDL3 (Ito et al., 2014). 
According to their report, polyoxyethylene benzylphenyl ether derivatives can be 
used for total HDL-C assay. The maximum concentration of surfactant employed 
was 3%. However as was shown above, even up to a concentration of 6% (w/v) 
Emulgen B-66, 95% of cholesterol in HDL-C was recovered. Therefore, 6% (w/v) 
Emulgen B-66 was used as a HDL-C selective surfactant for further work. However, 
thus far, recovery had only been evaluated using a single concentration of either 
HDL-C or LDL-C alone. As both of these will vary across a typical range of 1 to 4 
mM in real serum samples, the accuracy of the method should be assessed across 
a range of values and the assay optimised further if necessary. 
3.4  Determination of HDL-C in mixtures of HDLC and LDL-C  
The optimised concentrations of enzymes and surfactant were used to measure the 
cholesterol in 2.0 mM HDL-C while in the presence of 0, 1.0, 2.0, 3.1 and 4.2 mM 
LDL-C in delipidated serum. 6% (w/v) Emulgen B-66 was used to determine HDL-C 
levels while non-esterified cholesterol present in the samples was measured by 
omitting ChEs from the reaction mixtures, the resulting absorbance from which was 
taken as 0% cholesterol recovery, according to Nakamura et al. (2009). As can be 
seen in Fig.  3.18, increasing the concentration of LDL-C led to an increase in the 
level of cholesterol measured in the presence of Emulgen B-66. However, when the 
level of freely available non-esterified cholesterol (which is not made selectively 
available by the Emulgen B-66) is subtracted, the estimated value for the measured 
HDL-C could be obtained.  Table  3.6 gives a summary of these recoveries, which 
demonstrates that the assay had a recovery of cholesterol from 2.0 mM HDL-C 
between 86 and 128%. As can be seen, all the absorbance values for TC 
measurement in the presence of Emulgen B-66 were above 1.0 AU which lies at 
the upper end of the linear absorbance range for spectrophotometry (Day and 
Underwood, 1974). This was observed particularly at higher concentrations of LDL-
C, which results in higher concentrations of free cholesterol and subsequently 
higher TC concentrations of the sample. Others have not mentioned this problem 
as almost all of the spectrophotometric measurement of HDL-C are based on the 
use of approx. 4 µL of sample in a total test volume of 100 µL resulting in a 
maximum concentration of 0.04 mM in the reaction mixture (Warnick, Nauck and 
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Rifai, 2001). However, one of the objectives of this project was to establish a 
method with a minimum dilution factor which would be capable of being employed 
for the direct amperometric measurement of HDL-C. For the method to be 
considered validated, the accuracy expressed as percent recovery, must be within 
80-120% unless otherwise specified (Food and drug administrator, FDA, 2014). As 
can be seen in Table  3.6, most of the individual recovery results fell within this limit 
with the exception of two measurements. This was due to the limitations of the 
method and the inability to run the experiment more than twice within a day to 
minimise the systematic error. For this reason and considering the total RSD of 
15% for measurement of esterified cholesterol in 2 mM HDL-C in the presence of 
different concentrations of LDL-C which is well within the specified FDA limits, 6% 
(w/v) Emulgen B-66 deemed to be effective for the selective measurement of HDL-
C over LDL-C. 
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Fig. ‎3.18. Effect of LDL-C concentration on the measured recovery of cholesterol from 2.0 mM HDL-C: absence of ChEs (free non-
esterified cholesterol)();  6% (w/v) Emulgen B-66 (); estimated HDL-C (), n=2  
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 Table ‎3.6. Effect of LDL-C concentration on the measured recovery of HDL-C (n=2). 
HDL-C 
(mM) 
LDL-C 
(mM) 
Control in the absence 
of surfactant and ChEs  
(n=2) 
Emulgen B-66 (6%) 
(absorbance) (n=2) 
Cholesterol ester 
(absorbance) (n=2) 
% HDL-C Recovery (n=2) 
Replicate 1 Replicate 2 Replicate 1 Replicate 2 Replicate 1 Replicate 2 Replicate 1 Replicate 2 
2 0 0.383 0.407 1.20 1.23 0.821 0.723 100 100 
2 1 0.550 0.535 1.38 1.45 0.828 0.916 101 127 
2 2 0.707 0.744 1.61 1.67 0.902 0.926 110 128 
2 3.2 0.891 0.907 1.68 1.74 0.789 0.829 96 115 
2 4.1 1.21 1.25 1.92 1.91 0.705 0.658 86 91 
        
Average cholesterol ester 
(AU) 
0.81   
  
     SD 0.12    
        RSD (%) 15     
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3.5  Conclusion 
A final formulation (Table  3.2) for spectrophotometric measurement of 0 to 4 mM 
cholesteryl acetate was established. This assay methodology showed acceptable 
linearity across this range confirming that none of the enzymes were limiting the 
enzymatic reaction. The assay time was found to be within 7 min at room 
temperature and so was suitable for application to an electrochemical biosensor.  
Effect of Triton X-100 and sodium cholate as non-specific surfactant and Emulgen 
B-66 as HDL-C specific surfactant on spectrophotometric measurement of 2.0 mM 
HDL-C and LDL-C were assessed. Both Triton X-100 and sodium cholate were 
found to be suitable surfactants in spectrophotometric measurement of total 
cholesterol in both HDL and LDL cholesterol. Considering that Triton X-100 is a 
non-ionic surfactant which may have less impact on its future application for 
amperometric measurement of H2O2 using silver modified electrodes, optimisation 
study was performed using different concentrations of Triton X-100 TC 
measurement. Therefore, 0.2 to 0.5% (v/v) Triton X-100 was found to be suitable 
for measuring TC in HDL and LDL using the enzyme assay and was used as the 
basis of any future experiments. The next step was to find the optimum 
concentration of HDL-C specific surfactant (Emulgen B-66) capable of reasonable 
differentiation between HDL-C and LDL-C. Consequently, 6% emulgen B-66 was 
found to have a good selectivity towards HDL-C over LDL-C. The final formulation 
was used to measure 2.0 mM HDL-C in the presence of 0 to 4 mM LDL-C. Almost 
the same signal was observed after subtracting the free cholesterol results across 
the range. 
To sum up, assay reagent summarised in Table  3.2 showed a reasonable linearity 
for the measurement of 0 to 4 mM Cholesteryl acetate and 6% Emulgen B-66 and 
0.2 to 0.5% Triton X-100 were found to be suitable for the measurement of HDL-C 
and TC respectively. As the aim of this project was to replace the final step of this 
assay with amperometric measurement using modified silver electrodes, the effect 
of individual assay components such as ChOx, ChEs, surfactants and samples on 
modified silver electrodes behaviour will be assessed first and subsequently 
modified silver electrodes will be employed for the measurement of 0 to 4 mM 
H2O2. 
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Chapter 4  
Evaluation of the effect of HDL-C and TC 
assay reagents on the electrochemical 
measurement of H2O2 using modified 
silver electrodes 
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4.1 Introduction 
The primary aim of this work was the development of an electrochemical biosensor 
for the selective measurement of cholesterols such as TC, HDL-C and, by 
calculation, non-HDL-C. This would be achieved by replacing the final enzymatic 
step of the spectrophotometric measurement of H2O2 in the presence of a 
colorimetric reagent with the amperometric detection of H2O2 generated in the final 
step of conversion of cholesterol to cholest-4-en-3-one which would take place at a 
printed, modified silver electrode which had been shown to have enhanced 
catalysis for the reduction of H2O2 (Gonzalez-Macia, Smyth and Killard, 2012, 
Gonzalez-Macia, 2011). Such an approach would reduce the complexity of the 
sensor system by reducing the number of enzymes involved from three to two, 
while also facilitating the use of a simple, rapid, low cost, disposable 
electrochemical sensing approach. 
The general electrochemical behaviour these electrodes to reduce H2O2 was 
assessed, first in stirred batch mode with semi-infinite diffusion and convection, 
followed by their characterisation in a thin layer (encapsulated) cell suitable for low 
volume blood sampling. To use the modified electrodes for the detection of 
cholesterol, it was necessary to find out whether the electrochemical sensing 
principle was compatible with the cholesterol assays, e.g., impact of the assay 
reagents on the electrocatalysis. Since the electrocatalysis observed for modified 
electrodes in the presence of H2O2 is based on surfactant/salt solutions and due to 
the fact that assay reagent also contained a surfactant which is prepared in PBS, 
the evaluation of the effect of buffer and surfactant on modified electrodes were 
necessary before combining the cholesterol bioassay with a above mentioned 
electrochemical sensor for the measurement of H2O2. The assay reagents 
developed in Chapter 3 for HDL-C measurement were then evaluated for their 
effect on amperometric measurement of H2O2. The effects of buffer, surfactants, 
enzymes, HDL-C sample and delipidated serum on sensor behaviour were 
assessed and optimised, followed by evaluation of the effect of the final assay 
reagent formulation on the quantitative measurement of H2O2 in delipidated serum.  
The effect of Triton X-100 as a suitable surfactant for TC measurement on modified 
silver electrode was also evaluated.   
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4.2 Assessment of the electrochemical behaviour of the modified silver 
electrodes on the measurement of H2O2  
Initial cyclic voltammetric and time-based amperometric experiments were carried 
out to compare the reduction of H2O2 at the silver paste electrodes before and after 
their modification with DBSA/KCl (Gonzalez-Macia, Smyth and Killard, 2011). 
Deposition of DBSA/KCl onto the silver electrodes was performed using inkjet 
printing in a manner similar to Gonzalez-Macia, Smith and killard (2012). A narrow 
potential window of -0.25 to 0 V (vs Ag/AgCl) for H2O2 measurement using modified 
electrodes suggested by Gonzalez-Macia et al. (2011) was used due to the 
oxidation of silver at more positive potentials and also oxygen interference at more 
negative potentials. The scan started and finished at -0.25 V vs. Ag/AgCl, with a 
scan rate of 100 mV/s (Fig.  4.1). 
  E/v
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Fig. ‎4.1. Cyclic voltammograms of silver electrodes measured in PBS and 10 
mM H2O2 (-0.25 to 0 to -0.25 V at 100 mV/s vs. Ag/AgCl): a) unmodified in PBS, 
b) modified in PBS, C) unmodified in 10 mM H2O2, d)modified in 10 mM H2O2. 
It can be seen that the non-faradaic or charging currents for unmodified and 
modified electrodes at -0.1 V were 6.410-7 and 2.510-5 A, respectively. This was 
a confirmation of previous reports which showed a significant in 32-fold increase in 
double layer capacitance due to the deposition of the DBSA/KCl lyotropic layer on 
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the electrode surface (Gonzalez-Macia, Smyth and Killard, 2011; Gonzalez-Macia, 
Smyth and Killard, 2012).  The cathodic current observed for the modified electrode 
at -0.1 V taken from cyclic voltammograms was approx. 5.210-5 A in the presence 
of 10 mM H2O2, after subtracting the background current in comparison with the 
unmodified electrode, which was 1.210-5 A. This represented a four-fold 
enhancement in catalysis, re-establishing the enhanced catalysis for H2O2 
reduction due to the modification process seen in previous work (Gonzalez-Macia, 
Smyth and Killard, 2011).  
Fig.  4.2 illustrates the amperometric responses for the modified and unmodified 
electrodes after addition of 1 mM injections of H2O2 (0 - 10 mM) in stirred batch 
solution at -0.1 V vs Ag/AgCl.  
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Fig. ‎4.2. Amperometric responses of silver paste electrodes at -0.1 V (vs 
Ag/AgCl) in 0 to 10 mM H2O2 in stirred batch solution: (a) unmodified and (b) 
modified, Inset: Plot of cathodic current vs the concentration of H2O2 at -0.1 V 
(vs Ag/AgCl) a) modified (slope=7.7510-6, r2=0.98), b) unmodified (slope= 
1.6710-6, r2=0.99). 
Although Fig.  4.1 showed that enhanced reduction began at -0.05 V and increased 
linearly up to the cathodic potential limit of -0.25 V, to avoid oxygen interference at 
more negative potentials, and based on previously reported work (Gonzalez-Macia, 
Smyth and Killard, 2012; Razmi and Habibi, 2009), -0.1 V was chosen for all the 
future amperometric studies, unless otherwise stated.  
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Amperometry also demonstrated an almost five-fold enhancement in 
electrocatalysis of H2O2 at the electrode following modification. The cathodic 
current observed for 10 mM H2O2 was 1.510
-5 A and 7.310-5 A for unmodified 
and modified, respectively which represented a five-fold enhancement in catalysis. 
Cathodic current enhancement of modified silver electrodes was previously shown 
to be 80-fold higher which was significantly greater than that observed in this work. 
This might, in part, be due to the use of silver working electrodes with greater 
surface area of 12.6 mm2 with a Ag/AgCl/NaCl (saturated) electrode and a platinum 
mesh electrode as reference and auxiliary electrodes (Gonzalez-Macia, Smyth and 
Killard, 2012). However, in the current work, silver paste electrodes with a surface 
area of 9 mm2 were used as a working electrodes while screen printed Ag/AgCl 
and carbon overprinted on silver used as a reference and auxiliary, respectively. 
Some of this difference may also be due to the use of inkjet printing modification of 
the silver electrodes compared to those prepared using dip-coating which was 
reported previously. This was also shown by Gonzalez-Macia et al. (2012) that dip-
coated modified silver electrodes gave cathodic currents two-fold greater than inkjet 
printed modified ones (Gonzalez-Macia, Smyth and Killard, 2012). Even the type of 
silver ink which was used for screen printing of silver electrodes can affect the 
catalytic activity of the electrodes towards H2O2 measurement. The silver paste ink 
consists of very fine silver particles dispersed in a thermoplastic resin as a binder 
which is suitable for screen printing (Electrodage®P410 data sheet). The nature of 
the binder was shown to have an impact on the catalysis and the formation of 
surfactant/salt lamellar structures (Gonzalez-Macia, Smyth and Killard, 2011) 
leading to different enhancements on catalytic activity of the modified electrodes 
depending on the type of the ink employed. Thus, these factors may have 
combined to reduce the catalysis from the previously determined 80-fold to the 
approximately five-fold demonstrated here. Since modified electrodes still showed 
improved amperometric responses to H2O2, the reproducibility of these electrodes 
was further assessed. Amperometric measurements of 1 to 10 mM H2O2 were 
performed in triplicate using stirred batch solution at -0.1 V (vs Ag/AgCl) leading to 
electrode responses with a slope of 1.8710-6, and linearity (r2) of 0.99 and average 
RSD of 13.9%. As was mentioned earlier, the non-zero baseline current was 
approached using modified electrodes because of bachgrounf and non-Faradic 
currents produced after modification. Therefore, the cathodic current in this work 
decreases based on a diffusion layer dependent on time related to unstirred layer 
but did not approach zero due to the non-zero baseline current. 
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4.2.1 Evaluation of electrocatalysis in encapsulated electrodes 
Current point of care diagnostic blood tests demand the use of small sample 
volumes to allow minimal discomfort with sampling typically performed by finger 
stick with measurement using capillary whole blood (Gubala et al., 2012; Lee et al., 
2011), and this was an objective of the cholesterol biosensors being developed 
here, with a target of ≤10 µL of sample. Thus, electrodes were developed that were 
modified with a small volume sample chamber using a hydrophilic lid and spacer 
(25 µm), denoted ‘encapsulated’ electrodes. The final sample volume was found to 
be approx. 8 µL. However, the electrochemical behaviour of such a system differs 
significantly from the stirred batch system illustrated earlier, and so an 
understanding of the electrochemical behaviour of the encapsulated electrodes was 
required. For preliminary studies, sensor responses to H2O2 (0 to 3 mM) were 
investigated, as this was stoichiometrically equivalent to the amount of H2O2 that 
would be typically generated from samples containing HDL-C. However, later 
optimisation for measurement of TC would be in the range 0 to 7 mM. All 
measurements were subsequently performed at -0.1 V (vs Ag/AgCl).  
As can be seen in Fig.  4.3, cathodic currents of 2.0610-7, 3.5510-7, 4.7010-7, 
6.0310-7 A at 420 s were observed in the presence of 0, 1, 2 and 3 mM H2O2, 
respectively, compared to currents obtained in the stirred batch system were 
2.210-7, 4.710-7, 3.6910-6, and 7.910-6A, illustrating an approximately ten-fold 
decrease in current due to the mass transport limitations introduced by the thin 
layer cell. This difference was more significant at higher concentrations of H2O2. 
The type of mass transport used in an electrochemical system has a direct effect 
on the current response.  
The Faradic current is a direct measure of the rate of the electrochemical reaction 
taking place at the electrode. Further, the current itself is dependent upon the mass 
transport (the rate at which H2O2 gets from the bulk of solution to the electrode, and 
the rate at which electrons can transfer across the interface. Diffusion, migration 
and convection are the three basic mechanisms of mass transport. The total mass 
transport of H2O2, or flux, to an electrode is described for one dimension by the 
Nernst-Planck equation: 
     (4.1) 
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where J is the flux (mol cm-2 s-1), D is the diffusion coefficient of the solution 
species (cm2 s-1), C is the concentration of H2O2 (mol/cm
3), C/x expresses the 
concentration gradient and Ф is the electrostatic potential, and vx is the 
hydrodynamic velocity. This equation shows that the flux of H2O2 towards the 
electrode surface is proportional to either of three slopes of concentration, 
electrostatic potential, or hydrodynamic velocity, all as a function of distance from 
the electrode surface. 
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Fig. ‎4.3. Chronoamperometric responses of encapsulated modified Ag SPEs 
measured at -0.1V (vs Ag/AgCl) in a) 0.1 M PBS pH 6.8, b) 1 mM H2O2, c) 2 mM 
H2O2 and d) 3 mM H2O2; Inset: Plot of the current vs H2O2 concentration at 
t=300 s.  
In stirred bulk solution, the flux of H2O2 towards the electrode surface is proportional 
to both diffusion and convection as a function of distance from the electrode 
surface. This means that convection will ensure the diffusion layer thickness is kept 
small and the bulk solution concentration will remain close to the initial value 
(Kissinger and Heineman, 1996). In other words, the bulk solution experiment is 
convection-diffusion controlled under semi-infinite diffusion conditions which allows 
setting up of a steady state condition provided the stirring rate is fast enough. 
Consequently the diffusion layer thickness is time independent, leading to a plateau 
in its current profile (Bott, 1996; Grieshaber, MacKenzie and Reimhul, 2008).    
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As was mentioned above, the stirred bulk solution experiment was performed under 
a semi-infinite diffusion condition which means that the diffusion layer thickness (d) 
was very small compared to the diffusion thickness of medium. In contrast, when 
the electrode is enclosed, the diffusion layer thickness is significant with respect to 
the thickness of the cell and the flux is related to the observed current at the 
working electrode by: 
              (4.2) 
where A is the electrode area (cm2), F is 96,485, n is the number of electrons and 
other symbols as mentioned in Eq. 4.1. Considering that the system is finite, at 
longer time scales, the current response is dependent on the mass transport. 
Consequently, due to the longer time required for analyte to diffuse to the electrode 
surface to achieve a steady state, the current decreases with time. Therefore, in the 
encapsulated thin layer cell, the depth of the depletion zone becomes significant in 
comparison to the depth of the available cell thickness, whereas in bulk solution, 
this layer is essentially infinite. Therefore when the H2O2 concentration is reduced 
at the working electrode (in the encapsulated electrode), its bulk solution 
concentration will decrease significantly. This is dependent on the size of the 
working electrode compared to the volume of the solution and the rate of 
electrolysis.  
In classical potential-step chronoamperometry, the signal decays to zero due to the 
total consumption of the reactant. Theoretically, the amperometric response would 
fall to 93% after t = L2/D, where L is the diffusion layer thickness (25 μm) and D is 
the diffusion coefficient of H2O2. Based on a value of D of 1.71 x 10
-5 cm2 s-1, this 
would occur after 365 ms. However, in this work, a pseudo steady-state response 
was evident after several hundred seconds. This is most likely due to a combination 
of barriers to diffusion slowing the process of complete reduction of the available 
H2O2 and the continued production of some H2O2 via the enzymatic catalysis of 
cholesterol. 
To sum up, it was shown that modified silver electrodes were capable of measuring 
0 to 10 mM H2O2 using stirred batch solution and 0 to 3 mM H2O2 using 
encapsulated electrodes. The next step was to assess if these electrodes could be 
used for the amperometric measurement of H2O2 produced from the enzymatic 
reaction of TC and HDLC. 
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4.3 Assessment of the impact of individual cholesterol assay reagents on 
the electrochemical behaviour of the modified electrode to H2O2 
reduction 
After assessing the suitability of the modified electrodes for the measurement of 
H2O2, the effect of the assay components used in the measurement of TC and 
HDL-C on the amperometric determination of H2O2 using the modified electrodes 
needed to be assessed. According to the spectrophotometric assay developed in 
section 3.2, for the final step of the assay, HRP, DMT and 4-AAP were used to 
measure the presence of H2O2. However, since the aim of this work was to 
measure H2O2 electrochemically, there was no need to evaluate the effect of these 
reagents on electrode behaviour. Consequently, the effect of assay surfactant, 
buffer, ChOx and ChEs were evaluated for their effect on modified silver electrode 
behaviour. Initial optimisation studies were performed in bulk stirred batch solution 
for reasons of experimental practicality and convenience and that, when optimised, 
were transferred to the encapsulated electrode configuration.  
4.3.1 Effect of surfactant on amperometric measurement of H2O2 using 
modified electrodes 
Firstly, the effect of Emulgen B-66 - as the surfactant used for the selective 
determination of HDL-C - on electrode performance was assessed. Fig.  4.4 shows 
the effect of a 1% (w/v) Emulgen B-66 on the electrocatalytic response of the 
modified electrode.  
As can be seen, enhanced catalytic activity was observed in the presence of 
Emulgen B-66, particularly at lower concentrations of H2O2. A response of 8.1×10
-7 
A in the presence of 1 mM H2O2 was observed with a modified electrode without 
Emulgen B-66, whereas the current obtained by the same electrode in 1% (w/v) 
Emulgen B-66 reached approx. 3.4×10-6 A, demonstrating a four-fold increase in 
catalysis in the presence of Emulgen B-66. While this enhanced catalytic activity 
might assist in achieving a better detection limit of the sensors, such an 
enhancement would have to be controlled and reproducible, but should be 
considered as a potential enhancement of the performance of the device. It is, as 
yet, unclear why Emulgen B-66 appears to enhance the performance of the 
modified electrode, although similar effects have been observed with this electrode 
modification in the presence of a range of surfactants (Gonzalez-Macia, Smyth and 
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Killard, 2011). However, Emulgen B-66 is a polyoxyethylene (PEO) derivative 
compound and was reported that PEO and DBSA interact strongly with each other 
(Mohammad and Zarshad, 2009). In the presence of a polymer such as PEO, a 
decrease in critical micellar concentration (CMC) of DBSA is observed. Therefore, 
in the presence of the polymer, formation of micelles at lower concentration is 
facilitated. Formation of micelles and their interaction with the silver screen printed 
electrodes has been reported as the basis of the enhanced electrocatalysis of H2O2 
(Gonzalez-Macia, Smyth and Killard, 2011; Gonzalez-Macia, Smyth and Killard, 
2012).  
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Fig. ‎4.4. Effect of Emulgen B-66 on the response of the modified electrode to 
the reduction of H2O2 (-0.1 V vs. Ag/AgCl). a) 1% (w/v) Emulgen B-66 in 0.1 M 
PBS pH 6.8; b) 0.1 M PBS pH 6.8. Inset: Detail of biosensor responses 
between 0 and 300 s.  
4.3.2 Effect of buffer in amperometric measurement of H2O2 using modified 
electrodes 
While the choice of buffer used in bioassay procedures can be a critical feature of 
their performance, the reagents employed in the spectrophotometric assay have 
been shown not to be particularly affected by the type of buffer used (Nakamura et 
al., 2009). However, the choice of buffer may still have a significant impact on the 
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electrocatalysis of the modified electrodes. Gonzalez-Macia et al. (2011) 
demonstrated that the catalytic mechanism of H2O2 reduction at the modified 
electrodes was decreased in the presence of H+, which is also in accordance with 
other models of H2O2 electroreduction (Brandt, 1983). However, since modified 
electrodes showed an acceptable response using a buffer with pH of 6.8 and blood 
pH is regulated within the range of 7.35 to 7.45, (Waugh and Grant, 2007), a buffer 
solution with physiological pH was deemed to be appropriate for any future sensor 
development. Based on this, several commonly used buffers operating at 
physiological pH were assessed for their effect on the behaviour of the sensor. 
These were Tris-HCl (0.1 M, pH 7.0), MOPS (50 mM, pH 7.3) and PBS (0.1 M pH 
6.8); the latter which had been used for previous work. Tris-HCl has been used 
previously for the amperometric measurement of HDL-C (Kinoshita et al., 1998)  
and Good’s buffer - which is similar to MOPS - was also reported to be suitable for 
use in the spectrophotometric measurement of HDL-C (Nakamura et al., 2009; 
Yamamoto, Yamamoto and Nakanishi, 2011). 
A solution of 1% (w/v) Emulgen B-66 was prepared using these buffers and the 
amperometric responses of the modified electrodes were assessed in H2O2. 
Amperometric measurement of 0 to 6 mM H2O2 in MOPS and Tris-HCl are shown 
in Fig.  4.5A and B, respectively. In both experiments, a measurement of the 
electrode response to H2O2 in PBS was performed before and after measurement 
in either MOPS or Tris-HCl. Almost no cathodic response was observed in MOPS 
buffer (Fig.  4.5A).  
This may be due to the fact that MOPS is an amphipathic molecule. MOPS also 
has a very similar structure to DBSA, having an aliphatic chain and a sulphonate 
group. This may result in interference with the surface modification of the 
DBSA/KCl lyotropic layer, while not contributing to the formation of such a layer and 
elimination of the enhanced electrocatalysis, The electrode showed a slight 
decrease in sensitivity after exposure to MOPS. This might be due to the transient 
disruption of K+ and Cl- structural organisation with the DBSA (and now Emulgen B-
66) which is also an important part of the catalysis and which is restored upon 
removal of MOPS. 
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Fig. ‎4.5. Amperometric response of the modified electrodes to H2O2 (0-6 mM) 
in 1% (w/v) Emulgen B-66 prepared in (A) 50 mM MOPS pH 7.3 and (B) 0.1 M 
Tris-HCl pH 7.0. (a) Response in 0.1 M PBS pH 6.8 before testing in 
MOPS/Tris; (b) responses in MOPS/Tris; (c) Response in 0.1 M PBS after 
testing in MOPS/Tris. 
Fig.  4.5B shows that, in the presence of Tris-HCl, the catalytic activity of the 
electrodes was also significantly reduced but was also restored after its 
replacement with PBS. This might be due to incompatibility of silver containing 
electrodes in the presence of Tris buffer (Ryan, 1969). Tris buffer solutions, when 
used with certain types of electrodes in particular Ag/AgCl reference electrodes, 
have been shown to cause undesirable side reactions. In addition, neutralising Tris 
buffer using HCl may affect the ionic strength of the solution, causing a negative 
effect on catalytic activity of the electrodes towards H2O2. A similar mechanism to 
that discussed for MOPS should also not be ruled out. 
To sum up, while it has been reported that there is no limitation on the type of 
buffer used in cholesterol assays, the importance of evaluation of the type of buffer 
used in amperometric measurement was highlighted. Based on these findings, 0.1 
M PBS pH 6.8 was used as the buffer for all further amperometric studies.  
Having selected the appropriate buffer for further studies and evaluated the 
behaviour of the electrode to Emulgen B-66, the response of the modified electrode 
to H2O2 in 1% (w/v) Emulgen B-66 in 0.1 M PBS was evaluated over a wider range 
of H2O2 concentrations in two ranges from 0.05 to 0.55 mM and 1 to 6 mM using 
chronoamperometry at -0.1 V vs. Ag/AgCl. Fig.  4.6 shows the resulting 
amperograms from 5 to 125 s. Here, most of the early charging current and initial 
faradaic current had decayed away and after 20-40 s, the electrodes had reached a 
quasi-steady state from which current measurements at fixed time points could be 
made. The currents observed for 0, 0.05, 0.1 and 0.15 mM H2O2 at 120 s were 
(A) (B) 
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2.3510-7, 2.3510-7, 2.3710-7 and 3.010-7 A, respectively. Currents rose above 
baseline at 0.1 mM concentration and showed good linearity up to 6 mM 
(slope=5.1110-6, r2 =0.99). 
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Fig. ‎4.6. Chronoamperometric measurement of H2O2 (0-0.55 mM) at modified 
electrodes in 0.1 M PBS pH 6.8, 1% (w/v) Emulgen B-66 at -0.1 V vs. Ag/AgCl. 
Inset: Current response at 120 s.  
 
Based on this, the limit of detection was taken as 0.15 mM which is three times the 
background current. These preliminary amperometric experiments demonstrated 
that Emulgen B-66 prepared in 0.1 M PBS was suitable for the amperometric 
measurement of H2O2. H2O2 could be measured from 0.1 to 6 mM, with a lower 
detection limit of 0.15 mM. Since the minimum clinically relevant concentration of 
HDL-C is 1 mM and the stoichiometry of cholesterol and H2O2 is 1:1 for a complete 
reaction, this would suggest that, under these conditions, the electrode would be 
suitable for the measurement of HDL-C. In addition, due to the borderline high level 
of 5.2-6.2 mM for TC measurement, modified silver electrodes would also be 
capable of measuring TC as well as HDL-C.  Having determined the effect of buffer 
and Emulgen B-66, the next step was to evaluate the effect of all other assay 
components through the amperometric measurement of H2O2 using the modified 
silver electrodes as the assay platform.       
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4.3.3 Effect of enzymes and HDL-C samples on H2O2 reduction  
To evaluate the electrochemical response of the electrode towards H2O2 in the 
presence of enzymes and HDL-C isolated from serum, time-based amperometric 
measurement of H2O2 was performed in the presence of ChEs, ChOx and HDL-C 
and using 1% (w/v) Emulgen prepared in 0.1 M PBS pH 6.8. The effect of the 
enzymes (ChEs and ChOx) and the HDL-C sample on the sensor response to H2O2 
was also investigated using amperometry in stirred batch solution. Fig. ‎4.7 shows 
the response of the modified sensor to H2O2 in the presence of 1% (w/v) Emulgen 
B-66 in PBS before, during and following exposure of the sensor to HDL-C, ChEs 
and ChOx. The response of the sensor was similar before (a) and after (b) the 
combined exposure of the electrode to these species. However, the response was 
reduced significantly in the presence of HDL-C (d) and ChOx (e) alone.  
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Fig. ‎4.7. Amperometric response of sensors to H2O2 (0.5 to 1.5 mM) in stirred 
solution containing 1% (w/v) Emulgen B-66: a) before exposure  and; b) after 
exposure to a solution of ChEs (39 U/mL), ChOx (23 U/mL) and serum 
containing 1.5 mM HDL-C; c) in the presence of ChEs (39 U/mL); d) in the 
presence of serum containing 1.5 mM HDL-C; e) in the presence of ChOx (23 
U/mL). 
The presence of HDL or ChOx appeared to significantly disrupt sensor behaviour, 
possibly by disrupting the functioning of the lyotropic layer on the electrode surface. 
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In the case of HDL, it has already been clearly demonstrated that it interacts 
selectively with Emulgen B-66 and may disrupt the lyotropic layers formed at the 
electrode surface. In the case of ChOx, it has also been found to be capable of 
disrupting phospholipid membranes via the “active site lid” mechanism (Ghoshroy, 
Zhu and Sampson, 1997). Phospholipid membranes are also formed from the 
organisation of amphiphilic molecules and are analogous to the lyotropic phases 
formed by the interaction of Emulgen B-66 and electrolyte at the electrode surface. 
Disruption may also relate to the highly hydrophobic nature of the ChOx active site 
and the presence of additional hydrophobic domains on its surface (Vrielink, Lloyd 
and Blow, 1991). The sensor response was not significantly affected by the 
presence of ChEs. These results also demonstrated the reversible nature of the 
effects of both lipoprotein and ChOx on the electrocatalytic response of the sensor, 
further suggesting that the formed lyotropic phase is disrupted, but not eliminated. 
In conclusion, while some reagents such as Emulgen B-66 increased H2O2 
reduction, others such as ChOx and the HDL-C sample reduced this effect. Such 
influences must thus be considered when employing these assay components in 
the measurement of H2O2 following the release and enzymatic conversion of 
cholesterol from lipoproteins.  
Preliminary studies on the effect of Emulgen B-66 on amperometric measurement 
of H2O2 using modified electrodes (see section 4.3.1) were performed at a 
concentration of 1% (w/v). However, later optimisation led to the selection of 6% 
(w/v) as the most suitable concentration which yielded maximum differentiation 
between HDL-C and LDL-C measurement. Therefore, the next step was to 
evaluate the effect of 6% (w/v) Emulgen B-66 in 0.1 M PBS pH 6.8 on the 
electrochemical measurement of H2O2 using the modified electrodes. Therefore, 
amperometric measurement of 0 to 3 mM H2O2 using unmodified and modified 
silver electrodes was this time performed in 6% (w/v) Emulgen/PBS solution. 
Significantly enhanced reduction currents (17-fold) were observed for unmodified 
electrodes in the presence of 6% (w/v) Emulgen B-66 compared to those in PBS 
(Fig.  4.8).  
In the absence of surfactant, unmodified electrodes had a response of 1.33×10-7 A 
(curve a) while in the presence 6% (w/v) Emulgen B-66, there was a response of 
2.2×10-6 A, showing an almost 17-fold enhancement in catalysis. A current 
response of 5.96×10-6 A was obtained for 3 mM H2O2 using DBSA/KCl modified 
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electrode in the presence of 6% (w/v) Emulgen B-66 (curve d), which was a 1.6-fold 
current increase over the one in PBS which was 3.6×10-6 A (curve c). This was 
almost the same as that observed for 3 mM H2O2 previously in the presence of 1% 
Emulgen B-66 which was 1.66-fold (section 4.3.1).  In addition, by employing a new 
set of silver screen printed electrodes prepared with a new batch of silver ink, the 
catalytic enhancement was 27-fold greater for DBSA/KCl  modified electrodes in 
PBS compared to the five-fold enhancement observed previously in section 4.2. 
This enhanced response might further assist in achieving a lower limit of detection 
of H2O2 with the sensor.  
t/s
0 200 400 600 800 1000
I/
A
0
2e-6
4e-6
6e-6
(a)
(b)
(c)
(d)
 
Fig. ‎4.8. Amperometric measurement of 0.5 to 3 mM H2O2 at  -0.1 V vs. 
Ag/AgCl in 5 ml stirred batch solution using: a) unmodified silver electrode in 
PBS; b) unmodified silver electrode in 6% (w/v) Emulgen B-66, c) modified 
electrode in PBS and d) modified electrode in 6% Emulgen B-66.  
To sum up, Emulgen B-66 is a nonionic surfactant which was prepared in an 
electrolyte solution of 0.1 M PBS pH 6.8. It is believed that an equivalent effect may 
be achieved by this combination as has previously been demonstrated with other 
surfactant/salt combinations. However, further enhancement appears to result from 
operation of the sensor in a solution of this surfactant and electrolyte, as opposed 
to the modification of the surface alone with DBSA and KCl. Further studies were 
performed on the suitability of using Emulgen B-66/PBS as an alternative 
modification solution which will be discussed in the following chapters. 
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4.3.4 Effect of delipidated serum in amperometric measurement of H2O2 
In order to evaluate the effect of serum components on the amperometric 
measurement of H2O2 using encapsulated modified electrodes, the suitability of 
using delipidated serum was evaluated. The amperometric responses of 3 mM 
H2O2 prepared in PBS was compared to that observed for 3 mM H2O2 prepared in 
delipidated serum using encapsulated modified electrodes (Fig.  4.9 and Table  4.1).  
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Fig. ‎4.9. Amperometric measurement of 3 mM H2O2 prepared in PBS 
compared to the one prepared in delipidated serum at 420 s. 
As can be seen, in Fig.  4.9, although the cathodic current observed for the modified 
electrode in the presence of delipidated serum decreased in comparison with the 
one in PBS, the signal to background current (S/B) just showed a slight increase in 
the presence of delipidated serum showing that there would be no loss in surface 
modification in the presence of delipidated serum. This might be due to the slight 
change in ionic strength of sample once prepared in delipidated serum compared to 
that in PBS (Cham and Knowles, 1976; Murphy, Allen and Hill, 2010). Since no loss 
in sensitivity of modified electrode was observed in the presence of delipidated 
serum, it was accepted that delipidated serum would be a suitable sample matrix 
for further assay development. 
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Table ‎4.1. Signal to background (S/B) response of modified electrode to 3 mM 
H2O2 prepared in PBS and delipidated serum. 
Substrate 
I/A Average 
S/B 1st repeat 2nd repeat 3rd repeat 
Control (in serum) 6.3910-8 1.0710-7 - - 
Control (in PBS) 1.5910-7 1.5510-7 - - 
3 mM H2O2 in serum 1.8210
-7 1.5010-7 1.9010-7 2 
3 mM H2O2 in PBS 2.6410
-7 2.6910-7 - 1.7 
4.3.5 Effect of final assay reagent formulation on the quantitative 
measurement of H2O2 in delipidated serum 
Based on the facts that some assay components enhance the electrocatalysis of 
the modified electrode and some diminish, which were found using stirred batch 
experiments, the response of the encapsulated biosensor system to 8 µL of H2O2 
prepared in delipidated serum in the presence of all the assay components was 
assessed in the 0 to 10 mM range (Fig.  4.10).  
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Fig. ‎4.10. Chronoamperometric response of modified electrodes to 8 µL of 
H2O2 (-0.1 V vs Ag/AgCl at 420 s) in the presence of the final assay reagent 
formulation and delipdated serum at 420 s, (slope=3.710-8 A/mM, r2=0.99, 
RSD=7.2%). 
The resulting responses took into account all processes which either enhanced the 
electrocatalysis such as the presence of Emulgen B-66, or which interfered with it, 
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such as HDL-C and ChOx. Chronoamperometric measurements were again 
performed at -0.1 V (vs Ag/AgCl) and the current responses recorded at 420 s. The 
sensor had excellent linearity from 0 to 10 mM H2O2 (slope=3.710
-8, r2=0.99, 
RSD=7.2%), which would make it suitable to be used in direct determination of 
HDL-C in serum initially and then progressively for TC measurement in serum, 
based on an end point enzyme assay protocol such as the one developed in 
Chapter 3. 
To employ this assay for the measurement of TC, the next step was to evaluate the 
effect of Triton X-100 as a non-specific surfactant for the measurement of TC 
compared to Emulgen B-66 in amperometric measurement of H2O2 using modified 
silver electrodes. 
4.3.6 Effect of Triton X-100 on modified silver electrode behaviour 
After assessing the effect of HDL-C specific surfactant on electrode behaviour, the 
effect of 0.5% (v/v) Triton X-100 as a non-specific surfactant for the measurement 
of TC was assessed. Therefore the response of the encapsulated sensor to 8 µL of 
4 mM H2O2 prepared in delipidated serum in the presence of 0.5% (v/v) Triton X-
100 and 6% (w/v) Emulgen B-66 was evaluated (Fig.  4.11).  
Fig.  4.11 shows the results of chronoamperometric measurements performed at -
0.1 V (vs Ag/AgCl) with current responses at 420 s. The same background current 
of 2.310-8 A was observed in the presence of both surfactants. The current 
responses in Triton X-100 were 1.1310-7 and 1.0710-7 A, compared to those in 
Emulgen B-66 which were 1.0010-7 and 1.1010-7 A, showing almost no difference 
in their effect on electrode behaviour which would make it suitable for specificity 
study which the results in different surfactants required to be assessed and 
compared with each other.  Triton X-100 has also been reported to enhance silver 
screen printed electrodes response in the presence of KCl (Gonzalez-Macia, Smyth 
and Killard, 2011). Thus, 0.5% (v/v) in 0.1 M PBS may be suitable for the 
development of a TC biosensor which will be discussed in the following chapter.  
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Fig. ‎4.11. Chronoamperometric response to 8 µL of 4 mM H2O2 (-0.1 V vs 
Ag/AgCl ) in the presence of 0.5% (v/v) Triton X-100 and 6% (w/v) Emulgen B-
66 at 420 s. Delipidated serum was used for controls.  
4.4 Conclusions 
DBSA/KCl-modified silver electrodes were evaluated for their ability to measure 
H2O2 in both stirred batch mode and using encapsulated electrodes using a non-
enzymatic electrochemical determination. Direct measurement of H2O2 at the 
relatively moderate potential of -0.1 V (vs Ag/AgCl) and in absence of enzyme has 
the unique advantages of not requiring the complex optimisation and 
implementation of a biological component, as well as providing the possibility of 
designing a simpler miniaturised device which can broaden its application. 
The effects of assay reagents such as buffer and surfactant on the electrode 
behaviour were assessed amperometrically in the presence of H2O2 solutions. Of 
three buffers evaluated, the electrodes showed a linear responses in 0.1M PBS 
(pH=6.8) with enhanced catalytic activity toward H2O2 in the presence of Emulgen 
B-66.  
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The effect of separate and combined cholesterol assay components on the 
DBSA/KCl modified silver electrodes was also assessed.  Although HDL-C sample, 
ChOx and delipidated serum showed a negative effect on electrode response, 
reagents such as Emulgen B-66 and Triton X-100 had a positive effect on 
electrocatalysis. Using Emulgen B-66 - which would be suitable for the selective 
measurement of HDL-C - the sensor showed excellent linearity from 0 to 10 mM 
H2O2 with slope=3.710
-8, r2=0.99, RSD=7.2%, which would make it suitable to be 
used for the direct determination of HDL-C in serum, based on an end point 
enzyme assay protocol such as that developed in Chapter 3. Finally, Triton X-100 
had a comparable effect on the amperometric measurement of H2O2 to Emulgen B-
66 which indicated that it would be suitable to form the basis of the amperometric 
measurement of TC. 
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Chapter 5  
Development of electrochemical 
biosensors for HDL-C and TC using 
external assay reagents 
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5.1 Introduction 
In the previous chapter, the application of optimised assay reagents for the 
colorimetric measurement of HDL-C and TC was investigated. The next step was to 
transfer this assay protocol to the measurement of HDL-C and TC using an 
electrochemical sensor. In Chapter 4, a preliminary assessment was performed to 
investigate the effect of assay reagents on the electrochemical measurement of 
H2O2 using DBSA/KCl modified silver electrodes. Some interference by ChOx and 
serum components was observed on the amperometric determination of H2O2. 
However, the modified electrodes were found to be suitable for the quantitative 
measurement of 0 to 10 mM H2O2. DBSA/KCl modified silver electrodes had 
previously been used for amperometric determination of the H2O2 released from the 
enzymatic reaction of glucose in the presence of glucose oxidase and O2 
(Gonzalez-Macia, Smyth and Killard, 2012a).  However, it had also been observed 
that Emulgen B-66, which was used for the selective determination of HDL-C, could 
also bring about enhanced catalysis in a manner similar to DBSA/KCl, which raised 
the prospect of replacing the DBSA/KCl modification entirely. 
In this chapter, the optimised assay reagents established in Chapter 4 were used 
for the measurement of firstly H2O2, followed by cholesteryl acetate and finally HDL-
C in PBS, followed by the measurement of H2O2, HDL-C and TC in delipidated 
serum. The linearity, sensitivity, and reproducibility of the sensor for determination 
of the released H2O2 were evaluated. Following this, the possibility of applying 
Emulgen B-66/PBS and Triton X-100/PBS were assessed as alternative electrode 
modifiers to DBSA/KCl for HDL-C and TC measurement, respectively and their 
suitability for the measurement of HDL-C and TC in delipidated serum was 
evaluated. Amperometric measurement of HDL-C and TC in clinically derived 
serum samples was also investigated.  
5.2 Development of the HDL-C biosensor  
Since DBSA/KCl modified electrodes showed an acceptable response to the 
amperometric measurement of 0 to 10 mM H2O2 in the presence of assay reagents 
(Section 4.3.5), in this section, these electrodes were first used to develop a HDL-C 
biosensor. Then, based on the fact that both un-modified silver electrodes and 
DBSA/KCl modified electrodes showed an enhanced catalytic activity towards H2O2 
in the presence of 6% (w/v) Emulgen B-66 (Sections 4.3.1 and 4.3.4), the 
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possibility of employing Emulgen B-66/PBS as a modification solution to develop a 
HDL-C biosensor was evaluated. 
5.2.1 Development of the HDL-C biosensor using DBSA/KCl modified 
electrodes 
In order to develop the HDL-C biosensor, the assay reagents discussed in Chapter 
4 were used first to measure 0 to 6 mM H2O2, followed by 0 to 6 mM cholesteryl 
acetate and finally 0 to 6 mM HDL-C, all prepared in PBS. As was shown in 
Chapter 3, final concentrations of 23 U/mL ChOx and 39 U/mL ChEs were found to 
be suitable for the spectrophotometric measurement of 0 to 4 mM cholesteryl 
acetate with acceptable linearity up to 4 mM. While the concentration of 6% (w/v) 
Emulgen B-66 was eventually found to be most optimal for measuring HDL-C over 
LDL-C in later studies, a concentration of 1% (w/v) was used for preliminary 
investigations here. Encapsulated DBSA/KCl modified electrodes were used for 
amperometric measurement, unless otherwise stated. Fig.  5.1 shows the 
amperograms from 0 to 420 s for 0 to 6 mM H2O2 in the presence of enzymes and 
surfactant using encapsulated electrodes. 
The amperometric responses of the biosensor to H2O2 and cholesteryl acetate at 
420 s are compared in Fig.  5.2. Both plots show good linearity of r2=0.97 up to 6 
mM, with cholesteryl acetate showing a slightly lower slope compared to H2O2. This 
might be due the fact that for cholesteryl acetate measurement, the H2O2 is 
released after two enzymatic reaction steps leading to the delayed release of H2O2 
during the assay period.  
HDL-C was also measured in the presence and the absence of assay reagents. 
Amperometric measurements in the absence of enzymes were used as controls. 
As can be seen in Fig.  5.3, the electrode responses were linear across the 
measured range showing a slope of  2.7810-8 A/mM which was approximately 2-
fold and 1.5-fold less than those observed for H2O2 and cholesteryl acetate 
measurements, respectively. This was also expected as the use of HDL-C as a 
substrate adds an additional kinetic step to the assay. Once again, despite the 
negative effect of the HDL-C sample on the electrode response which was 
discussed in Chapter 4, the method showed good linearity across the measured 
range.  The specificity of the method for measuring HDL-C over LDL-C in PBS was 
then assessed.     
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Fig. ‎5.1. Chronoamperometric measurement of H2O2 (0-6 mM) using 
encapsulated electrodes in the presence of HDL-C assay reagent at -0.1 V (vs 
Ag/AgCl). 
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Fig. ‎5.2. Chronoamperometric response to 8 µL of (a) 0 to 6 mM H2O2 and (b) 0 
to 6 mM cholesteryl acetate (-0.1 V vs Ag/AgCl at 420 s) in the presence of 
HDL-C assay reagents at 420 s, (slope=5.9310-8 A/mM, r2=0.97 for H2O2 and 
slope=4.0110-8 A/mM, r2=0.97 for cholesteryl acetate).  
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Fig. ‎5.3. Biosensor response to 0-6 mM HDL-C in PBS at -0.1 V (vs Ag/AgCl). 
a) 0 mM  in the presence of ChEs and ChOx and 1 to 6 mM in the absence of  
enzymes; b) in the presence of 1% (w/v) Emulgen B-66, 39 U/mL ChEs and 23 
U/mL ChOx; (slope=2.7810-8 A/mM, r2=0.99). 
5.2.1.1 Measurement of the selectivity of the biosensor for measurement of 
HDL-C over LDL-C 
It was shown previously in Chapter 3 that Emulgen B-66 was capable of bringing 
about the selective measurement HDL-C over LDL-C, while use of Triton X-100 
allowed the measurement of TC. To assess whether this remained the case with 
amperometric measurement, HDL-C (1 mM) in the presence or absence of LDL-C 
(1 mM) was used to measure the HDL-C and TC content of the samples in the 
presence of HDL-C selective and non-selective surfactants. 1% (w/v) Emulgen B-
66 and 0.5% (v/v) Triton X-100 were used for HDL-C and TC measurements, 
respectively (Fig.  5.4 and Fig.  5.5).  Almost the same cathodic current was 
observed in the presence of Emulgen B-66 and Triton X-100 for the amperometric 
measurement of 1 mM HDL-C (1.710-7 A and 1.810-7A, respectively), while a 
mixture of 1 mM HDL-C and 1 mM LDL-C showed an approx. 1.1-fold greater 
cathodic current in the presence of Emulgen B-66 for its HDL-C measurement 
(1.910-7 A), which might be due to the presence of some FC present in the LDL-C 
sample. However, the current observed for the mixture of HDL-C and LDL-C in the 
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presence of Triton X-100 (2.4510-7 A) was significantly higher compared to that 
observed for HDL-C measurement, demonstrating that Emulgen B-66 was 
selectively measuring HDL-C over LDL-C in the biosensor.  
The selectivity according to Murphy et al., (2009) can be calculated as that the ratio 
of the GLDL in the presence of specific surfactant vs of the GLDL in its absence which 
should be less than 1 and more preferably around 0.3 where G is the gradient of 
the measured response which is the current measured verus the known 
concentrations of the sample. Therefore, the selectivity according to this method 
after removing the background current observed in the presence of each surfactant 
(controls in Fig.  5.5), was calculated to be 0.44 which was within the acceptable 
limit reported by Murphy et al., (2009). 
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Fig. ‎5.4. Chronoamperometric measurement of 1 mM HDL-C in the presence 
and absence of 1 mM LDL-C at -0.1 V (vs Ag/AgCl),  Emulgen B-66 and Triton 
X-100 were used for HDL-C and TC measurements, respectively. Inset: Detail 
of biosensor responses between 380 and 420 s.  
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Fig. ‎5.5. Chronoamperometric response at 420 s (-0.1 V (vs Ag/AgCl)) to 1 mM 
HDL-C in the presence and the absence of 1 mM LDL-C using selective and 
non-selective surfactants. 
5.2.1.2 Effect of Emulgen B-66 concentration on the selectivity of the HDL-C 
biosensor 
The effect of a number of surfactants and their concentration on the 
spectrophotometric measurement of HDL-C over LDL-C in PBS was assessed in 
Chapter 3 showing that the selectivity of HDL-C over LDL-C was improved by 
increasing the concentrations of Emulgen B-66 from 1 to 2.5 and 6% (Section 
3.3.3). While 1% (w/v) Emulgen B-66 showed acceptable selectivity towards HDL-C 
in PBS during amperometric measurement (Section 5.1.2), in this section, the effect 
of higher concentrations of the surfactant was investigated, initially using DBSA/KCl 
modified electrodes for the measurement of 0 to 5 mM H2O2 in stirred batch 
solution and then for HDL-C and LDL-C measurement in delipidated serum using 
encapsulated biosensors. As can be seen in Fig.  5.6, increased concentrations of 
2.5 and 6% (w/v) Emulgen B-66 had no significant effect on biosensor response to 
different concentrations of H2O2.  
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Fig. ‎5.6. Chronoamperometric measurement of H2O2 in 1, 2.5 and 6% (w/v) 
Emulgen B-66 (-0.1 V vs Ag/AgCl) in stirred batch solution.  
Therefore, HDL-C biosensors  containing 2.5 and 6% (w/v) Emulgen B-66 were 
further used to measure 2 and 4 mM LDL-C and 2 mM HDL-C to assess their 
selectivity towards HDL-C when measured amperometrically. Delipidated serum 
was used to prepare HDL-C and LDL-C solutions and was also used as a control 
(see Section 4.3.4). Fig.  5.7 and Table  5.6 illustrate that the background current did 
not change significantly for delipidated serum in the presence of different surfactant 
concentrations, showing that both Emulgen B-66 and Triton X-100 had similar 
effects on sensor response, which is likely to be due to the similar non-ionic 
properties of both detergents (see Section 4.5). HDL-C (2 mM) in the presence of 
both surfactants showed almost the same current responses, which again 
confirmed the result previously obtained from the spectrophotometric assay 
performed in PBS. LDL-C at 2 and 4 mM showed hardly any recovery in the 
presence of 6% (w/v) Emulgen B-66. In conclusion, 0.5% (v/v) Triton X-100 and 6% 
(w/v) Emulgen B-66 were found to be suitable for the amperometric measurement 
of HDL-C and TC prepared in delipidated serum. 
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Fig. ‎5.7. Biosensor responses of 2 mM HDL-C, 2 and 4 mM LDL-C in the 
presence of HDL-C selective and non-selective surfactants at 420 s and after 
180 s incubation time. 
 
Table ‎5.1. Current response of the biosensor to 2 mM HDL-C and 2 and 4 mM 
LDL-C prepared in delipidated serum in the presence of HDL-C selective and 
non-selective surfactants at 420 s after 180 s incubation.  
Sample 
I/A 
2.5% (w/v) 
Emulgen B-66 
6.0% (w/v) 
Emulgen B-66 
0.5% (v/v) 
Triton X-100 
Delipidated serum 1.36810-7 1.24210-7 1.24910-7 
2 mM HDL-C 2.04410-7 1.9510-7 2.1810-7 
2 mM LDL-C 1.60310-7 1.17610-7 2.14810-7 
4 mM LDL-C 1.64710-7 1.22110-7 2.60710-7 
To sum up, the DBSA/KCl modified silver electrodes were found to be suitable for 
the amperometric measurement of 0 to 6 mM HDL-C in PBS, and they were also 
found to be capable of measuring HDL-C over LDL-C amperometrically in PBS and 
delipidated serum with optimised selectivity in the presence of 6% (w/v) Emulgen 
B-66. As was discussed in Chapter 4, delipidated serum best represents the 
sample matrix for further assay development, having as it does a normal 
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composition of serum components except lipids. Therefore amperometric 
measurement of HDL-C in the 0 to 4 mM range was next assessed, this time using 
delipidated serum with 6% (w/v) Emulgen B-66.   
5.2.1.3 Amperometric measurement of HDL-C in delipidated serum 
The biosensor was first applied to the measurement of HDL-C in PBS and linearity 
and reproducibility studies were performed (Section  5.2.1). However, since the final 
aim of the project is to measure HDL-C in real serum samples, in this section the 
performance of the biosensor to the amperometric measurement of HDL-C 
prepared in delipidated serum using 6% (w/v) Emulgen B-66 was evaluated (Fig. 
 5.8, Fig.  5.9 and Table  5.2).  
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Fig. ‎5.8. Chronoamperometric response of encapsulated biosensors to 0 to 4 
mM HDL-C in delipidated serum at -0.1V (vs Ag/AgCl). Inset: Detail of 
biosensors response between 360 and 420 s.  
The amperometric response was taken at 420 s, this time following 180 s 
incubation time with an additional 60 s which was taken prior to amperometric 
measurement to equilibrate the three screen printed electrode system (240 s total 
reaction time) (Grennan, Killard and Smyth, 2001).  
Fig.  5.9 shows the unsubstracted chronoamperometric responses of the biosensor 
across the HDL-C measurement range. Controls (no enzyme and 0 mM HDL-C) 
show consistent background currents of <1 x 10-7 A, which is an acceptable value 
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of electrochemical background, most likely due to a combination of non-faradaic 
processes, most notably from the double layer charging effects of the DBSA/KCl 
surface modification. The cathodic current observed at 420 s was also found to be 
proportional to the HDL-C concentration and the encapsulated modified electrodes 
had a linear response of 4.510-8 A/mM (r2 = 0.998, n=3) between 0.5 and 4 mM 
HDL-C with an average RSD of 7.5 % (Table  5.2). A comparison of these results 
with those performed in PBS (Section 5.2.1) illustrated a 1.6-fold increase in slope 
in the presence of delipidated serum compared to PBS (slope=2.7810-8 A/mM) 
while the linearity did not change. Better reproducibility was observed after 
introducing the 60 s equilibration period before the start of amperometric 
measurement (RSD of 11.8% in PBS and 7.5% in delipidated serum). The current 
observed for 4 mM HDL-C in PBS was 2.6710-7 A which was very similar to that 
observed in delipidated serum (2.7610-7 A). However, the S/B observed for 4 mM 
HDL-C in PBS was calculated to be 2.0 while this was 2.9 in delipidated serum, 
showing an improvement in S/B current observed in the presence of delipidated 
serum, leading to a potentially better detection limit of the biosensor. This effect 
was also observed previously in Chapter 4 for the amperometric measurement of 3 
mM H2O2 in serum (Section 4.3.4). However, it can not be discounted that the 
improvement in slope might also be due to variations in the batches of screen 
printed electrodes used throughout the research which used different batches of 
silver ink (Gonzalez-Macia, Smyth and Killard, 2011). 
Table ‎5.2. Analytical data of amperometric measurement of 0 to 4 mM HDL-C 
in delipidated serum at 420 s after 240 s incubation using encapsulated 
biosensors. 
HDL-C 
(mM) 
Average 
current (A) 
S/B SD RSD (%) 
0 9.6710-8 - 8.8910-9 9.1 
0.5 1.1310-7 1.17 1.3210-8 11.6 
1 1.4110-7 1.46 9.7710-9 6.9 
2 1.7910-7 1.85 1.1110-8 6.2 
3 2.1610-7 2.23 2.0810-8 9.6 
4 2.7610-7 2.85 4.9910-9 1.8 
Average RSD (%) 7.5 
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Fig. ‎5.9. Biosensor response to HDL-C in delipidated serum at -0.1 V (vs 
Ag/AgCl); a) Biosensor containing 6% (v/v) Emulgen B-66, 39 U/mL ChEs and 
23 U/mL ChOx; (slope=4.4910-8, r2=0.998, n=3) (240 s incubation time, due to 
1 min for equilibrium); b) Biosensor controls in the absence of ChEs and 
ChOx (0.5 to 4 mM HDL-C) and in the presence of all assay components at 0 
mM (delipidated serum).  
In conclusion, the biosensor was capable of measuring HDL-C in delipidated serum 
with acceptable linearity, with reproducibility nearly always below 10% RSD. 
However, it was necessary to again establish that the biosensor was capable of 
selective measurement of HDL-C in the presence of LDL-C in a serum matrix. In 
the next section, amperometric measurement of HDL-C (up to 3 mM) prepared in 
delipidated serum containing 4 mM LDL-C was evaluated. 4 mM LDL-C was 
chosen as it is clinically a high borderline limit for LDL-C measurement.  
5.2.1.4 Selective amperometric measurement of HDL-C in mixtures of HDL-C 
and LDL-C in delipidated serum  
Selectivity of HDL-C over LDL-C in PBS was previously investigated in Section 
 5.2.1.1 using 1% (w/v) Emulgen B-66. However 6% (w/v) Emulgen B-66 was 
shown to have better selectivity towards HDL-C over LDL-C in delipidated serum 
( 5.2.1.2) and also demonstrated good sensitivity and linearity in measuring 0 to 4 
mM HDL-C in delipidated serum ( 5.2.1.3). In this section, the amperometric 
measurement of HDL-C (0 to 3 mM) was investigated in delipidated serum 
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containing 4 mM LDL-C with a 240 s incubation time using the encapsulated 
biosensors.  
Fig.  5.10 illustrates the amperometric measurement of delipidated serum containing 
4 mM LDL-C in the presence of Emulgen B-66 and Triton x-100. The presence of 
FC in the LDL-C serum sample was also assessed by omitting ChEs and 
surfactant. As can be seen, a comparable response was observed for FC and HDL-
C measured in 4 mM LDL-C, confirming that the slight increase in current observed 
in the presence of Emulgen B-66 might be due to FC present in the LDL-C. The 
different concentrations of HDL-C did not show any change in measured FC, 
suggesting that there was minimal FC present in the HDL-C material used (Fig. 
 5.11). The presence of a small quantity of FC has been reported by Nakamura et 
al., (2009) to be a source of uncertainty in HDL-C measurement using 
spectrophotometric methods (Nakamura et al., 2009). The response of the 
biosensor at 420 s to concentrations of HDL-C is shown in Fig.  5.12, showing a 
slope of 410-8 A/mM (r2=0.93). A slight decrease in sensitivity and linearity was 
observed in the presence of LDL-C compared to HDL-C alone (slope=4.5010-8 
A/mM, r2=0.998) ( 5.2.1.3).  
As shown in Table  5.3, some increase in the RSD (approx. 5%) was observed 
compared to samples prepared without LDL-C (Table  5.2) which might be due to 
some variability in sensor batches, as well as a slight negative effect on the sensor 
due to the presence of 4 mM LDL-C and finally a slight change in sample matrix 
which might be due to the presence of some insoluble LDL-C aggregates which 
may effect the way the produced H2O2 reaches the electrode surface (Gonzalez-
Macia, Smyth and Killard, 2011; Helm, Jalukse and Leito, 2010; Jeroschewski, 
Steuckart and Kulhl, 1996; Kondo, 1999; Segrest et al., 2001). Kondo et al., (1999) 
used electron microscopy technique to investigate the reaction in Daiichi HDL-C 
homogeneous assay kit containing polyanion-polymer/detergent showing that 
almost every lipoprotein aggregates in the presence of polyanion-polymer while 
only HDL-C aggregates was capable of being resolved and undergone the 
enzymatic reaction (Kondo, 1999).   
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Fig. ‎5.10. Chronoamperometric measurement of TC, HDL-C and FC present in 
delipidated serum containing 4 mM LDL-C using the developed biosensor. 
Inset: Biosensor response at 420 s in delipidated serum was used as control. 
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Fig. ‎5.11. Chronoamperometric measurement of FC present in delipidated 
serum containing 0 to 3 mM HDL-C and 4 mM LDL-C. Inset: Biosensor 
response at 420 s in delipidated serum was used as control. 
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Fig. ‎5.12. HDL-C biosensor response to delipidated serum containing 0 to 3 
mM HDL-C and 4 mM LDL-C. Inset: calibration curve (slope:  410-8 A/mM, 
r2=0.93, n=3). 
 
Table ‎5.3. Amperometric responses of the HDL-C biosensor to delipidated 
serum containing 0 to 3 mM HDL-C and 4 mM LDL-C at 420 s. 
HDL-C 
(mM) 
I/A  
(average current 
at 420 s) 
SD 
RSD 
(%) 
0 1.1210
-7
 1.3210
-8
 11.8 
0.5 1.3110
-7
 4.0410
-9
 3.1 
1 1.4910
-7
 8.1110
-9
 5.4 
1.5 1.6010
-7
 2.0310
-8
 12.7 
2 1.9610
-7
 4.4610
-8
 22.7 
2.5 1.9510
-7
 2.3710
-8
 12.2 
3 2.6610
-7
 5.2510
-8
 19.7 
Average RSD 12.5 
To sum up, the biosensor based on the DBSA/KCl modified silver electrode was 
successfully used to measure HDL-C in delipidated serum while in the presence of 
LDL-C. However, it was also observed that employing the surfactant Emulgen B-66 
in PBS resulted in a similar catalytic enhancement effect to the DBSA/KCl 
modification. It was hypothesised that the DBSA/KCl modification step could be 
removed and replaced entirely by Emulgen B-66. The next step, therefore, was to 
evaluate the effect of 6% (w/v) Emulgen B-66/PBS as an alternative electrode 
modifier to DBSA/KCl. Therefore in following section, this combination of 
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surfactant/salt was used to assess its effect on the modification of the silver screen 
printed electrodes and their sensitivity towards H2O2.  
5.2.2 Development of the HDL-C biosensor using Emulgen B-66/PBS 
modified electrodes 
As was mentioned by Gonzalez et al., (2011), a combination of surfactant/salt was 
found to enhance the catalytic activity of silver electrode towards H2O2. KCl in 
combination with DBSA was an example showing that the presence of salt was 
important factor to enhance catalytic activity of silver electrodes towards H2O2 
(Gonzalez-Macia, Smyth and Killard, 2011; Gonzalez-Macia, Smyth and Killard, 
2012b). However, the enhancement was also demonstrated for a range of 
surfactant/salt combinations. This effect was also observed using 6% (w/v) 
Emulgen B-66 in combination with 0.1M PBS on silver paste electrodes in stirred 
batch solution, as shown in Fig.  5.13.  
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Fig. ‎5.13. Amperometric measurement of 0 to 3 mM H2O2 using modification 
solution containing: a) 6% (w/v) Emulgen B-66 prepared in deionised water 
and b) 6 % (w/v) Emulgen B-66 prepared using 0.1 M PBS. 
The dependency of the effect on the presence of supporting electrolyte is clearly 
demonstrated here and further validates the nature of the effects previously 
observed which required the formation of electrolyte stabilised surfactant structures 
such as lamellar phases which modify the electrode surface.  
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The suitability of Emulgen B-66/PBS as a catalytic modifier was further investigated 
using different deposition techniques such as dip-coating, drop coating and finally 
inkjet-printing, the latter of which was proven to be a reproducible, quick and simple 
technique for patterning and depositing defined volumes of the modification 
solution. To begin with, a three electrode system containing screen printed silver 
working electrode was dipped into 6% (w/v) Emulgen B-66/PBS solution for 0, 5, 60 
and 180 min and then studied using cyclic voltammetry. As is shown in Fig.  5.14, 
by increasing the exposure time of the silver electrodes to the modification solution, 
the non-Faradic or charging current increased, showing that surface modification 
was occurring and was increasing in a time-dependent manner (Gonzalez-Macia, 
Smyth and Killard, 2011).  
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Fig. ‎5.14. Cyclic voltamograms of a) unmodified silver electrodes measured 
in PBS following exposure to 6% (w/v) Emulgen B-66/PBS for b) 0 min, c) 5 
min, d) 60 and e) 180 min. 
Following this, 3 µL of 6% (w/v) Emulgen B-66/PBS was drop-coated onto silver 
screen printed electrodes and allowed to incubate for 180 min. Drop coating using 
a defined volume of the modification solution was performed to see whether it was 
possible to move towards an inkjet-printing process, as had been demonstrated for 
DBSA/KCl previously (Gonzalez-Macia, Smyth and Killard, 2012b). Electrodes 
modified by inkjet printing were then prepared by printing five layers of 6% (w/v) 
Emulgen B-66/PBS at a nozzle voltage of 26 V using a 16-nozzle head cartridge 
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(approx. 1.2 µL reagent deposition). The electrode was allowed to dry for 5 min and 
the excess modification solution was washed using deionised water before cyclic 
voltammetric experiment was performed (Fig.  5.15).  
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Fig. ‎5.15. Cyclic voltamograms of unmodified silver electrode measured in 
6% (w/v) Emulgen B-66 using: a) un-modified electrode in PBS, b) electrodes 
dipped in 6% (w/v) Emulgen B-66/PBS for 180 min, c) drop coated electrode 
using 3 µL of 6% (w/v) Emulgen B-66/PBS, d) inkjet-printed electrode using 5 
layers 6% Emulgen B-66 (1.2 µL) 
The non-Faradic current observed at -0.1 V (vs Ag/AgCl) after 180 min modification 
time, was 2.3710-5 A for drop-coated modified silver electrode and 8.6210-7 A for 
electrode being dipped in 6% (w/v) Emulgen B-66/PBS while 2.5410-7 A was 
observed for an unmodified silver electrode in PBS. This was up to 900 and 300 
fold greater non-faradaic current for drop-coated compared to unmodified and dip-
coated modified electrodes, respectively showing again a significant modification of 
the surface with a capacitive double layer formed by Emulgen B-66 and PBS. The 
non-Faradic current observed for inkjet-printed modified electrodes was 1.1610-5A 
which was two-fold lower than that for the drop-coating technique, which might be 
due to the smaller volume of reagent used. The fact that modified electrodes 
prepared using the drop coating and inkjet printing techniques showed massive 
increases in their non-Faradic current and therefore on surface modification 
compared to those dipped into modification solution for 180 min, without the 
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requirement for a subsequent drying step, illustrates that the micellisation due to 
surfactant/salt aggregation which occurs at greater surfactant concentrations after 
deposition on the surface after inkjet-pinting and drop-coating may lead to better 
modification in comparison with dip-coating which requires diffusion of surfactant 
molecules from the bulk to the surface and then adsorption which depends on 
the surfactant concentrations (Eastoe, 2010).   
Amperometric measurement of H2O2 using un-modified electrodes and those 
modified using the inkjet-printing technique were then performed in both PBS and a 
solution of 6% (w/v) Emulgen B-66/PBS in stirred batch solution. The response of 
the inkjet-print modified electrodes showed the greatest sensitivity (2.5610-6 
A/mM) and linearity (r2=0.998), in a solution of 6% (w/v) Emulgen B-66/PBS while 
this was 9.5110-8 A/mM with r2 of 0.924 for un-modified electrode in PBS (Fig. 
 5.16). The current observed using unmodified electrodes in PBS was 22-fold lower 
than unmodified electrodes in 6% (w/v) Emulgen B-66/PBS which shows better 
catalysis in the presence of Emulgen B-66/PBS solution. However, this was still 8-
fold greater than the current observed for 3 mM H2O2 using unmodified electrodes 
in PBS. However, the current observed for 3 mM H2O2 in 6% (w/v) Emulgen B-66 
using modified electrodes were only 1.3-fold greater than that using unmodified 
electrodes. This demonstrated that 6% (w/v) Emulgen B-66/PBS could be 
employed as a modification of silver electrode for amperometric measurement of 
H2O2 in an assay solution which also contained 6% (w/v) Emulgen B-66/PBS.  Such 
an approach would be optimal, firstly for an optimised biosensor based on 
externally applied assay reagents, as well as for a biosensor in which the assay 
reagents have been fully integrated through printing (Chapter 6). 
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Fig. ‎5.16. Amperometric response of un-modified electrodes and those 
modified using inkjet-printed of 6% Emulgen B-66/PBS to 0 to 3 mM H2O2 in 
both PBS and 6% Emulgen B-66/PBS (stirred batch experiment).   
After demonstrating the possibility of employing of 6% (w/v) Emulgen B-66 for the 
modification of the silver electrodes, the next step was to optimise the volume of 
modification solution deposited using inkjet-printing. Inkjet printing is capable of 
rapid and reproducible deposition of very small volumes of ink and is suitable for 
mass production of modified electrodes at low cost. This is dependent on the 
physical properties of the ink. Ejection volume and nozzle voltage are also 
important factors for the optimisation of inkjet printing deposition (Hutchings and 
Martin, 2013; Magdassi, 2008; Tekin, Smith and Schubert, 2008). Since nozzle 
voltage did not show any significant affect on the formation of the catalytic surface 
(data not shown), and based on the density of ink solution, 26-27 V was found to be 
a suitable voltage for ejecting through a 16 nozzles printer cartridge. Considering 
the pattern of 3.23.2 mm with 20 µm spacing which provides 25,921 drops per 
layer, 0.24 µL of 6% (w/v) Emulgen B-66 was deposited on the silver electrode 
surface in each printed layer. By increasing the number of printed layers, the mass 
of deposited material will increase, while the concentration of solution does not 
change. Therefore, 5, 10 and 15 layers of 6% (w/v) Emulgen B-66/0.1 M PBS were 
printed on the surface of the silver electrodes and allowed to be dried for 5 min 
after printing. The excess modification solution was washed using deionised water 
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and then cyclic voltammetry and amperometric studies were performed using these 
electrodes in H2O2 solutions (0 to 3 mM). As can be seen in Fig.  5.17 A, the non-
Faradic current at -0.1 (vs Ag/AgCl) for 0, 5 and 10 prints was 4.3510-7 to 1.2 10-5 
and 2.1210-5 A, respectively, confirming that surface modification had occurred. 
By further increasing the print layers to 15, the shape of the voltammogram 
changed and the charging current of 9.2310-6 was observed which was approx. 
1.3 and 2.2 times less than those observed for 5 and 10 layers of prints. The 
current observed for 3 mM H2O2 at -0.1 V (vs Ag/AgCl) (Fig.  5.17B), using 15 layers 
inkjet-printed modified electrodes was also slightly lower than that observed for 10 
layers.  
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Fig. ‎5.17. Cyclic voltammogram of 0, 5, 10 and 15 layers inkjet-printed 6% 
(w/v) Emulgen B-66 modified silver electrodes in A) 6% (w/v) Emulgen B-
66/PBS  and B) 3 mM H2O2 prepared in 6% (w/v) Emulgen B-66/PBS solutions. 
A possible explanation for this behaviour might be due to the volume of 
modification solution required to be adsorbed to the silver electrode surface and the 
importance of the concentration of deposited modification solution on the electrode 
surface. The volume of deposited liquid on the electrode surface was 1.2, 2.4 and 
3.6 µL for 5, 10 and 15 layers, respectively. Since the same drying time of 5 min 
was used after printing of all different numbers of print layers before washing the 
excess modification solution, the extra modification solution in 15 layers prints may 
interfere with micellisation and aggregation of modification solution on the electrode 
surface in a similar way observed in electrode prepared by dipping into the 
modification solution (Eastoe, 2010). Killard and coworkers (2012b) also reported 
the similar effect at higher volume of modification solution.  
The effect of the number of print layers on the amperometric response to H2O2 
prepared in 6% (w/v) Emulgen B-66 is shown in Fig.  5.18 and detailed analytical 
data are illustrated in Table  5.4.  
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Fig. ‎5.18. Amperometric measurement of 0 to 3 mM H2O2 in 6% (w/v) Emulgen 
B-66 using 0, 5, 10 and 15 layers inkjet-printed 6% (w/v) Emulgen B-66/PBS 
modified electrodes (n=3) (stirred batch experiment). 
As can be seen, by increasing the number of prints from 5 to 10 and 15, sensitivity 
increased slightly from 2.0810-6 to 2.3310-6 and 2.4810-6, while linearity 
remained almost the same (r2=0.99). Random standard error was significantly 
improved after modification, with good reproducibility in 5 and 15 print layers. The 
error increased from 8% at 5 layers to 19.6% at 10 layers which might be due some 
variability in one of the silver electrodes out of the three used for this experiment. 
Since 15 layers did not show any significant improvement on silver electrode 
catalytic activity and based on the fact that 5 layers produced good linearity and 
reproducibility as well as presenting good catalytic activity, 5 prints were used for 
any future experiments. 5 print layers were also reported previously to provide an 
optimum modification solution for catalytic activity of silver surface (Gonzalez-
Macia, Smyth and Killard, 2012b). The fact that unmodified electrode in 6% (w/v) 
Emulgen B-66/0.1M PBS demonstrate slightly lower sensitivity than modified 
electrodes may be a good case for development of integrated biosensor which will 
be discussed in Chapter 6.  
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Table ‎5.4. Detailed analytical data of amperometric measurement of H2O2 (0 to 3 mM) using 0, 5, 10 and 15 layers Emulgen B-66 
modified electrodes (N=3). 
H2O2 
(mM) 
5 layers 
(I/A) 
SD 
RSD 
(%) 
10 layers 
(I/A) 
SD 
RSD 
(%) 
15 layers 
(I/A) 
SD 
RSD 
(%) 
unmodified 
electrode 
(I/A) 
SD 
RSD 
(%) 
0 3.2810
-8 
5.5210
-9
 16.8 4.7510
-8
 1.0810
-8
 22.8 3.1610
-8
 6.3910
-9
 20.2 1.1310
-8
 3.2910
-9
 29.2 
0.5 4.8210
-7
 4.7810
-8
 9.9 5.3110
-7
 1.1510
-7
 21.6 7.3710
-7
 4.0710
-8
 5.5 1.3910
-7
 6.0410
-8
 43.4 
1 1.2910
-6
 3.9810
-8
 3.1 1.5510
-6
 3.2110
-7
 20.7 1.8210
-6
 7.2710
-8
 4 1.0410
-6
 2.9010
-7
 27.8 
1.5 2.2610
-6
 1.2310
-7
 5.4 2.7410
-6
 4.7410
-7
 17.3 3.1210
-6
 1.1310
-7
 3.6 2.1610
-6
 5.3510
-7
 24.8 
2 3.4110
-6
 2.3410
-7
 6.9 3.8910
-6
 7.0710
-7
 18.2 4.3610
-6
 2.2110
-7
 5.1 3.1410
-6
 7.3910
-7
 23.6 
2.5 4.5010
-6
 3.1910
-7
 7.1 5.1110
-6
 9.4510
-7
 18.5 5.5510
-6
 2.7510
-7
 5 4.0510
-6
 9.3110
-7
 23 
3 5.6110
-6
 3.9510
-7
 7 6.3210
-6
 1.1510
-6
 18.1 6.9210
-6
 2.8110
-7
 4.1 4.8810
-6
 1.0810
-6
 22.2 
Average RSD 8.0 Average RSD 19.6 Average RSD 6.8 Average RSD 27.7 
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A final comparison study was performed between amperometric measurements of 
H2O2 in stirred batch mode using DBSA/KCl modified silver electrodes and those 
modified with 6% (w/v) Emulgen B-66/PBS which is shown in Fig.  5.19. Signal to 
background data for each concentration is detailed in Table  5.5. 
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Fig. ‎5.19. Comparison of electrode response to H2O2 with modification using 
DBSA/KCl or Emulgen-B66/PBS: A) DBSA/KCl modified electrodes and B) 
Emulgen B-66/PBS modified electrodes; Amperometric response to H2O2 
using: C) DBSA/KCl modified electrodes (Slope=1.6110-6A/mM; r2=0.988) and 
D) Emulgen B-66/PBS modified electrodes (slope=1.3110-6A/mM; r2=0.991). -
0.1 V vs. Ag/AgCl. 
Table ‎5.5. Signal to background (S/B) data of amperometric measurement of 0 
to 3 mM H2O2 using DBSA/KCl modified electrodes and those modified using 
6% Emulgen B-66/PBS both in 6% (w/v) Emulgen B-66/PBS. 
H2O2 
(mM) 
DBSA/KCl modified 
electrode in 6% 
Emulgen B-66  
6% Emulgen B-66/PBS 
modified electrode in 
6% Emulgen B-66  
  
I/A 
(Average) 
S/B 
I/A 
(Average) 
S/B 
0 8.1510
-8
 - 3.7110
-8
 - 
0.5 4.1510
-7
 5.1 3.7510
-7
 10.1 
1 1.1910
-6
 14.6 1.0510
-6
 28.3 
2 2.8910
-6
 35.4 2.3610
-6
 63.6 
3 4.7910
-6
 58.8 3.8910
-6
 104.8 
135 
 
Although no significant change was observed in the amperometric response of the 
modified electrodes to H2O2 as was shown in Fig.  5.19 using either of the 
modification methods, the signal to background responses observed for 6% (w/v) 
Emulgen B-66/PBS were almost two-fold higher compared to those modified with 
DBSA/KCl (Table  5.5). This might be due to the fact that most of the early charging 
current and initial faradaic current had decayed away for Emulgen B-66/PBS 
modified electrodes within 10 s and the electrodes had reached a quasi-steady 
state from which current measurements at fixed time points could be made while 
for DBSA/KCl modified electrodes this was around 150 s showing higher 
background current (Fig.  5.20). Therefore, better signal to background response as 
well as better sensitivity at lower concentration (0.5 mM) which is important in HDL-
C measurement was obtained for Emulgen B-66/PBS modified electrodes which 
made them a suitable alternative for amperometric measurement of HDL-C. In 
addition, the ability to employ Emulgen B-66/PBS as a modification solution instead 
of DBSA/KCl may reduce the number of preparation step in the development of a 
biosensor with integrated reagents, which will be discussed in next chapter.  
t/s
0 100 200 300 400
I/
A
0
1e-7
2e-7
3e-7
4e-7
5e-7
6e-7
DBSA/KCl modified electrode 1
DBSA/KCl modified electrode 2
DBSA/KCl modified electrode 3
t/s
0 100 200 300 400
I/
A
0
1e-7
2e-7
3e-7
4e-7
5e-7
6e-7
Emulgen B-66 Modified electrode 1
Emulgen B-66 Modified electrode 2
Emulgen B-66 Modified electrode 3
(A) (B)
 
Fig. ‎5.20. Background current and the current observed for 0.5 mM H2O2 in 
6% (w/v) EmUlgen B-66/PBS solution using: A) DBSA/KCl modified electrodes 
and B) Emulgen B-66/PBS modified electrodes (Stirred batch experiment). 
To summarise, five layers of inkjet-printed 6% (w/v) Emulgen B-66/PBS showed an 
acceptable analytical performance for the measurement of H2O2 in stirred batch 
experiments in the presence of 6% (w/v) Emulgen B-66/PBS, making it to be 
suitable as an alternative modification method to be used for the amperometric 
measurement of HDL-C. The next step was then to see if sensors prepared in this 
way would still be capable of measuring H2O2 in the presence of all other assay 
reagents.   
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5.2.2.1 Amperometric measurement of H2O2 in the presence of assay reagents 
using encapsulated electrodes 
After assessing the amperometric response of modified electrodes in stirred batch 
solution, the amperometric response of encapsulated electrodes modified using 
Emulgen-B66/PBS to 0 to 10 mM H2O2 in the presence of assay reagents was 
assessed and compared to those performed using DBSA/KCl modified electrodes 
(Fig.  5.21, Table  5.6). 
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Fig. ‎5.21. Amperometric measurement of H2O2 at 420 s in the presence of 
assay reagents using A) DBSA/KCl modified electrodes and B) Emulgen B-
66/PBS modified electrodes (240 s incubation time). 
Table ‎5.6. Signal to background (S/B) data of amperometric measurement of 0 
to 10 mM H2O2 at 420 s using encapsulated DBSA/KCl and 6% (w/v) Emulgen 
B-66/PBS modified electrodes (240 s incubation time). 
H2O2/
mM 
DBSA/KCl 
modified 
electrodes  (I/A) 
S/B 
Emulgen B-66/PBS 
modified electrodes  
(I/A) 
S/B 
0 7.7610
-8
 - 4.0910
-8
 - 
0.5 8.1810
-8
  1.05 4.5010
-8
 1.10 
1 8.8710
-8
 1.14 5.1810
-8
 1.27 
2 1.2410
-7
 1.60 6.9810
-8
 1.70 
4 2.0810
-7
 2.68 1.0710
-7
 2.62 
6 2.7410
-7
 3.53 1.4310
-7
 3.50 
8 3.6810
-7
 4.74 1.9410
-7
 4.74 
10 4.1510
-7
 5.35 2.4210
-7
 5.92 
The slope of 2.110-8 with linearity (r2) of 0.994 was observed for encapsulated 
Emulgen B-66/PBS modified electrodes which was 1.76-fold lower compared to the 
one observed for encapsulated DBSA/KCl modified electrodes (3.710-8) with 
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almost the same linearity for amperometric measurement of 0.5 to 10 mM H2O2. 
However, a slightly better S/B was observed for Emulgen B-66/PBS modified 
electrodes compared to those modified with DBSA/KCl (Table  5.6). To sum up, the 
encapsulated Emulgen B-66/PBS modified electrodes were capable of measuring 
H2O2 in the presence of assay reagents with acceptable linearity and sensitivity. 
Therefore, the next step was to evaluate the amperometric response of these 
electrodes to the amperometric measurement of HDL-C in delipidated serum.  
5.2.2.2 Measurement of HDL-C using a biosensor based on Emulgen B-
66/PBS modified electrodes  
The response of Emulgen B-66/PBS modified electrodes to 8 µL of 0 to 4 mM HDL-
C in the encapsulated electrodes is shown in Fig.  5.22 and Table  5.7. 
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Fig. ‎5.22. Biosensor response to HDL-C in delipidated serum at -0.1 V (vs 
Ag/AgCl). a) Biosensor controls in the absence of ChEs and ChOx; b) 
Biosensor containing 6% (w/v) Emulgen B-66, 39 U/mL ChEs and 23 U/mL 
ChOx; (slope=3.3210-8, r2=0.999, n=5). 
The amperometric response taken at 420 s and after 240 s incubation time was 
found to be proportional to the HDL-C concentration. The encapsulated biosensor 
showed a slope of 3.3210-8 A/mM with linearity (r2) of 0.9999 for five repeats 
between 0.5 to 4 mM HDL-C prepared in delipidated serum while DBSA/KCl 
modified electrodes had a slope of 4.510-8 A/mM with linearity (r2) of 0.998 for 
three repeats. Once again, slight decrease (1.36-fold) in slope was observed using 
Emulgen B-66/PBS modified electrodes compared to modification using DBSA/KCl. 
However, better signal to background data and consequently better sensitivity was 
observed for amperometric measurement using Emulgen B-66/PBS modified 
electrodes compared to that observed for DBSA/KCl. This might be due to the 
smaller and more stable background currents observed for Emulgen B-66 modified 
electrodes, which was discussed previously in Section 5.2.2. Average RSD 
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observed for five repeat measurements using Emulgen B-66/PBS modified 
electrodes was 9.5% while this was 7.5% for three repeats using DBSA/KCl 
modified electrodes.  
Table ‎5.7. Detailed analytical data of amperometric measurement of 0 to 4 mM 
HDL-C using encapsulated Emulgen B-66/PBS modified electrodes. 
HDL-C 
(Mm) 
Average 
current (A) 
S/B SD 
RSD 
(%) 
0 4.0710-8 - 3.0910-9 7.6 
0.5 4.8010-8 1.18 6.9610-9 14.5 
1 6.3510-8 1.56 5.0510-9 7.9 
2 9.7410-8 2.39 1.2810-8 13.2 
3 1.3110-7 3.22 7.7710-9 5.9 
4 1.6410-7 4.02 1.2510-8 7.6 
Average RSD 9.5 
Kinoshita et al., (1998) developed one of the first amperometric HDL-C sensors 
based on a homogeneous assay in which a peroxidase-entrapped and ferrocene-
embeded carbon paste electrode was used to measure the H2O2 produced after the 
enzymatic reaction of HDL-C. PEG-modified enzymes in the presence of -
cyclodextrin sulphate and MgCl2 were employed to impart selectivity to the 
measurement of HDL-C. This method was performed at 37°C and was only linear 
up to 0.04 mM. However, since it is important to measure HDL-C directly up to at 
least 2 mM preferentially at room temperature, their method would be unsuitable for 
the development of a point of care device.  
Foster, Cassidy and O’Donoghue, (2000) developed an electrochemical device for 
HDL-C based on a precipitation methodology in which phosphotungstic acid (PTA) 
and MgCl2 were employed as the precipitation reagents. However, incorporation of 
this method on a disposable platform has also proved challenging. Murphy et al., 
(2009) in their patent also reported the use of a surfactant selected from sucrose 
esters and maltoside to selectively measure HDL-C. This method is based on using 
coenzyme (NAD+) and a redox agent capable of accepting electrons from the 
coenzyme and transfers it to the electrode. They have also employed delipidated 
serum for control measurement and the current response at 154 s was used to 
produce a calibration curve. Using a mediatorless sensor as a platform such as in 
the sensor developed in this research may lead to simpler device compared to 
those in the presence of redox mediator. 
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To sum up, by changing the modification method from DBSA/KCl to Emulgen B-
66/PBS, an improvement on the signal to background of the biosensor was 
observed with no other significant changes on HDL-C biosensor parameters. Since 
use of Emulgen B-66/PBS modified electrode may remove a preparation step for 
an integrated HDL-C biosensor, this modification solution was used for all future 
experiments for the analysis of clinical samples. 
5.2.3 Clinical HDL-C sample measurement 
The application of the HDL-C biosensor was evaluated in serum samples. Two sets 
of samples were used.  One set was referred to as ‘calibrators’ and were spiked 
human serum samples. The other set was composed of donor samples which were 
un-manipulated ‘off the clot’ serum samples from a donor population in San Diego, 
USA (Table  5.8).  
Table ‎5.8. Detailed analytical results of serum samples as per certificate of 
analysis and those measured using Abcam assay kit. Calibrators highlighted 
in grey. 
Samples 
ID 
TG 
(mg/dL) 
TC  
(mM) 
FC (mM) 
colorimetric 
value  
GLU 
(mg/dL) 
HDL-C(mM) 
Certified 
value 
Colorimetric 
value 
1 39.5 1.47 0.18 26 0.3 0.31 
2 138 3.57 0.45 48 0.72 0.53 
3 163.5 4.23 0.63 70 0.95 0.88 
4 183.5 4.93 0.68 92 1.2 1.12 
5 127.5 4.89 0.52 113 1.39 0.98 
6 127 4.17 0.42 136 1.7 1.2 
7 126.5 3.63 0.41 183 2.175 1.21 
8 160.5 5.56 0.63 231 0.699 0.58 
9 211 6.34 0.63 267 1.24 0.87 
10 174 7.5 0.7 316 0.44 0.66 
11 205 8.96 0.72 360 0.62 0.61 
1085S 104.1 5.5 0.7 73 2.33 1.14 
1087S 94.1 4.11 0.57 128.8 1.2 0.63 
1106s 289.9 3.7 0.64 120.7 0.74 0.29 
The HDL-C concentration in all the samples provided was measured using a 
spectrophotometric precipitation assay methodology (Abcam, UK) at the same time 
as  the developed biosensor as HDL-C levels have been shown to decline in 
samples during storage and deviated from their certificated values (Ignatius et al., 
2009; Valentine Charlton-Menys, 2007). According to Table  5.8, samples 1, 2, 5, 7 
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and 10 with HDL-C concentrations of 0.31, 0.53, 0.98, 1.21 and 0.66 were used to 
prepare a calibration curve and the rest were used for HDL-C sample 
measurements (Fig.  5.23).  
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Fig. ‎5.23. Amperometric responses of the HDL-C biosensor to clinical serum 
samples. 
The calibration curve showed a sensitivity of 3.1810-8 A/mM with r2 of 0.95. The 
linearity was decreased compared to that prepared using HDL-C in delipidated 
serum which might be due to some variability in serum matrix as a result of 
presenting different concentrations of triglyceride, glucose and other serum 
constituents in each sample (Helm, Jalukse and Leito, 2010; Zhang, Ju and Wang, 
2008). The correlation between the HDL-C biosensor and Abcam assay kit had a 
slope of 0.87 and a Pearson correlation coefficient of 0.76 (n=13) (Fig.  5.24 and 
Table  5.9).   
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Fig. ‎5.24. Correlation of HDL-C in serum measured by the biosensor and the 
Abcam assay kit (n=13) (slope= 0.87, r=0.76). 
Table ‎5.9. HDL-C concentrations measured using HDL-C sensor in 
comparison with the result measured using Abcam assay kit. 
sample 
ID 
Assay kit/ 
mM 
HDL-C sensor/ mM 
1st 
repeat 
2nd 
repeat 
3rd 
repeat 
1 0.32 0.56 0.02 -  
2 0.53 0.76 0.77 0.58 
5 0.98 1.19 0.78  - 
7 1.21 1.44 1.26  - 
10 0.66 0.65 0.93  - 
3 0.88 0.90 0.63 0.33 
4 1.12 1.18 0.98  - 
6 1.20 0.89 1.14  - 
8 0.58 0.74 0.87  - 
9 0.87 1.31 1.31  - 
11 0.61 1.98 1.90  - 
1085S 1.14 0.80 0.73 0.63 
1087S 0.64 0.34 0.18 1.26 
1106S 0.29 0.33 0.47 0.23 
Sample 11 showed very high HDL-C in its both measurements. Although the 
reason for that is unknown, this might be due to the presence of high levels of FC. 
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Falsely elevated HDL-C in patients with type III hyperlipoproteinaemia was reported 
for the Roche assay in serum when it was compared with phosphotungstate 
magnesium precipitation which was due to the VLDL sub-fraction (Lackner and 
Schmitz, 1998). Since there was no more information about the samples other than 
those detailed in Table  5.9, by discarding the results for sample 11, the Bland–
Altman plot which calculates the mean difference between the two methods of 
measurement is shown in Fig.  5.25.  No significant bias was observed between the 
two methods across the measured range with most of the measurements within two 
standard deviations of the mean (Bland and Altman, 1999).  
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Fig. ‎5.25. Bland–Altman plot of the difference between sensor/abcam assay 
kit against the mean measurement of two methods in the 26 measurements 
The mean of differences shown in the Bland-Altman plot is the estimated bias 
(difference between methods) which was 0.029 mM for HDL-C biosensor 
developed in this research and the standard deviation (SD) according to the Bland-
Altman plot was approx. 0.26 mM which presents random fluctuations around its 
mean (Owiredu, Teye and Quaye, 2013). If the limits of agreement which is the 
mean difference ± 2SD between two methods are not clinically important, the two 
methods are comparable. However, according NCEP accuracy guideline, the 
mathematical mean of biases for HDL-C measurement should be less than 1 mg/dL 
(0.0259 mM) when compared with CDC method (Warnick, 1995). While the method 
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developed in this research showed agreement with the precipitation method used 
for comparison, its estimated bias (0.029) was 1.1-fold greater than the NCEP 
accepted higher bias level of 0.0259 mM.    
Kinoshita et al., (1998) reported the only previous example of an externally mixed 
amperometric HDL-C sensor which was used to measure HDL-C in 34 human 
serum samples showing an mean difference between methods of -0.05 mM and SD 
of approx. 0.3 mM for its Bland–Altman plot compared to the sensor developed in 
this research which had a mean difference of 0.029 mM and SD of approx. 0.26 
mM. 
By looking at two HDL-C point of care testing systems such as CardioCheck PA 
and Cholestech LDX with CRMLN certification, the correlation coefficient of 0.77 
(n=101) and 0.95 (n=119) were reported against IL 600 and Kodak 700 analyser, 
respectively (Batki et al., 1995; Batki et al., 2005; Patel et al., 2011). IL 600 and 
Kodak 700 were used as NECP certified methods. The CardioCheck PA and 
Cholestech LDX are the two smallest POCT HDL-C and total cholesterol 
measurement systems that support the NHS health check vascular risk 
assessment. Cardiocheck PA is based on a spectrophotometric method and the 
measurement of the light reflected off a test strip that has changed colour after 
applying blood. The analyzer converts this reading into an HDL result and displays 
it (CardioCheck PA user manual). The Cholestech LDX System combines the 
enzymatic methodology and solid-phase technology to measure TC, HDL-C, TGs, 
glucose, and others.  The sample is applied to a Cholestech LDX cassette. The 
cassette is then placed into the Cholestech LDX analyzer that can measure the 
resultant colour by reflectance photometry (Cholestech LDX user manual). Both of 
the machines are used as a near patient POC device and require an expert for 
perfuming test (Batki et al., 2005; Panz et al., 2005). 
In general, the biosensor indicated slightly higher HDL-C concentrations compared 
to the assay kit. Although the exact reason for that is not known, it may be due to 
varying levels of free cholesterol present in the samples, as this has been shown to 
affect the response of this type of assay (Yamamoto, Yamamoto and Nakanishi, 
2011). Nakamura et al., suggested a method employing a reaction accelerator such 
as Flufenamic acid in combination with ChOx as a sample pretreatment to remove 
free cholesterol before measuring cholesterol contained in specific lipoprotein 
(Nakamura et al., 2009).  
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On the other hand, HDL-C measurement is very challenging due to very small 
differences in its concentrations which can lead an even small analytical error to 
misclassification. Even newer assay kit showed a poor agreement with designated 
comparison methods (DCM) (Contois, 2012). Miller et al.,(2010) also reported that 
out of eight homogeneous HDL-C assays, six of them failed to meet NCEP total 
error goals in the healthy control group, while all of them failed to meet goals for the 
donors with cardiovascular disease or lipoprotein disorders (Miller et al., 2010). It 
has been also reported that most homogeneous assay methodologies give positive 
predictive values due to the presence of intermediate density lipoproteins (IDL) in 
the serum, or in the presence of high levels of Lp(a) (Nakamura et al., 2006). While 
the biosensor was developed based on the homogeneous assay methodology, the 
Abcam assay kit is based on the precipitation principle (Arranz-Peña, 1998; 
Bairaktari et al., 1999; Cobbaert et al., 1998; Harris et al., 1997). Therefore, 
discrepancies between the two methods are very likely to be due to the differences 
in the methods and how they process and respond to the complex mixtures of lipids 
and lipoproteins in the sample.  
To sum up, an electrochemical biosensor was developed for the selective 
measurement of HDL-C. The sensor was able to achieve both selectivity and 
sensitivity enhancements using the surfactant Emulgen B-66. The presence of this 
surfactant was shown to selectively dissolve HDL over LDL. In addition, it also 
resulted in an enhanced electrocatalysis of H2O2 which is produced following the 
release of cholesterol ester and cholesterol from HDL and its catalysis by ChEs and 
ChOx, respectively. The biosensor was shown to have good linearity across the 
diagnostically relevant range. Despite some deviation which was observed in some 
of the samples, the biosensor was successfully applied to the measurement of 
HDL-C in real samples. Following development of the HDL-C biosensor by mixing 
assay reagents externally, the next step was to evaluate whether the same strategy 
could be used to develop TC biosensor by substituting Emulgen B-66 with Triton X-
100 which will be discussed in the following section.  
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5.3 Development of a TC biosensor 
The first step in the enzymatic reaction of TC in serum samples is through the 
disruption of all the lipoproteins carrying serum cholesterol using Triton X-100 
which was shown to successfully disrupt lipoproteins and make their cholesterol 
ester available for enzymatic reaction with cholesterol esterase (Deacon and 
Dawson, 1979; Kinoshita et al., 1998). Initial investigations were performed to find 
the optimal Triton X-100 concentration suitable for the enzymatic reaction of TC 
(Section 3.3) and its effect on the electrocatalysis of the DBSA/KCl modified 
electrodes was evaluated via amperometric measurement of H2O2 (Section 4.3.6). 
As was the case of the HDL-C biosensor, the DBSA/KCl modified silver electrode 
was used initially as a platform for the TC biosensor. However, the possibility of 
using an alternative modification solution of 0.5% (v/v) Triton X-100/PBS for 
development of the TC biosensor was evaluated and its application to the 
amperometric measurement of TC in serum samples was assessed.  
5.3.1 Development of the TC biosensor using DBSA/KCl modified electrodes 
Initially, the same concentrations of the enzymes applied for HDL-C measurement 
were used to measure TC. LDL-C stock solution with a TC concentration of 151.67 
mM, FC concentration of 34.88 mM and HDL-C concentration of 5.26 mM was 
used to prepare 2 to 16 mM TC in delipidated serum. Encapsulated DBSA/KCl 
modified electrodes were used to measure TC in the presence of the same 
concentrations of enzymes as was mentioned previously in section 5.2 and 0.5% 
(v/v) Triton X-100. The amperometric responses of biosensors to each 
concentration were then measured at 420 s after 240 s incubation at room 
temperature and are shown in Fig.  5.26. As can be seen, a linear response was 
observed from 2 to 8 mM cholesterol, but which plateaued with a slight decrease at 
concentrations above 10 mM.  Since the final aim of the project was to measure TC 
directly and without any dilution, ChEs and ChOx concentrations were re-optimised 
in order to improve linearity up to 10 mM TC (5 mM final solution concentration). 
Therefore, the effect of different enzymes concentration on the amperometric 
response of the biosensor to 8 µL of delipidated serum containing LDL-C (0 to 10 
mM) was evaluated. 
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Fig. ‎5.26. Amperometric response of the TC biosensor at 420 s to 2 to 16 mM 
TC in the presence of 23 U/mL ChOx, 39 U/mL ChEs and 0.5% (v/v) Triton X-
100 (240 s incubation time was applied) 
As was mentioned in Chapter 3, enzymatic assays can be performed either when 
the reaction has gone to completion, or kinetically, by looking at the rates of 
reaction during the earlier phase of the assay (Copeland, 2000; Tipton, 1992). 
Therefore, for optimisation purposes, and based on the fact that this is a coupled 
enzyme reaction, different combinations of ChEs/ChOx as summarised in Table 
 5.10 were investigated and amperometric measurement was performed following 
240 s incubation at room temperature and the current responses at 200 s and 420 
s  were assessed. The results for each ChEs/ChOx combination are shown in 
Table  5.10 and plotted as shown in Fig.  5.27.  
As can be seen, measurement at 200 s did not show acceptable linearity or 
reproducibility, which might be due to some interference caused by non-Faradic 
current at the beginning of the measurement as well as incompletion of the reaction 
at higher TC concentrations, while the biosensor showed better linearity and 
reproducibility at 420 s resulting in it being used as a suitable measurement time in 
further experiments. As can be seen in Fig.  5.27, almost all the ChEs/ChOx 
combinations failed to give linearity greater than 0.96 for up to 11 mM TC 
measurements. Only the combination in Fig. 5.27 G (156 U/mL ChEs and 60 U/mL 
ChEs) showed the greatest slope of 2.8610-8 A/mM with linearity of 0.978 (r2) for 
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up to 11 mM TC concentration using the encapsulated DBSA/KCl modified 
electrodes. Further increase in ChOx concentrations in the presence of 156U/mL 
ChEs (Fig. 5.27 H) led to a significant decrease in both linearity and slope which 
might be due the coupled enzymes characteristic of the reaction. This was also 
reported by Noma and Nakayama (1976). As is summarised in Table  5.10, no 
significant improvement was observed by changing the concentrations of ChEs and 
ChOx. This might be due to the coupled enzyme properties of the reaction which, in 
the first step, cholesterol ester in the presence of ChEs produces non-esterified 
cholesterol. Then non-esterified cholesterol in the presence of ChOx produces 
H2O2. In this coupled assay, the concentration of non-esterified cholesterol 
depends on its rate of formation by ChEs and the rate of removal by ChOx. If the 
concentration of cholesterol ester is greater than its Km for ChEs (310
-5 M), the first 
reaction is zero order. Therefore the concentration of esterified cholesterol does not 
change significantly when non-esterified cholesterol is formed. The concentration of 
non-esterified cholesterol then increases to reach a steady-state concentration 
which is high enough that the rate of ChOx becomes almost equal to the rate of 
ChEs. Reaching of non-esterified cholesterol to its steady-state concentration very 
much depends on its Michaelis constant for ChOx and the concentration of ChOx 
presents. The time which non-esterified cholesterol is building up, results in a lag 
phase in enzymatic reaction.  
Table ‎5.10. ChEs and ChOx concentrations applied for optimisation study in 
amperometric measurement of TC and biosensor analytical response at 200 
and 420 s. 
Sample 
ID 
ChEs 
(U/mL) 
ChOx  
(U/mL) 
at 200 s at 420 s 
Slope  
linearity         
(0-11 mM) 
Slope 
linearity         
(0-11 mM) 
A 78 20 2.1310-8 0.948 2.6210-8 0.957 
B 78 40 5.1810-8 0.923 1.9010-8 0.948 
C 78 60 3.7410-8 0.482 2.5010-8 0.883 
D 78 100 4.5310-8 0.885 2.4810-8 0.750 
E 156 20 4.0410-8 0.603 2.7510-8 0.889 
F 156 40 5.3510-8 0.873 2.4310-8 0.905 
G 156 60 3.4210-8 0.509 2.8210-8 0.953 
H 156 100 2.4110-8 0.362 2.2110-8 0.774 
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Fig. ‎5.27. Amperometric response of the TC biosensor at TC concentrations 
of 0 to 11 mM at t=200 s and 420 s in the presence of different ChEs/ChOx 
combinations: A) 78/20, B) 78/40, C) 78/60, D) 78/100, E)156/20, F) 156/40, G) 
156/60 and H) 156/100 U/mL. 
As can be seen this type of assay has unusual feature of having a long lag phase 
which the amount of second enzymes can influence the rate of the first enzyme as 
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well as kinetic characteristics of the reaction. So depends on the activity of the 
enzymes (ChEs and ChOx) and the lag phase of coupled enzymatic reaction, the 
amount of H2O2 produced may be vary (Copeland, 2000; Tipton, 1992). The 
optimum slope and linearity was thus observed in the presence of 156 U/mL ChEs 
and 60 U/mL ChOx up to 11 mM TC concentration as shown in Table  5.10. 
To assess whether a shorter incubation time lead to better linearity on the 
DBSA/KCl modified electrode response, due to coupled characteristic of the 
reaction, an assay employing the optimum enzyme concentrations was used to 
measure TC (0 to 11 mM) in the presence of 0.5% (v/v) Triton X-100, this time 
following 180 s incubation (Fig.  5.28).  
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Fig. ‎5.28. Amperometric measurement of 0 to 11 mM TC in the presence of 
156 U/mL ChEs and 60 U/mL ChOx and after 180 s incubation time. Inset: 
Biosensor response to 0 to 11 mM TC concentration at 420 s. 
As can be seen the current response at 420 s had a sensitivity of 2.110-8 A/mM 
which was 1.4-fold less than that observed following 240 s incubation, while 
linearity was similar with r2=0.960. Therefore, since 240 s provided better sensitivity 
compared to 180 s, while having comparable linearity this incubation time was 
employed for future TC measurements. 
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Noma and Nakayama (1976) reported the first polarographic method based on the 
consumption of oxygen produced after the enzymatic reaction of serum cholesterol 
using ChEs, ChOx and 0.1% (v/v) Triton X-100 in phosphate buffer pH 7.0. This 
method was unsuitable for the clinical laboratory as the measurement of oxygen 
consumption was not reliable. The most suitable enzymatic methods for TC 
measurement as described in Chapter 1 have been the spectrophotometric 
measurement of H2O2 using a HRP, 4 AAP and a Trinder’s dye. The first enzymatic 
determination of TC in serum using cholesterol ester hydrolysis and ChOx was 
reported by Allain et al., (1974) which used a 100-fold sample dilution and was 
linear up to 15 mM (Allain et al., 1974). ChEs from Pseudomonas sp. appeared to 
be the preferred enzyme with significant improvement in specificity for the 
enzymatic reaction of TC (Rifai, Warnick and Dominiczak, 2001).  While most 
methods employing reagent additions are based on spectrophotometric methods, 
almost all the recent reports for TC biosensors have been based on methods on 
which the enzymes are immobilised on the electrode surface (Arya, Datta and 
Malhotra, 2008). Since TC measurement is critical for calculation of non-HDL-C 
and LDL-C, development of a TC biosensor using the same platform as HDL-C was 
found to be very essential.   
To sum up, enzyme concentrations of 156 U/mL ChEs and 60U/mL ChOx were 
found to be optimum for the enzymatic reaction of TC using DBSA/KCl modified 
electrodes in the presence of 0.5% (v/v) Triton X-100. However, in a manner 
analogous to that already established for the HDL-C assay, it was hypothesised 
that a TC biosensor could also be based on the silver paste electrodes modified 
with Triton X-100/PBS rather than DBSA/KCl, so removing an unnecessary 
preparation step in the assay and facilitating more effective integration of a fully 
printed biosensor as will be demonstrated in Chapter 6.  
5.3.2 Development of the TC biosensor using Triton X-100/PBS modified 
electrodes 
It was shown in the previous chapter (Section 4.3.6) that 0.5% (v/v) Triton X-100 
had almost the same effect on the electrocatalysis of modified electrodes towards 
H2O2 prepared in delipidated serum as that observed in 6% (w/v) Emulgen B-66. 
Furthermore, Triton X-100 has been reported to enhance the response of silver 
screen printed electrodes in the presence of KCl (Gonzalez-Macia, Smyth and 
Killard, 2011). While Gonzalez-Macia et al., (2011) reported the use of 33 mM 
151 
 
Triton X-100 (approx. 2% (w/v)) in the presence of a lower salt concentration (0.1 
mM KCl) as achieving optimal electrocatalysis, a concentration of 0.5% (v/v) Triton 
X-100 was found to be optimal for measurement of TC. Thus, the effect of 0.5% 
(v/v) Triton X-100/PBS as a modification solution was compared to DBSA/KCl 
modified electrodes. Five layers of 0.5% (v/v) Triton X-100/PBS were inkjet-printed 
on silver paste electrode using a similar method employed for DBSA/KCl. Cyclic 
voltammetric experiments was performed using both modified electrodes in 0.5% 
(v/v) Triton X-100 in PBS followed by 3 mM H2O2 in the same solution (Fig.  5.29). 
Although Triton had a slightly different double layer charging, especially around -0.1 
V, which might reduce the signal to background, DBSA/KCl showed marginally 
better electrocatalysis. 
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Fig. ‎5.29. Cyclic voltammograms of electrodes modified in Triton X-100/PBS 
solution (a and c) or DBSA/KCl (b and d), measured in Triton/PBS (a and b) or 
Triton/PBS and 3 mM H2O2 (c and d) (vs. Ag/AgCl).   
0.5% (v/v) Triton X-100/PBS was then assessed as an electrode modifier and its 
effect on the cyclic voltammetric and amperometric measurement of H2O2 in stirred 
batch solution on silver paste electrodes was investigated In a similar way as was 
mentioned in Section  5.2.2. Five layers of 0.5% (v/v) Triton X-100/PBS solution 
were inkjet-printed onto silver paste electrodes and their electrocatalytic response 
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to H2O2 studied in stirred solution (Fig.  5.30). Detailed analytical data are shown in 
Table  5.11.  
Table ‎5.11. Detailed analytical results of amperometric measurement of 0 to 5 
mM H2O2 using unmodified and Triton X-100/PBS modified electrodes. 
[H2O2] 
/mM 
unmodified 
in PBS 
Unmodified in Triton 
X-100/PBS 
Triton X-
100/PBS 
modified 
in PBS 
Triton X-100/PBS 
modified in Triton X-
100 
1 5.4210
-8
 8.8010
-7
 1.0610
-6
 8.3110
-7
 1.7610
-6
 1.7610
-6
 
2 1.8310
-7
 2.6010
-6
 3.1110
-6
 2.2510
-6
 4.5410
-6
 4.5810
-6
 
3 3.2210
-7
 3.9410
-6
 5.2110
-6
 3.9210
-6
 7.2910
-6
 7.1010
-6
 
4 4.6510
-7
 5.3410
-6
 7.1710
-6
 5.5910
-6
 1.0110
-5
 9.73(10-6 
5 5.9110
-7
  6.5510
-7
 9.1310
-7
 7.3010
-7
 1.3010
-7
 1.2410
-5
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Fig. ‎5.30. Amperometric measurement H2O2 in stirred solution at 420 s using 
unmodified and Triton X-100/PBS modified electrodes in both PBS and 0.5% 
(v/v) Triton X-100/PBS solution. 
The current observed using an electrode modified in Triton X-100/PBS and 
measured in Triton/PBS was 1.2810-5 A for 5 mM H2O2 which was approx. 216-
fold greater than that observed for unmodified electrode in PBS (5.9110-7 A) 
illustrating a significant catalytic effect when the electrode was both modified with 
Triton/PBS using inkjet printing and when measurement was performed in the 
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presence of Triton/PBS. Unmodified electrodes which were used to measure H2O2 
in Triton/PBS solution showed almost the same catalysis as that observed for 
modified electrodes in PBS showing that the presence of Triton X-100/PBS is 
essential for enhanced catalysis. Amperometric measurement of H2O2 in 0.5% (v/v) 
Triton X-100/PBS solution was also assessed using both electrodes modified with 
both DBSA/KCl and Triton/PBS in stirred batch solution (Fig.  5.31). Slightly better 
current responses were observed for H2O2 concentrations using the DBSA/KCl 
modified electrodes compared to 0.5% (v/v) Triton X-100/PBS which might be due 
to the use of Triton X-100 and PBS at concentrations optimised for TC 
measurement, rather than for electrocatalysis. However, only a slight reduction was 
observed due to this difference, demonstrating the suitability of using Triton/PBS as 
an alternative modification method to DBSA/KCl.  
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Fig. ‎5.31. Amperometric response of electrodes modified using DBSA/KCl or 
Triton/PBS to H2O2 in stirred batch solution at -0.1 V (vs. Ag/AgCl) (n=3). 
A further experiment was performed to find the optimum volume of modification 
solution to achieve maximum electrocatalysis and electrode reproducibility. 
Electrodes were modified by inkjet-printing of 5, 10 or 15 layers of 0.5% (v/v) Triton 
X-100/PBS at a nozzle voltage of 26 V using a 16-nozzle head cartridge (approx. 
1.2 µL reagent deposition). The electrodes were allowed to dry for 5 min and the 
excess modification solution was then washed using deionised water. A cyclic 
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voltammetric study was then performed. Fig.  5.32 A shows increases in charging 
current of 13-fold for 5 and 10 layers and 23-fold for 15 layers compared to un-
modified electrodes. CVs in 5 mM H2O2 showed increased cathodic currents 
following modification (Fig.  5.32 B). 
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Fig. ‎5.32. Cyclic voltammograms of unmodified electrodes and those 
modified with 5, 10 and 15 inkjet-printed layers in: A) 0.5% (v/v) Triton X-
100/PBS solution and B) 5 mM H2O2 . 
Table ‎5.12. Detailed analytical data of the amperometric measurement of H2O2 
in stirred batch solution using different volumes of inkjet-printed modification 
solution.  
[H2O2]/
mM      
Unmodified 5 layers 10 layers 15 layers 
I/A I/A I/A I/A 
0 1.810
-8
 4.910
-8
 6.510
-8
 4.710
-8
 6.210
-8
 6.110
-8
 4.510
-6
 
1 7.510
-7
 1.410
-6
 1.610
-6
 1.210
-6
 1.610
-6
 1.410
-6
 1.710
-6
 
2 2.610
-6
 3.510
-6
 4.010
-6
 2.910
-6
 4.110
-6
 3.310
-6
 4.310
-6
 
3 4.410
-6
 5.910
-6
 7.210
-6
 4.910
-6
 6.710
-6
 5.510
-6
 7.310
-6
 
4 6.010
-6
 8.410
-6
 1.010
-5
 7.110
-6
 9.510
-6
 7.710
-6
 1.010
-6
 
5 7.510
-6
 1.110
-5
 1.510
-5
 9.610
-6
 1.310
-5
 1.010
-5
 1.410
-6
 
Amperometric measurement of H2O2 in 0.5% (v/v) Triton X-100/PBS in stirred batch 
experiments employing electrodes modified with 5, 10 and 15 printed layers of 
Triton/PBS showed almost the same enhancement of catalytic activity, which all 
were moderately more catalytic than those observed for 0 to 5 mM H2O2 using 
unmodified electrode in 0.5% (v/v) Triton X-100/PBS solution (Table  5.12 and Fig. 
 5.33). Electrodes modified with five layers may have illustrated a slight 
improvement over 10 and 15 layers. In conclusion, since there were not any 
significant different between 5, 10 and 15 layers modification, and based on the fact 
that fewer layers requires less preparation time and materials, electrodes modified 
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with 5 layers of Triton/PBS were used for the quantitative measurement of TC in 
delipidated serum. 
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Fig. ‎5.33. Amperometric measurement of H2O2 in 0.5% (v/v) Triton X-100/PBS  
in stirred batch cell at -0.1 V vs. Ag/AgCl using unmodified electrodes, and 
electrodes modified with 5, 10 and 15 inkjet-printed layers of Triton/PBS.  
5.3.2.1 Amperometric measurement of TC in delipidated serum  
The application of electrodes modified with Triton/PBS as a TC biosensor was 
assessed. The amperometric response of encapsulated electrodes to 8 µL TC in 
delipidated serum in the presence of 0.5% (v/v) Triton X-100 in combination with 
optimised enzyme concentrations (Section  5.3.1) was evaluated (Table  5.13 and 
Fig.  5.34).  
The modified electrodes showed a slope of 2.2410-8 A/mM for TC measurement 
up to 10 mM which was 1.2-fold lower compared to that observed using DBSA/KCl 
modified electrodes (2.8210-8 A/mM). Triton/PBS modified electrodes showed 
better linearity (r2 = 0.984, n=3) up to 10 mM TC, as compared to DBSA/KCl (r2= 
0.978 to 9 mM; 0.953 to 11 mM TC). Almost the same background current was 
observed for 2 to 10 mM TC prepared in delipidated serum confirming that using 
delipidated serum may provide more suitable sample matrix. Average RSD 
observed for three repeats measurement was 10.8 %. Kinoshita et al., (1998) also 
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reported the use of their own HDL-C platform (a peroxidase-entrapped and 
ferrocene-embeded carbon paste electrode) for TC measurement by replacing only 
0.5% (v/v) Triton X-100 as a non-specific surfactant. However, no detailed analytical 
data was reported for TC measurements. To summarise, the biosensor platform 
developed for the measurement of HDL-C was adapted for the measurement of TC 
by modifying the electrodes with 0.5% (v/v) Triton X-100/PBS. The biosensor was 
found to be suitable for the amperometric measurement of TC in delipidated serum 
in the presence of optimised assay reagents which again employed 0.5% (v/v) 
Triton X-100 in combination with ChEs and ChOx. Analysis of clinical samples 
using the TC biosensor 
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Fig. ‎5.34. Biosensor response to total cholesterol in delipidated serum at -0.1 
V (vs Ag/AgCl) after 420 s. a) modified electrode using externally mixed 
reagents containing 0.5% (v/v) Triton X-100, 156 U/mL ChEs and 60 U/mL 
ChOx; (slope=2.2410-8 A/mM, r2=0.984 and RSD=10.8%; n=3); b) controls in 
the absence of ChEs and ChOx. 
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Table ‎5.13. Detailed analytical data of amperometric measurement of TC 
using the optimised TC biosensor. 
TC/
mM 
Average 
(I/A) 
SD 
RSD 
(%) 
Control 
0 - --   4.6010-8 
2 8.4410-8 1.1010-8 13.0 4.6010-8 
4 1.2910-7 3.9610-9 3.1 3.4010-8 
6 1.6110-7 1.2010-8 7.4 3.8010-8 
8 2.0810-7 2.5010-8 12.0 4.3010-8 
10 2.7910-7 5.2010-8 18.7 4.4010-8 
Average RSD 10.8 - 
5.3.3 Analysis of clinical samples using the TC biosensor 
The developed TC biosensor was used to measure TC in serum samples. Two 
types of samples were used as mentioned earlier (Section  5.2.3, Table  5.8). Since 
keeping the samples in the freezer did not show any significant change in TC 
serum concentration, the TC concentration in all the samples was taken from the 
certificate of analysis which accompanied the samples (Ignatius et al., 2009).  
Samples 1, 3, 9, 10 and 11 with TC concentrations of 1.47, 4.23, 6.34, 7.50 and 
8.96 mM, respectively were used as calibrators and the remaining samples in Table 
 5.14 were used for clinical sample measurements (Fig.  5.35). Serum-based 
calibrators were also employed for spectrophotometric measurement of TC by 
Nakamura et al., (2006), to provide a comparable calibrator matrix to the clinical 
samples. The calibration curve yielded a slope of 2.3410-8 A/mM which was 
slightly lower than that observed previously using just LDL-C in delipidated serum 
as calibrators with a linearity (r2) of 0.98 (n=2) which was very similar to that 
observed in  5.3.2.1 showing that variability in the serum matrix including different 
concentrations of triglycerides and glucose for each clinical sample did not show 
any significant impact on electrodes response. The TC concentrations of 11 
samples (2, 4 to 8 and 18 to 22 ) were then measured amperometrically using the 
biosensor and their TC values were then determined by interpolation on the linear 
region of the calibration curve. Each sample was only measured twice due to 
sample limitations. The results are shown in Table  5.14 and correlated against 
certified value reported by Alere using Cholestech LDX in Fig.  5.36 A.  
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Fig. ‎5.35. TC biosensor responses to clinical samples at -0.1 V vs. AgAgCl, 
420 s after 240 s incubation at room temperature, TC concentrations of 1.47, 
4.23, 6.34, 7.50 and 8.96 were used as calibrators while the remaining were 
used for sample measurement which were either duplicate measurements of 
spiked human serum samples or the San Diego donor population. 
 
Table ‎5.14. TC concentrations calculated using TC biosensor compared to 
the results taken from certificate of analysis reported by Alere. Samples 2, 4-8 
are spiked human serum with the same sample matrix as those used for 
calibration curve and the samples 18-22 are real samples from donor 
population in San Diego.  
samples 
ID 
TC/mM   
TC sensor 
1st 
repeat 
2nd 
repeat 
2 3.57 3.06 2.79 
7 3.63 3.08 3.01 
6 4.17 4.51 3.81 
5 4.89 4.22 4.10 
4 4.93 4.81 4.50 
8 5.56 5.46 3.98 
21 3.70 1.92 1.14 
19 4.11 1.49 1.35 
20 4.70 1.00 1.50 
22 5.30 3.67 3.29 
18 5.50 3.04 2.48 
Samples 2, 4 to 8 had the same matrix as the calibrators showing the deviation of 
less than 1 mM in 92% of the measurement. Samples collected by donor 
population in San Diego (18 to 22) showed a significant deviation which was 
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between 2 to 3 mM which might be due to the matrix effect which may not be very 
similar to those used for making a calibration curve (Helm, Jalukse and Leito, 
2010). The correlation had a slope of 1.07 and a Pearson correlation coefficient of 
0.87.  
CardioChek PA and Cholestech LDX, the two POCT systems that support the total 
cholesterol measurement in NHS health check, showed a slope of 0.72 and 0.95 
and pearson correlation coefficient of 0.86 and 0.95 respectively (Batki et al., 1995; 
Batki et al., 2005; Patel et al., 2011). A luminol electrochemiluminescence-based 
biosensor in conjunction with ChEs in solution for TC was also reported which was 
capable of measuring TC in human sera within 900 s with the lower TC observed in 
normal serum compared to the Pathological serum samples (Marquette, Ravaud 
and Blum, 2000).   
Fig.  5.36 B demonstrates the Bland–Altman plot of the developed TC biosensor 
against the certified values which calculates the mean difference between two 
methods of measurement was within mean ±2*SD limit indicating that no significant 
bias was observed between the two methods across the measured range (Bland 
and Altman, 1999). The mean difference of the method representing the estimated 
bias was found to be 0.92 mM with SD of approx. 1.34 mM showing an 
approximate deviation of 3 mM or less which is significant across the measurement 
range. Since average bias for TC measurement according to NECP guideline was 
reported to be less than 3% (0.16 mM), the estimated bias according to this method 
was 5.8-fold greater. This greater deviation mostly related to un-manipulated ‘off 
the clot’ serum samples from a donor population in San Diego. The biosensor 
indicated slightly lower total concentrations for some of the clinical samples 
collected from the donor population in San Diego which might be due to either 
incompatibility of the calibrator matrix with donor samples or some unknown 
reasons such as the effect of other unknown serum components present in donor 
populations (Helm, Jalukse and Leito, 2010).  
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Fig. ‎5.36. Correlation of total cholesterol in serum measured by the biosensor 
and certified value (slope= 1.07, r=0.87). Inset: plot of differences versus 
average with 95% limits of agreement 
Although there are many reports for TC measurement using biosensors (Arya, 
Datta and Malhotra, 2008), there has only been limited reporting of TC biosensors 
employing measurement in serum.  
Dey and Raj (2014) reported a TC biosensor developed by integrating ChOx and 
ChEs using reduced graphene oxide-dendritic Pd nanoparticle (rGO-nPd) hybrid 
material without any redox mediator as a platform for H2O2 detection which was 
successfully applied for the measurement of two human serum samples after 10-
fold dilution using PBS to minimise the sample matrix effect. Their biosensor was in 
very close agreement with clinical data (RSD=3.45 and 1.51 for two samples), 
However, the assay required a 10-fold dilution which would not be suitable for 
direct TC serum measurement.         
Urmila et al., (2011) reported the application of immobilized ChEs and ChOx on to 
a gold electrode modified with electrode multiwalled carbon nanotubes (MWCNTs) 
uniformly dispersed in a Nafion matrix using a layer by layer technique to measure 
TC in real samples. A dilution factor of 30-fold was used to make the final sample 
concentration fall within the biosensor linear range limit (0.080–0.950mM) (Urmila 
et al., 2011). Although it was found that the result taken from the biosensor was in 
good agreement with the enzymatic cholesterol assay estimation kit (CHOD-PAP 
method), once again applying a dilution factor of 30-fold would make it unsuitable 
for direct measurement of TC in serum.  
A disposable amperometric TC biosensor was also developed containing a sensing 
electrode and a reference electrode which were in contact with an integrated 
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reagent layer formed by coating a working ink containing ChEs, cholesterol 
dehydrogenase, coenzyme, redox mediator, surfactant and stabilizer. Cholesteryl 
acetate was used as a substrate. The biosensor response was linear up to 12.95 
mM with minimum detection limit of 1.3 mM. No significant interfererences were 
found for the measurement of 5 mM cholesteryl acetate in the presence of ascorbic 
acid, glucose, uric acid, EDTA, acetone and bilirubin and acetaminophen at their 
physiological or therapeutic levels. Once again there was no report on the 
application of biosensor to the direct measurement of TC in serum samples (Fang, 
2011). 
In summary, the TC biosensor was used to measure TC in delipidated serum with 
good linearity across the diagnostically relevant range. It was applied to the 
measurement of TC in clinical serum samples. Although measurement of TC was 
more straight forward than HDL-C measurement due to the fact that there was no 
requirement for differentiation between different lipoproteins, challenges remain in 
the precision and accuracy of the developed biosensor.  
5.4 Conclusion 
To sum up, while most of the spectrophotometric assay protocols using externally 
mixed reagents and sample with a typical minimum 100-fold dilution of sample with 
assay reagents, the biosensor using the modified electrodes developed in this 
research employed only a two-fold dilution as the ultimate aim of this thesis is to 
develop a fully integrated TC biosensor. Therefore, an amperometric assay based 
on optimised HDL-C assay reagents as mentioned in Chapter 3 and using 
DBSA/KCl modified silver electrodes was developed which was used for the 
quantitative measurement of H2O2 and cholesteryl acetate in PBS and for HDL-C in 
both PBS and delipidated serum. The same strategy was also applied to the 
measurement of TC in delipidated serum using the same electrodes. A study on the 
possibility of replacing the DBSA/KCl modification of the electrodes with either 
Emulgen B-66/PBS for HDL-C and Triton X-100/PBS for TC demonstrated that 
both exhibited acceptable enhancement in catalysis of the silver electrodes for 
H2O2.  
Two types of biosensors were developed which were based on the external mixing 
of assay reagents (buffer, surfactants and enzymes) with the sample prior to their 
measurement using the modified electrodes. Biosensors employing modification 
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and measurement in 6% (w/v) Emulgen B-66/PBS with 39 U/mL ChEs and 23 
U/mL ChOx were applied to the measurement of HDL-C (0 to 4 mM) in delipidated 
serum. The biosensor yielded a slope of 3.3210-8 A/mM with a linearity (r2) of 
0.999  and average RSD of 9.5% (n=5).  
Biosensors employing modification and measurement in 0.5% (v/v) Triton X-
100/PBS with 156 U/mL ChEs and 60 U/mL ChoX were used for the measurement 
TC (0 to 10 mM) in delipidated serum. The biosensor had a sensitivity of 2.2410-8 
A/mM with linearity (r2) up to 10 mM of 0.984 and average RSD of 10.8% (n=3).  
Both biosensors were employed for the measurement of HDL-C and TC in clinical 
samples with calibration curves prepared using calibrators provided by Alere to 
provide a comparable sample matrix.  The correlation between the HDL-C sensor 
and the Abcam assay kit had a slope of 0.87 and a Pearson correlation coefficient 
of 0.76 (n=13) (Fig.  5.24 and Table  5.9) while the correlation for TC measurement 
had a slope of 1.07 and a Pearson correlation coefficient of 0.87. However, 
significant deviation was observed for amperometric measurement of TC in donor 
samples which were un-manipulated ‘off the clot’ serum samples from a donor 
population in San Diego calculated by interpolation on the linear region of the 
calibration curve which was prepared using calibrators which were spiked human 
serum samples. Considering that there are still challenges in real sample 
measurement and method correlation with other standard methods, the next step 
was to fabricate printed integrated biosensors that could more effectively measure 
TC and HDL-C which will be discussed in next chapter. 
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Chapter 6  
Development of integrated HDL-C and TC 
biosensors 
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6.1 Introduction 
Monitoring HDL-C and TC using point of care testing provides several advantages 
compared to clinical laboratory testing including ease of use, patient accessibility, 
low cost and instant results. However, currently there are just two certified point of 
care cholesterol monitoring devices available in the UK which are capable of 
measuring TC and HDL-C which may be used in the doctor’s office, clinic or home. 
As was discussed in Chapter 3, most of the cholesterol point of care testing devices 
are based on Trinder reaction for the optical determination of TC (Taylor, 2004). 
However, in the last ten years, biosensors have gained much more attention in the 
development of TC point of care devices (Arya, Datta and Malhotra, 2008).  
In order to develop a disposable biosensor suitable for POCT, an integrated 
biosensor ideally needs to be fabricated by deposition of assay reagents on the 
sensor in a way that results in the controlled, reproducible interaction of assay 
components in both time and space, which is achieved by using assay reagents 
that result in uniform and stable enzyme activity and assay components diffusion 
rates, etc. Thus, the ability of the method to re-solubilise the deposited reagent and 
provide reproducible and stable responses is also crucial. Although there are many 
reports of the measurement of TC using amperometric biosensors (Arya et al., 
2008), there are just few reports of the amperometric determination of HDL-C 
(Foster, Cassidy and O'Donoghue, 2000; Kinoshita et al., 1998; Murphy et al., 
2009). An important step in the fabrication of biosensors is finding simple and 
suitable techniques to deposit the assay reagents in a reproducible way. Among 
deposition techniques, inkjet-printing is one such technique capable of the 
controlled deposition of small droplets of reagents onto a substrate in a simple, 
rapid and reproducible manner, which is suitable for the mass production of 
biosensors (Komuro et al., 2013; Tekin, Smith and Schubert, 2008). In addition, 
graphical software can be used for printing different pattern depending on the 
electrode design.  
In this chapter, the effect of direct deposition of assay reagents using inkjet-printing 
technology on the amperometric behaviour of the resulting integrated biosensor 
while measuring HDL-C and H2O2 was investigated. Enzymes are biocatalysts in 
which their activities may differ once deposited compared to those in solution due 
to irreversible protein misfolding which may occur when water molecules are 
removed from the protein following immobilisation (Bommarius and Payeb, 2013). 
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The mode of deposition may also alter their stability, activity or selectivity, and so 
changes in assay reagent (ink) formulation may be required to improve the 
enzymes activity and stability as well as ink characteristic for its suitability to be 
inkjet-printed and immobilised (Bommarius and Payeb, 2013; Komuro et al., 2013; 
Rodrigues et al., 2013). In order to stabilize enzymes, there are several ways such 
as immobilisation, medium engineering (formulation), protein engineering. Among 
them, a simple enzyme immobilisation technique may be employed to prevent 
removal of water molecules and unfolding during the deposition step. 
Immobilisation techniques may be reversible such as adsorption, ionic binding, 
affinity binding, chelation or metal binding and disulphide bonding or irreversible 
such as the formation of covalent bond, entrapment, micro-encapsulation and 
cross-linking (Brena and Batista-Viera, 2006). Based on the fact that enzymes may 
possess a net positive or negative charge depending on their isoelectric point and 
the pH of the solution, using ionic interactions by introducing an oppositely charged 
mediator may increase the rigidity of the active site (Bommarius and Payeb, 2013; 
Hanefeld, Cao and Magner, 2013). Some optimisation of the assay reagent 
formulation to make it suitable for deposition and immobilisation in this manner was 
performed here, initially for the development of an integrated HDL-C biosensor. 
Understanding of these new assay conditions was then applied to the fabrication of 
the TC integrated biosensor. In addition to these sensor design issues, diffusional 
barriers are often used to limit the diffusion rate of substrates, effectively diluting 
the sample before measurement, However, in this research a direct measurement 
approach was taken to eliminate the need for diffusional barriers, as this approach 
had been previously shown to be successful for the colorimetric measurement of 
HDL-C (Tamura et al., 2009).  
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6.2 Development of an integrated HDL-C biosensor  
It was shown in Chapter 5 that Emulgen B-66/PBS modified electrodes were 
suitable for the amperometric measurement of H2O2 following the enzymatic 
reaction of HDL-C using externally mixed assay reagents. However, to develop a 
point of care biosensor, the next step was to remove the assay reagent addition 
step through their deposition on the electrode surface in a reproducible and stable 
manner. Therefore, the first attempt was to apply assay reagent formulated in 
Chapter 3 and 4 and used in Chapter 5, directly onto the electrode surface to 
evaluate its effect on the amperometric measurement of HDL-C. 
6.2.1 Inkjet-printed deposition of HDL-C assay reagents on Emulgen B-
66/PBS modified electrodes 
Initial experiments using 3 µL of assay reagent deposited using drop-coating onto 
the sensor working electrodes resulted in the formation of a surface film after being 
kept at room temperature for 2 hrs to dry which can be seen in Fig.  6.1 
A B
 
Fig. ‎6.1. SEM images of modified electrodes: A before drop-coating of assay 
reagent and B after deposition. Acceleration voltage of 20 keV. (5000x 
magnification). using GSE detector. 
Consequently, the experiments were performed to evaluate the effect of the inkjet-
printed deposition of assay reagents on the amperometric measurement of HDL-C. 
Therefore, ChOx (122 U) and ChEs (261 U) were dissolved in 2 mL 6% (w/v) 
Emulgen B-66/PBS solution to yield final concentrations of 130.5 U/mL for ChEs 
and 62 U/mL for ChOx and this was inkjet printed onto a modified electrode. First, 
modified electrodes were prepared by inkjet printing of five layers of 6% (w/v) 
Emulgen B-66/PBS on a single silver electrode (3.2  3.2 mm) and then employed 
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for HDL-C determination unless otherwise stated. All the modified electrodes were 
dried for at least 10 min and washed prior to the assay reagent deposition step.  
6.2.1.1 Optimisation of print layers 
The number of layers of printed reagent was investigated. Initially, 10 layers of 
assay reagent with the total volume of assay reagent of 2.38 µL were inkjet-printed. 
This was calculated using a droplet volume of 9.210-6 µL which was 
experimentally obtained using drop volume calibration feature and 3.2  3.2 mm 
pattern representing 25,921 droplets. A single silver electrode was used for 
deposition of assay reagent (Fig.  2.6 A). This was then used following 
encapsulation to measure 8 µL of 0.5 to 4 mM HDL-C in delipidated serum. The 
cathodic current at -0.1 V (vs Ag/AgCl) was measured at 360 s and 420 s following 
240 s incubation at room temperature. A minimum of two repeats were performed 
at each concentration. 
Fig.  6.2 shows that in general by increasing the concentration of HDL-C, the current 
increased proportionately. However, some variability was observed in the case of 
some of the encapsulated biosensors which might be due to some variability 
caused by the silver electrodes and their modification characteristics as well as the 
homogeneity of final solution after re-solubilisation and enzymatic reaction. The 
current measured at 360 s and 420 s showed almost the same signal 
demonstrating that measurement could be performed at either of these two time 
points. Further assays were measured after 420 s. 
A comparison between the amperometric measurement of HDL-C using externally 
mixed reagents performed in Chapter 5 (Section 5.2.2) and the integrated 
biosensor shown here showed that the sensitivity decreased from 3.3210-8 A/mM 
to 1.7610-8 A/mM, with a loss of linearity (r2) from 0.999 to 0.745 which may be 
due to rates of re-solubilisation, changes in rates of diffusion or effects on enzyme 
activity following deposition. As can be seen in Table  6.1, the percentage error 
increased by 2.2-fold using the integrated biosensor, as compared to externally 
added reagent which could also be due to loss of enzyme activity over time or an 
inability to solubilise the deposited reagent in a reproducible manner as well as 
homogeneity of the final solution following storage at room temperature after 
deposition. Variability from the modified silver electrodes may also contribute to 
this.  
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Fig. ‎6.2. Chronoamperometric measurement (-0.1 V vs Ag/AgCl) of HDL-C 
using encapsulated HDL-C biosensors prepared using 10 layers of assay 
reagent inkjet-printed on Emulgen/PBS modified silver electrodes. The 
current was measured at 420 s after 240 s incubation; (slope=1.7610-8A/mM, 
r2=0.745). 
 
Table ‎6.1. Detailed analytical data for HDL-C measurement following inkjet-
printed of 10 layers of assay reagent on Emulgen/PBS modified silver 
electrodes. 
HDL-C/ 
mM 
Average 
current at 
420 s (A) 
SD 
RSD 
(%) 
0.5 1.6110
-7
 4.3910
-8
 27.3 
1 1.9010
-7
 5.7010
-8
 30.0 
2 1.8710
-7
 3.9910
-8
 21.3 
3 1.9010
-7
 3.1210
-8
 16.4 
4 2.4110
-7
 1.9810
-8
 8.2 
Average RSD 20.6 
As was shown, by deposition of assay reagents using inkjet printing, analytical 
parameters such as linearity, sensitivity and reproducibility were altered 
significantly. This may be due to not only loss of enzyme activity, but also some 
changes in kinetics of the reaction taking place inside the encapsulated biosensor 
including the concentration verses time profiles of reaction products across and 
throughout the sample chamber during the measurement, the speed of reagent 
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dissolution inside the sample chamber and the resulting rates of formation of H2O2 
and its concentration distribution and rate of diffusion to the surface, in the 
presence of all the assay and matrix components. The kinetics of the sensor are 
complex and are driven by multiple processes including fluid dynamics and 
convection of the sample filling the chamber, sample chamber geometry, 
reproducibility and surface properties, the rates of resolubilisation and rehydration 
of the enzymes and their concentration profiles as they diffuse into the sample, the 
kinetics of the enzymes as they interact with the multi-step pathway and the final 
kinetics of the formation and distribution of the generated H2O2, followed by its 
catalysis at the electrode surface. The result of this complexity is ultimately 
manifested in the quality of the chronoamperograms of the sensor. Minute 
variations in the properties of the electrodes that impact these processes introduce 
variability in response and the sensor reproducibility ultimately defines the 
robustness of the technique and how well it compares with other sensor systems. 
While removal of a biological molecule such as HRP is mostly considered 
advantageous due to the inherent issues related to the use of biological molecules, 
this must be counter-balanced by the fact that HRP is a highly efficient and well-
behaved enzyme, and that the electrocatalytic modification may, itself, introduce 
variability into the assay system. 
The first step in order to improve the analytical parameter of the method was to 
evaluate the number of prints considering that the deposition step may reduce the 
enzyme activity, causing a decrease in the sensitivity of the method. Therefore, the 
same experiments as mentioned above was performed but this time by inkjet-
printing of 20 layers (4.77 µL) on single modified electrode representing double the 
enzyme concentrations compared to the previous experiment. This was done to 
see if double enzyme concentration will improve the sensitivity of the integrated 
biosensor (Fig. 6.3). 
Although some variability could still be seen in sensors fabricated using 20 layers, a 
slight increase in sensitivity and linearity was observed in comparison with 10 
layers suggesting that the increase in enzyme concentration improved the 
analytical performance of the biosensor. However the percentage error also 
increased to 32.9% for 20 printed layers compared to 20.6% observed for 10 layers 
(Table  6.2). This might be expected as by increasing the printed layers, the 
systematic error may increase resulting in the increased percentage error of the 
measurement. Moreover, when the sample is introduced into encapsulated 
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electrodes by capillary force, the deposited assay reagents must be dissolved in 
order to initiate the enzymatic reaction. Since the assay reagent was so far only 
deposited on the working electrode area, this may have had an affect on the 
homogeneity of the assay solution which may have led to the poor reproducibility of 
the integrated biosensor. 
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Fig. ‎6.3. Chronoamperometric measurement (-0.1 V vs Ag/AgCl) of HDL-C 
using encapsulated HDL-C biosensors using 20 layers of inkjet-printed assay 
reagent deposited on a single Emulgen b-66/PBS modified silver electrode, 
after 240 s incubation at room temperature, (slope=1.8610-8A/mM, r2=0.782). 
 
Table ‎6.2. Detailed analytical data of amperometric measurement (-0.1 V vs 
Ag/AgCl) of HDL-C using 20 layers of assay reagent deposited on single 
modified‎silver‎electrode‎(n‎≥3). 
HDL-C/ 
mM 
Average 
current at 
420 s (A) 
SD 
RSD 
(%) 
0.5 1.0510
-7 
2.4010
-8
 22.9 
1 1.4010
-7
 6.3110
-8
 45.2 
2 1.4610
-7
 4.1010
-8
 28.1 
3 1.8210
-7
 4.7910
-8
 26.3 
4 1.7110
-7
 7.2110
-8
 42.2 
Average RSD 32.9 
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6.2.1.2 Optimisation of the printed area 
Since increasing the number of assay reagent layers on a single electrode from 10 
to 20 showed some improvement in assay sensitivity and linearity but no 
improvement in reproducibility, the next experiment was performed using 10 layers 
of assay reagent inkjet-printing on the two silver electrodes (Fig.  2.6 B) to assess if 
any improvement in method reproducibility would be achieved by depositing the 
assay reagent in two sample chamber locations instead of one while the same 
concentration of deposited reagent was used ( 2.4.7). This may help to improve the 
product concentration/time profile across and throughout the sample chamber 
during the measurement as well as the speed of reagent dissolution inside the 
sample chamber. In addition this may improve the rate of H2O2 formation and its 
even diffusion to the surface resulting in better homogeneity of the final solution. 
The final total volume of assay reagent deposited was 4.77 µL which was very 
similar to that deposited using 20 layers on a single electrode and was double that 
of 10 layers deposited on a single electrode. The encapsulated biosensors were 
then used to measure HDL-C in delipidated serum. The results are shown in Fig. 
 6.4 and Table  6.3.  
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Fig. ‎6.4. Chronoamperometric measurement (-0.1 V vs Ag/AgCl) of HDL-C 
using encapsulated HDL-C biosensors using 10 layers of inkjet-printed assay 
reagent deposited on both silver electrodes, after 240 s incubation at room 
temperature, (slope=2.4210-8A/mM, r2=0.958). 
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Table ‎6.3. Detailed analytical data of amperometric measurement of HDL-C 
using 10 layers of inkjet-printed assay reagents deposited on both silver 
electrodes‎(n‎≥‎3). 
HDL-C 
/mM 
Average 
current at 
420 s (A) 
SD 
RSD 
(%) 
0.5 1.1110
-7
 6.3210
-9
 5.7 
1 1.3810
-7
 1.5910
-8
 11.6 
2 1.5610
-7
 3.6610
-8
 23.5 
3 1.7310
-7
 2.5310
-8
 14.6 
Average RSD 13.9 
To assess whether this variability was due to the inhomogeneous diffusion of the 
released H2O2 following the introduction of the HDL-C using capillary force into the 
encapsulated biosensors, the same experiment was performed, with HDL-C 
substituted with H2O2 in delipidated serum (Fig.  6.5 and Table  6.5). Evaluation with 
H2O2 eliminates any variability caused by the enzymatic reaction steps and 
provides a sample solution with better homogeneity which requires only dissolution 
of the deposited assay reagents. Improved sensitivity (3.6210-8 A/mM) was 
observed for the measurement of H2O2 compared to the measurement of HDL-C 
(2.4210-8A/mM), which may result from a range of causes such as the kinetics of 
the enzymatic reactions and rates of diffusion when measuring HDL-C compared to 
H2O2. Although no significant changes in linearity and reproducibility of the method 
were observed for the measurement of H2O2 compared to HDL-C measurement, 
the linearity and reproducibility of the externally mixed experiment for HDL-C 
measurement (r2=0.999, RSD=9.5%; n=5) (Section 5.2.2) were better than the 
integrated biosensor used for amperometric measurement of H2O2 (r
2=0.956, 
RSD=12.6%; n=3) which might be due to some inhomogeneity caused following re-
solubilisation of the deposited assay components by the H2O2 sample. 
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Fig. ‎6.5. Chronoamperometric measurement (-0.1 V vs Ag/AgCl) of H2O2 using 
encapsulated HDL-C biosensors using 10 layers of inkjet-printed assay 
reagent deposited on both silver electrode, after 240 s incubation at room 
temperature, (slope=3.6210-8A/mM, r2=0.956). 
 
Table ‎6.4. Detailed analytical data of amperometric measurement (-0.1 V vs 
Ag/AgCl) of H2O2 using 10 layers of inkjet-printed assay reagents deposited 
on both silver electrodes, n=3). 
H2O2 
/mM 
Average 
current at 
420 s (A) 
SD 
RSD 
% 
0.5 7.2910
-8
 2.0610
-8
 28.3 
1 7.7010
-8
 8.2610
-9
 10.7 
2 1.1510
-7
 1.3010
-8
 11.3 
3 1.3910
-7
 4.5810
-8
 3.3 
4 2.0210
-7
 1.8910
-8
 9.3 
Average RSD 12.6 
In order to further improve assay reagent homogeneity, assay reagent was next 
inkjet-printed across an area of 15  8 mm (Fig.  2.6), instead of just onto the silver 
working electrodes as was shown in Chapter 2. This may help accessibility of 
introduced HDL-C sample to assay reagent following being introduced by capillary 
force in a homogeny and reproducible way. As was mentioned before, 10 layers of 
assay reagent deposited on silver electrodes represented 4.77 µL of assay reagent 
being deposited in total. By increasing the print area to 15  8 mm, the number of 
prints was reduced from 10 to two layers of assay reagent containing ChEs (261 U) 
and ChOx (122.2 U) prepared in 2 mL of 6% (w/v) Emulgen B-66/PBS. The use of 
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two layers on a 15  8 mm electrode surface represented 5.54 µL of assay reagent 
which was similar in volume to the previous two electrode print (4.77 µL) presenting 
1.16-fold increase in enzyme concentration. Amperometric measurement of HDL-C 
using the developed sensors is shown in Fig.  6.6 and Table  6.5. As can be seen, 
the biosensors yielded a sensitivity of 2.0610-8A/mM and linearity (r2) of 0.952 for 
four repeat measurements with an average RSD of 11.5% demonstrating a slight 
improvement in reproducibility of the integrated biosensors compared to those with 
printing on two electrodes (12.6%). Again little improvement in sensitivity or linearity 
was achieved.  
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Fig. ‎6.6. Chronoamperometric measurement (-0.1 V vs Ag/AgCl) of HDL-C 
using encapsulated HDL-C biosensors using 2 layers of assay reagent inkjet-
printed on 15  8 mm of Emulgen/PBS modified electrode, after 240 s 
incubation at room temperature, (slope=2.0610-8A/mM, r2=0.952, n=4). 
 
Table ‎6.5. Detailed analytical data of amperometric measurement (-0.1 V vs 
Ag/AgCl) of HDL-C using two layers of assay reagents on 15  8 mm
 of 
Emulgen/PBS modified electrode (n=4).  
HDL-C 
/mM 
Average current 
at 420 s (A) 
SD RSD % 
0.5 1.1810
-7
 2.2410
-8
 19.0 
1 1.3410
-7
 1.1010
-8
 8.2 
2 1.6610
-7
 1.4310
-8
 8.6 
3 1.9010
-7
 1.5910
-8
 8.4 
4 2.0010
-7
 2.7010
-8
 13.5 
Average RSD 11.5 
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To summarise, some of the main challenges in the development of the integrated 
biosensor was the variability observed in some of the encapsulated biosensors due 
to the silver electrodes and their modification characteristics as well as the 
homogeneity of the final solution after re-solubilisation and enzymatic reaction and 
therefore reproducibility of the integrated system. The rate of re-solubilisation and 
consequently the rates of diffusion of H2O2 and enzyme activity following deposition 
were also other ramification for development of integrated cholesterol sensor. 
Improved reproducibility was obtained following enzyme deposition using the 
pattern shown in Fig. 2.6C. However, further improvement in the linearity, 
sensitivity and reproducibility of the biosensor were still required. Since the 
amperometric measurement of H2O2 using the integrated biosensor showed similar 
sensitivity to that observed for HDL-C measurement when assay reagent was 
added externally (Section 5.2.2), and considering factors such as enzyme activity, 
reagent dissolution and sample filling characteristics which are all important factors 
in improving the analytical performance of an integrated biosensor, the catalytic 
activity of the enzymes was probably affected by the deposition and immobilisation 
processes which might be through different mechanisms such as reducing enzyme 
dynamic properties as well as accessibility of the substrate to enzymes active sites 
due to changes in their structure after immobilisation (Secundo, 2013). Further 
studies were performed, now employing deposition across the entire dual electrode 
cell to see whether the selectivity and stability was affected following deposition of 
assay reagent. 
6.2.1.3 Measurement of the selectivity of the integrated biosensor for the 
measurement of HDL-C over LDL-C  
It was shown in Chapter 5 that the Emulgen/PBS modified biosensor was capable 
of selectively measuring HDL-C over LDL-C using externally added reagents. To 
assess whether this remained the case using an integrated biosensor design, 
amperometric measurement of LDL-C (1 and 2 mM), HDL-C (2 mM) and 
combinations of LDL-C and HDL-C were performed using the encapsulated 
integrated biosensor. Two layers (total 5.54 µL) of assay reagent containing  ChEs 
(261 U) and ChOx (122.2 U) prepared in 2 mL of 6% (w/v) Emulgen B-66/PBS 
inkjet-printed on a 15  8 mm electrode surface were used to prepare the 
integrated biosensor. Delipidated serum was used for control measurements.  
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As can be seen in Fig.  6.7, almost the same current response was observed for the 
amperometric measurement of 1 mM HDL-C in the presence or absence of 1 mM 
LDL-C, and which was half the current observed for 2 mM HDL-C after removing 
the background signal. LDL-C at 1 and 2 mM showed almost the same current as 
that observed for delipidated serum, confirming that the selectivity of the integrated 
biosensors toward HDL-C over LDL-C was not reduced in comparison the the 
externally added sensor approach. 
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Fig. ‎6.7. Chronoamperometric measurement (-0.1 V vs Ag/AgCl) of LDL-C, 
HDL-C and combination of HDL-C and LDl-C using using two layers of assay 
reagent inkjet-printed on 15  8 mm of Emulgen/PBS modified electrode, after 
240 s incubation at room temperature (t=420 s). 
 
Table ‎6.6. Detailed analytical data of amperometric measurement (-0.1 V vs 
Ag/AgCl) corresponding to selectivity measurement of HDL-C over LDL-C at 
420 using 2 layers assay reagents on 158 mm of Emulgen/PBS modified 
electrode (n=3). 
Substrate 
Average 
current at 
420 s (A) 
SD RSD % 
Delipidated serum 9.8910
-8
 9.9810
-9
 10.1 
1 mM LDL 1.1010
-7
 3.1910
-8
 29.0 
1 mM LDL+1mM LDL 8.3310
-8
 1.5210
-8
 18.2 
1 mM HDL+1 mM LDL 1.4610
-7
 2.3010
-8
 15.8 
1 mM HDL-C 1.5110
-7
 2.1110
-8
 14.0 
2 mM HDL 1.7110
-7
 2.3910
-8
 13.9 
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6.2.2 Evaluation of biosensor stability 
The next step was then to assess the biosensor stability over time after inkjet-
printing of assay reagent. To do this, four sets of encapsulated biosensors were 
prepared using a single inkjet printed layer of assay reagent printed on 15  8 mm 
electrode surface. Three sets were tested immediately following fabrication, while 
the fourth was tested five hours later. Fig.  6.8 demonstrates a clear decrease in 
biosensor response following storage for five hours.  
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Fig. ‎6.8. Chronoamperometric measurement of HDL-C using encapsulated 
HDL-C biosensors inkjet-printed using one layer of assay reagent 158 mm2 
electrode surface after 240 s incubation at room temperature: a) 3 sets 
performed after printing (slope: 2.0510-8A/mM, r2=0.984, n=3), b) set 4 
performed 5 hrs after printing (slope: 2.0810-8A/mM, r2=0.954). 
 
The average current response of 1.9610-7, 1.7610-7, 1.6110-7 and 1.3310-7 A 
was observed for 4, 3, 2 and 1 mM HDL-C using three set of electrodes used after 
fabrication while these were 1.4910-7, 1.4110-7, 1.1410-7 and 8.8210-8 A for 
biosensors used five hours after fabrication showing 1.32, 1.25, 1.41 and 1.5-fold 
decrease in current intensity respectively. This could be due to some changes in 
surface modification related to the presence of enzymes deposited on the 
Emulgen/PBS modified electrode surface over time (Gonzalez-Macia, Smyth and 
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Killard, 2012) as well as reduction in enzyme activity due to the removal of water of 
hydration over time. 
Since this experiment did not provide adequate information regarding the stability of 
biosensor, the following experiment was performed a week after printing by 
comparing  the amperometric measurement of HDL-C performed on the same day 
of the preparation of the integrated biosensors with those performed after a week 
kept in desiccator at room temperature. As can be seen in Fig.  6.9, the current 
response of 8.9310-8, 1.5710-7 and 2.0310-7 A were observed for 0.5, 2.0 and 
4.0 mM HDL-C using biosensors printed and used in the same day while this was 
between 5.3 10-8 and 9.0810-8 A for all HDL-C concentrations using biosensors 
kept at room temperature for a week showing almost the same current response for 
different concentrations of HDL-C. 
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Fig. ‎6.9. Amperometric measurement of HDL-C (-0.1 V vs Ag/AgCl) using the 
developed biosensor used on the day of fabrication (black)  and after one 
week in a desiccator at room temperature. 
The catalytic activity of enzymes depends on the correct position and geometry of 
specific amino acids responsible for the enzyme’s action towards a given substrate. 
Deposition, followed by removal of water molecule over time when stored at 
ambient temperature may alter the enzyme’s structure and consequently affect its 
catalytic activity by reducing substrate accessibility to the enzyme active site, loss 
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of enzyme dynamic properties and alteration of conformational integrity (Secundo, 
2013; Tsou, 1993). Enzyme conformation plays a crucial role in enzyme catalytic 
activity, which may change at low temperatures and temperatures above its 
unfolding temperature due to dehydration (Rodrigues et al., 2013; Secundo, 2013). 
It has been shown that the addition of reagents containing a sugar, PEG or albumin 
into ink formulations before deposition appears to protect the enzyme from the 
negative effects of organic solvents as well as influencing the positive disruption of 
water molecules in the enzyme and protecting them against the shear produced 
during droplet ejection during inkjet-printing (Hanefeld, Cao and Magner, 2013). 
As was mentioned above, although the selectivity of the integrated biosensor was 
not affected by the deposition and immobilisation processes, the biosensor 
demonstrated poor stability when stored at room temperature following deposition 
and drying step. Since protected enzymes are expected to show less alteration in 
their structure compared to the free enzymes once deposited (Hanefeld, Cao and 
Magner, 2013; Rodrigues et al., 2013), it was necessary to re-formulate the ink 
composition in a way to protect the enzymes before deposition. The influence of 
storage temperature on integrated biosensor stability was also assessed. 
6.2.3 Optimisation of biosensor stability 
Inkjet printing has been reported to be suitable in overcoming issues such as speed 
limitation and reagent waste in comparison to traditional reagent deposition 
techniques such as screen printing and drop deposition (Delaney, Smith and 
Schubert, 2009; Hutchings and Martin, 2013). However, developing a robust 
formulation for the assay reagents to make them suitable for printing and minimise 
the impact on enzyme structure and activity has been shown to be challenging 
(Jospeh, 2012; Magdassi, 2008). An important consideration in drop-on-demand 
inkjet printing is whether the printable ink formula can be ejected from the nozzle in 
a reproducible and stable manner (Delaney, Smith and Schubert, 2009). Ink 
physical properties such as viscosity and surface tension are important. It has been 
shown that the viscosity of the ink does not change in the presence of enzymes at 
the typical concentrations used (Hutchings and Martin, 2013; Jospeh, 2012). An 
important issue was whether features of the printing process such as the shear 
produced during droplet ejection damages the protein structure. The rapid and 
intense pressure pulse set up by piezoelectric printers to eject a drop may result in 
denaturation of enzymes, the effect of which can be reduced by the addition of 
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stabilisers such as sugars which are polar compound helping enzyme to preserve 
its hydration state while it could also protect enzymes from shear stress produced 
by inkjet-printing (Hutchings and Martin, 2013). The precise mechanism by which 
some enzyme denatured in the absence of stabilizers through inkjet-printing is not 
fully understood (Delaney, Smith and Schubert, 2009).    
 
Some of the important factors in developing an ink formulation for inkjet printing 
enzymes  are as follows (Jospeh, 2012): 
- It was reported that most enzymes were capable of tolerating the shear 
produced by the cartridge head without losing their activity during printing 
procedure.  
- It is important that the ink formulation containing enzymes stabilises the 
enzyme structure to protect them from un-folding due to the drying step and 
storage condition. 
- There should be no cracking or flaking once the reagent film is formed. 
- Surface tension was also found to be important as when it is too high it does 
not allow proper mixing of the printed reagent droplets and when it is too 
low it results in the spreading of the reagent film as well as leakage from the 
nozzle.  
- The surfactant present in the ink is also important as ionic surfactants may 
damage enzyme activity due to their amphiphilic characteristics. However, 
surfactants may decrease the surface tension and are found to be 
compatible with the enzyme/mediator system 
- Polymers used in the ink formulation may have an effect on the 
homogeneity of the reagent layer (Iyer and Ananthanarayan, 2008).  
Therefore, an optimal ink formulation may contain ingredients such as a plasticiser 
like ethylene glycol, a polymer to act as a film former,  rheological modifiers such as 
polyvinylpyrrolidone (PVP) (Tamura et al., 2009), a surfactant such as Triton X-100, 
a buffer such as phosphate buffer, enzymes and an ionic strength modifier such as 
KCl or NaCl (Jospeh, 2012).  
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As was shown in the previous section, direct inkjet-deposition of the developed 
assay reagent did not show sensitivity, reproducibility or linearity comparable to that 
observed for externally added reagent. In addition, the integrated biosensor did not 
show good shelf-life when stored at room temperature. This might have been 
expected as enzymes can be unstable in aqueous solution at room temperature in 
the absence of stabilizers and are typically required to be stored in a frozen state or 
liquid at a minimum of -20°C. Protecting enzymes while present in solution and 
prior to deposition may prevent them from denaturation after inkjet-print deposition. 
By changing the storage condition and storing the biosensor at 2-8°C, the shelf-life 
and operational stability of the integrated biosensor might be improved (Gibson, 
1999).  When proteins (e.g., enzymes) unfold or denature, their structure changes 
which may effect in the arrangement of its active site resulting in loss of activity. 
Several approaches such as introducing some additives to the ink formula, use of 
solvents and water modifiers such as sugars and polyhydric alcohols and protein 
engineering techniques have been used for the protecting of enzymes. The 
deposition process in conjunction with the optimised ink formulation and storage 
condition may lead to a more stable integrated biosensor (Rosier, Cruz and 
Wilkosz, 2001). One enzyme stabilisation technique is based on the electrostatic 
assembly of oppositely charged polyelectrolytes (Gibson, 1999). Enzymes are 
polyelectrolytes where their charge is dependent on their isoelectric point (IP) and 
the solution pH (Kang et al., 2014). ChEs from Pseudomonas sp. and ChOx have 
isoelectric points of less than 6, which is below the assay reagent pH of 6.8, 
resulting in the enzymes being negatively charged which can be used as polyanion 
under these experimental conditions (Schuurmans Stekhoven, Gorissen and Flik, 
2008). Enzymes are thus able to make an electrostatic bond with a polycation film 
without any complex chemical reactions leading to strong and rigid enzyme 
structure which is linked to enzyme activity (Ram et al., 2001; Rodrigues et al., 
2013). In this work, poly(dimethyldiallyammonium chloride) (PDA) was used as a 
hydrophilic polycation to prepare an enzyme-polyelectrolyte surface. PDA has been 
reported as a suitable polycation for use in the assembly of enzyme electrodes 
using the layer-by-layer deposition technique (Eguílaz et al., 2011; Kang et al., 
2014). 
As was mentioned above, the other component which is important in the formation 
of a homogeneous reagent film is a polymer. Several polymers such as Natrosol 
250 LR, polyvinylpyrrolidone (PVP) K25 and K30 and Aquazol 50 have been 
investigated as film formers for inkjet deposition of reagents. Among them, both 
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PVP K25 and K30 were found to be suitable film formers, capable of being inkjet-
printed. Both possess good solubility in all conventional solvents and have 
adhesive power with good affinity to hydrophilic and hydrophobic surfaces (Jospeh, 
2012).   
Kang et al., (2014) reported the use of 1% (w/v) PDA for layer-by-layer assembly of 
enzyme electrodes and 0.5% (w/v) PVP K30 was reported to be suitable and 
reliable for inkjet-printing (Jospeh, 2012). Studies were performed here to optimise 
the PDA and PVP K30 concentrations to make them suitable for combination with 
the modified silver electrodes with minimal impact on electrocatalysis. In order to 
optimise concentration, solution phase experiments were performed using 
Emulgen/PBS modified silver electrodes and the electrode responses to 4 mM 
H2O2 in 6% (w/v) Emulgen B-66 was assessed. Polymers were assessed 
individually and in combination. Cyclic voltammograms (Fig.  6.10) demonstrated a 
slight decrease in non-Faradic current in the presence of 1% (w/v) PDA, showing a 
slight negative effect on the Emulgen B-66/PBS surface modification. No other 
interferences were observed in the presence of PDA at these applied potentials.         
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Fig. ‎6.10. Cyclic voltamogram of modified electrodes in a) 6% (w/v) Emulgen 
B-66, b) 1% (w/v) PDA, c) 4 mM H2O2 in 6% (w/v) Emulgen B-66 and d) 4 mM 
H2O2 in 1% (w/v) PDA, delipidated serum was used for control experiments. 
Following this, the effect of PDA (0.1 to 1.0% (w/v) prepared using 0.1 M PBS pH 
6.8) on the amperometric measurement of 4 mM H2O2 on Emulgen B-66/PBS 
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modified electrodes in un-stirred batch solution was evaluated. As is shown in Fig. 
 6.11,  the current observed was elevated in the presence of 0.1, 0.2 and 0.3 % 
(w/v) PDA, showing some positive effect on catalytic activity of the modified 
electrode. However, further increases in PDA concentration led to significant 
decreases in current. This might be due to some disruption of the Emulgen/PBS 
surface structures at higher concentrations. A concentration of 0.2% (w/v) PDA was 
used for any further formulation. 
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Fig. ‎6.11. Effect of PDA concentration on chronoamperometric measurement 
(-0.1 V vs Ag/AgCl) of 4 mM H2O2 in the presence of different concentrations 
of PDA using modified electrodes in non-stirred batch solution, delipidated 
serum was used for control experiments. 
After looking at the effect of PDA on the catalysis of the modified electrode towards 
H2O2 measurement, the next step was to evaluate the effect of PVP in a similar 
way. Fig.  6.12 demonstrates cyclic voltammograms of modified electrodes in the 
presence and the absence of 1% (w/v) PVP. As can be seen, a 1.6-fold decrease in 
non-Faradic current was observed in the presence of 1% (w/v) PVP K30, showing a 
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negative effect on surface modification. The current observed for 4 mM H2O2 
measurement at -0.1 V (vs Ag/AgCl) also decreased by approx. 1.3-fold in the 
presence of increasing concentrations of PVP which might be due to some 
diffusional effect. PVP is a polymer used in drug formulation in pharmaceutical 
industries which is capable of solubilizing poorly water-soluble drugs in a way very 
similar to surfactants by exploiting the large dipole moment of its side group which 
can interact with any dipole present in the solution which may lead to some change 
in critical micelle point of present surfactant (Reintjes, 2011).  
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Fig. ‎6.12. Cyclic voltamogram of modified electrodes in a) 6% (w/v) Emulgen 
B-66, b) 0.1% (w/v) PVP, c) 4 mM H2O2 in 6% (w/v) Emulgen B-66 and d) 4 mM 
H2O2 in 0.1% (w/v) PVP, Delipidated serum was used for control experiments. 
Fig.  6.13 shows the amperometric measurement of 4 mM H2O2 in PVP from 0 to 
1.0%. The current observed decreased with increasing PVP concentration, showing 
some negative effect on catalytic activity of the modified electrode. This might be 
due to some disruption of the Emulgen/PBS surface structures at higher 
concentrations or maybe changes in the rates of diffusion. Since, 0.1 and 0.2 % 
(w/v) PVP showed comparable amperometric responses, 0.2% (w/v) was used for 
future experiments. Since 0.2 % (w/v) PDA showed a slight positive effect on 
surface modification while 0.2% (w/v) PVP showed some negative effect, the effect 
of both PVP and PDA (0.2% (w/v)) on the amperometric measurement of 4 mM 
H2O2 was assessed (Fig.  6.14). As can be seen, a smoother amperometric 
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response, with almost the same current response was achieved at 420 s in the 
presence combined 0.2% (w/v) PVP and PDA. 
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Fig. ‎6.13. Effect of PVP concentration on chronoamperometric measurement 
(-0.1 V vs Ag/AgCl) of 4 mM H2O2 in the presence of different concentrations 
of PVP using modified electrodes in non-stirred batch solution, delipidated 
serum was used for control experiments.  
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Fig. ‎6.14. Amperometric measurement of H2O2 (4 mM) in the absence (b) and 
the presence (c) of combined 0.2% (w/v) PVP and PDA in 6% (w/v) Emulgen 
B-66/PBS; Delipidated serum used for control measurement (a) in the 
absence of combined 0.2% (w/v) PVP and PDA. 
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To summarise, the combined addition of 0.2% (w/v) PVP and 0.2% (w/v) PDA in 
6% (w/v) Emulgen B-66/PBS were shown to have only a slight reduction on 
electrode catalysis for the amperometric measurement of H2O2. Therefore, this 
formulation was used for the preparation of assay reagents. The suitability of the 
final assay reagent formulation following inkjet-print deposition on the electrode 
surface was evaluated followed by assessment of its ability to measure HDL-C.  
ChEs (261 U) and ChOx (122.2 U) were dissolved in 2 mL of 6% (w/v) Emulgen B-
66 containing 0.2% (w/v) PVP and 0.2% (w/v) PDA with a final pH of 6.8. Two 
layers of the final solution were then inkjet-printed onto 158 mm of electrode 
surface. All the electrodes had been modified previously using Emulgen B-66/PBS. 
Approx. 8 µL of HDL-C sample was introduced by capillary force into the 
encapsulated biosensors and amperometric measurement was performed following 
two incubation periods of 240 s and 360 s. Measurement after 360 s incubation 
was performed to assess if any increase in incubation time would lead to improved 
response, as further increases in incubation time may increase the amount of H2O2 
released. Fig.  6.15 shows the amperometric response of the integrated biosensor 
to HDL-C in delipidated serum on the same day of sensor fabrication.  
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Fig. ‎6.15. Amperometric measurement (-0.1 V vs Ag/AgCl) of HDL-C in 
delipidated serum using the integrated biosensor: a) after 240 s incubation 
(slope=2.5710-8 A/mM and r² = 0.825, n=3) and b) after 360 s Incubation 
(slope=3.2010-8 A/mM and r² = 0.952, n=3). 
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The biosensor showed only marginally improved sensitivity and linearity 
(slope=3.2010-8 A/mM and r²=0.952) after 360 s incubation compared to 240 s 
incubation (slope=2.5710-8 A/mM and r²=0.825) showing that the enzymes may 
still limit the enzymatic reaction.  The amperometric results for HDL-C (0 to 4 mM) 
using two layers of assay reagent inkjet-printed on modified electrodes in the 
absence of PVP and PDA had a sensitivity of 2.0610-8A/mM with linearity (r2) of 
0.952 for n=4 (RSD=11.5%) measurements (Fig.  6.6 and Table  6.5). A comparison 
of HDL-C measurement after 240 s incubation in the presence and absence of PDA 
and PVP illustrated an improvement in the sensitivity and reproducibility of the 
method (Table  6.7 vs Table  6.5) showing improved reproducibility, stability and loss 
of enzymes activity. However, linearity may be further improved by an increase in 
enzyme concentration. 
Table ‎6.7. Detailed analytical data of amperometric measurement (-0.1 V vs 
Ag/AgCl) of HDL-C in delipidated serum using the integrated biosensor (n=3). 
HDL-C 
/mM 
Average 
current at 
420 s (A) 
SD RSD % 
0.5 7.0010
-8
 3.4610
-9
 4.9 
1 1.1310
-7
 2.0210
-8
 17.9 
2 1.5510
-7
 4.3610
-9
 2.8 
3 1.5810
-7
 1.7610
-8
 11.2 
4 1.6010
-7
 1.6710
-9
 10.4 
Average RSD 9.5 
It was shown previously in Section  6.2.2 that integrated enzymes developed using 
inkjet-print deposition of assay reagent showed reduction in enzyme activity even 
within a day of preparation, while showing almost no activity after being kept at 
room temperature for one week. Since enzymes stabilised before deposition may 
show less alteration in their structure compared to free enzymes following 
deposition, future evaluation was performed to assess if the new formulation 
containing PVP and PDA could provide better biosensor stability. Therefore two 
sets of biosensors employing the inkjet-printed assay reagent formula detailed 
earlier in this section were stored at 2-8°C for two days in a desiccator and 
measurement of HDL-C at 420 s was compared with responses from biosensors 
used on the day of fabrication (Fig.  6.16). Control experiments were performed 
using enzymes-less assay reagents. As can be seen, better sensitivity and linearity 
(slope= 3.3210-8, r² = 0.849) was observed for biosensors stored at 2-8°C 
compared with those used on the same day of fabrication (slope= 2.5710-8, r² = 
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0.825) showing that enzymes may need some time to stabilise themselves after 
being deposited on the modified electrodes. This was also reported by Pemberton 
et al., 2013 that the reliable response of the microfabricated glucose biosensor was 
obtained when used fresh without any drying step at room temperature before use 
or when stored immediately at 4 °C. The other explanation for the increase in 
sensitivity may be due to increases in enzyme activity, rates of diffusion, changes in 
the kinetics of the reaction as well as changes in surface modification following 
contact with the solution containing Emulgen B-66/PBS/PVP/PDA. Both PDA and 
Emulgen B-66 were shown to positively effect on the catalysis while measuring 
H2O2. 
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Fig. ‎6.16. Amperometric measurement (-0.1 V vs Ag/agCl) of HDL-C at 420 s 
using the integrated biosensor after 240 s incubation: a) control experiment 
in the absence of the enzymes), b) response from biosensors tested on the 
same day as fabrication  (slope= 2.5710-8, r² = 0.825, (n=3))   and c) after two 
days storage at 2-8 °C (slope= 3.3210-8, r² = 0.849, (n=2))  
While the stability and sensitivity of the integrated biosensors was significantly 
improved in the presence of PDA and PVP, the integrated biosensor had not yet 
demonstrated adequate linearity across the clinical range. In order to assess 
whether by increasing the number of inkjet-printed layers and consequently 
increasing the assay reagent concentration, the linearity of the method would be 
improved, four layers of assay reagent formulation (Section 6.2.3) were inkjet-
printed on Emulgen B-66/PBS modified electrodes. On this occasion, biosensors 
193 
 
were kept at 2-8°C in a sealed container in the presence of silica gel and were 
tested after two days and 20 days storage (Fig.  6.17 and Table  6.7).  
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Fig. ‎6.17. Amperometric measurement of HDL-C at -0.1 V vs Ag/AgCl using 
integrated biosensors with four printed reagent layers following: a) two and; 
b) 20 days storage at 2-8 °C. a) slope=3.5210-8 and r2=0.92, n=4. b) 
slope=3.3310-8  and r2=0.87, n=2.   
As can be seen, the amperometric response from biosensors with four printed 
layers showed a sensitivity of 3.5210-8 with linearity (r2) of 0.92 after two days 
storage,  showing an increase in linearity and sensitivity compared to those 
performed using two layers (slope= 2.5710-8, r²=0.825; n=3). The biosensors also 
exhibited very similar current signals after 20 days with just a slight decrease in 
sensitivity and linearity, suggesting that the new formulation containing PVP and 
PDA did bring about an improvement in biosensor performance by improving 
enzyme stability, re-solubilisation and consequently better homogeneity. A 
comparison between these results and those performed in the absence of PDA and 
PVP at room temperature, illustrates a significant improvement in biosensor 
stability with storage at 2-8°C (Pemberton et al., 2013)  in combination with the 
stabilizers. 
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Table ‎6.8. Detailed analytical data of amperometric measurement of HDL-C at 
-0.1 V vs Ag/AgCl using integrated biosensors with four printed reagent 
layers following two and 20 days storage at 2-8 °C. 
 Two days kept at 2-8°C 20 days kept at 2-8°C 
HDL-C 
/mM 
Average 
current at 
420 s (I/A) 
SD 
RSD 
(%) 
1st repeat  
Average 
current at 420 s 
(I/A) 
2nd repeat 
Average 
current at 420 
s (I/A) 
0 7.5310
-8 
2.2510
-8
 29.9 8.3010
-8
 - 
0.5 1.0010
-7
 4.1610
-9
 4.1 1.0210
-7
 8.7710
-8
 
1 1.5110
-7
 7.5710
-9
 5.0 1.3810
-7
 1.4910
-7
 
2 1.7410
-7
 4.9510
-9
 2.9 1.9010
-7
 1.9010
-7
 
3 2.0410
-7
 1.7810
-9
 8.7 2.0510
-7
 1.9910
-7
 
4 2.1810
-7
 8.5410
-9
 3.9 2.0810
-7
 2.0710
-7
 
Average RSD 9.1   
A similar experiment was performed, this time with biosensors stored in a 
desiccator at room temperature, with measurement at one day and 20 days 
following fabrication (Fig.  6.18).  
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Fig. ‎6.18. Amperometric measurement of HDL-C at -0.1 V vs Ag/AgCl using 
integrated biosensors with four printed reagent layers following: a) one 
(slop=3.4710-8, r2=0.95, n=2) and; b) 20 days storage at room temperature.  
As can be seen in Fig.  6.18, the sensitivity of 3.4710-8 and linearity (r2) of 0.95 for 
two repeat measurements using biosensors fabricated with four layers assay 
reagent and stored for one day at room temperature were observed which 
195 
 
demonstrated much better sensitivity and linearity when compared with those 
reported in Section  6.2.2 which were in the absence of PVP and PDA at room temperature, 
confirming that the addition of PDA and PVP were suitable for stabilising enzymes 
after deposition.  However, after 20 days storage, although sensors still exhibited 
some activity, there had been a significant decrease in analytical performance. 
However, after 20 days, enzymes still showed some activity, while in the absence 
of PDA and PVP almost no activity was observed after a week of storage at room 
temperature. 
In summary, a combination of 0.2 % (w/v) PDA and PVP was able to significantly 
improve enzyme stability. This may be due to some electrostatic bonding with 
enzyme to maintain structural integrity as well as keeping them hydrated in order to 
prevent denaturation and make them suitable to be re-solubilised in the presence of 
substrate to produce a solution with better homogeneity. Consequently, the 
reproducibility of the biosensors was improved due to more consistency in assay 
reagent deposition, reagent rehydration and re-solubilisation in a more consistent 
manner which will be assessed in the following sections. Although the analytical 
performance of the integrated biosensor was improved using four printed layers, it 
still suffered from lack of linearity (r2=0.92) when compared to externally mixed 
experiments (r2=0.999).   
As was mentioned in Chapter 5, a two-fold dilution factor was used when reagent 
was externally added to the substrate. In other words, while 0.5 to 4 mM HDL-C 
were introduced as substrate, the final concentrations of HDL-C in solution after 
addition of assay reagent were from 0.25 to 2 mM. However, due to removal of the 
dilution step with reagent integration, the integrated biosensor must actually 
measure 0.5 to 4 mM, which is effectively twice the concentration measured by the 
externally mixed reagent approach. This range was very similar to the TC final 
concentration measured by externally addition of reagent which was discussed in 
Chapter 5. Considering the dilution factor of 2, the final concentration of TC 
measured using externally added reagent was up to 5 mM. Therefore, the next step 
was to assess whether increasing the enzyme concentration in the assay reagent 
would further improve the analytical performance of the integrated biosensor 
Increasing the number of printed layers may increase the systematic error and 
consequently the reproducibility of the integrated biosensor, As a result, increasing 
enzyme concentration was preferred over increasing the number of layers. 
Therefore, ChOx (218 U/mL) and ChEs (633 U/mL) were prepared in 6% (w/v) 
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Emulgen B-66/PBS containing 0.2% (w/v) PVP and PDA and was used to fabricate 
HDL-C integrated biosensor. Sensitivity, linearity and reproducibility of them were 
evaluated. Control experiment was performed using integrated biosensor having 
four layers enzymes-less assay reagent.  
Fig.  6.19 demonstrates the measurement of HDL-C using the biosensor at the 
elevated enzyme concentrations. The biosensor showed an acceptable sensitivity 
of 3.3310-8 with linearity (r2) of 0.993 and reproducibility of 10.3% (n=4) for HDL-C 
measurement (0.5 to 4 mM). These results were comparable with those observed 
for HDL-C measurement using externally mixed reagents as presented in Chapter 
5 (slope=3.3210-8, r2=0.999, RSD=9.5% n=5). However, the integrated biosensor 
was not able to differentiate between 0 and 0.5 mM HDL-C resulting in an LOD of 
0.5 mM (Table  6.9).  
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Fig. ‎6.19. Amperometric measurement of HDL-C (0.5-4 mM) at -0.1 V vs 
Ag/AgCl using integrated biosensors with four printed reagent layers 
containing ChOx (218 U/mL) and ChEs (633 U/mL) in 6% (w/v) Emulgen B-
66/PBS and 0.2% (w/v) PVP and PDA (slop=3.3310-8, r2=0.993 and 
RSD=10.3%; n=4), Enzymes-less assay reagent inkjet-print deposited on 
modified electrode surface was used for control measurement.  
As a result of a further elevation in enzyme concentration, linearity (r2) increased 
from 0.92 to 0.99 which was very similar to that observed using externally mixed 
reagents and was within the acceptable criteria for HDL-C measurement according 
to NECP guideline (r20.975) (CRMLN, 2002).  Although the reproducibility of the 
integrated biosensor was very similar to the one based on externally added 
reagents, it did not meet the CRMLN criteria which were less than 5%. In order to 
improve reproducibility, the next step was to evaluate whether removal of the 
electrode modification step, with the potential accompanying reduction in 
systematic error would improve the precision of the integrated biosensor.    
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Table ‎6.9. Detailed analytical data of amperometric measurement of HDL-C at 
-0.1 V vs Ag/AgCl using integrated biosensors with four printed reagent 
layers containing ChOx (218 U/mL) and ChEs (633 U/mL) in 6% (w/v) Emulgen 
B-66/PBS and 0.2% (w/v) PVP and PDA. 
HDL-C/  
mM 
I/A (average 
at 420 s) 
S/B SD RSD (%) 
0 1.7510
-7 - 2.1610
-8
 12.4 
0.5 1.6410
-7
 0.9 1.5110
-8
 9.3 
1 1.8010
-7
 1.0 1.0310
-8
 5.8 
2 2.2110
-7
 1.3 1.8710
-8
 8.5 
3 2.5210
-7
 1.4 2.8310
-8
 11.3 
4 2.7810
-7
 1.6 3.3010
-8
 11.9 
Average RSD 10.3 
6.2.4 Assessment of biosensor performance in the absence of electrode 
modification 
As was discussed in Chapter 5, inkjet printing of five layers of 6% (w/v) Emulgen B-
66/PBS onto silver paste electrodes was successfully used as a means of 
modifying the silver paste electrodes to achieve enhanced electrocatalytic reduction 
of H2O2. The modified electrodes were then employed as a platform for the 
amperometric measurement of HDL-C by external addition of assay reagents and 
for the fabrication of the integrated HDL-C biosensor. Although this step was shown 
to increase the catalytic activity of silver electrode towards H2O2, the additional 
processing step required may contribute to the irreproducibility of the integrated 
biosensor. Since the assay reagents also contain surfactant and salt it was thought 
possible that sufficient catalysis could be achieved without this additional 
preparation step. Therefore, four layers of assay reagent were inkjet-printed on the 
electrode surface without any prior modification. All biosensors were stored in a 
sealed container at 2-8 °C for two days and then used for measurement of HDL-C 
(Fig.  6.20 and  
Table  6.10). As can be seen, the background current observed at -0.1 V (vs 
Ag/AgCl) was 1.0410-7 A which was 1.7-fold lower than that observed on modified 
electrodes which may be due to a reduction in formation of surface structures on 
the electrode. However, a significant improvement was observed in sensitivity and 
reproducibility (slope=4.5510-8, RSD=6.6%; n=3) of these biosensors compared to 
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those reported using Emulgen/PBS modified electrodes (slope=3.3310-8, 
RSD=10.3%; n=4).   
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Fig. ‎6.20. a) Measurement of HDL-C using unmodified silver paste electrodes 
(slope=4.5510-8, r2=0.993, RSD=6.6%; n=3); b) control in the absence of 
enzymes. 
 
Table ‎6.10. Detailed analytical data of amperometric measurement (-0.1 vs 
Ag/AgCl) of HDL-C using unmodified silver paste electrodes (n=3). 
HDL-C / 
mM 
I/A 
(average 
at 420 s) 
S/B SD 
RSD 
(%) 
0 1.0410
-7 - - - 
0.25 1.0710
-7
 1.0 1.2710
-8
 11.9 
0.5 1.2110
-7
 1.2 2.3110
-9
 1.9 
1 1.4610
-7
 1.4 1.4910
-8
 10.2 
2 1.9810
-7
 1.9 8.5010
-9
 4.3 
3 2.2710
-7
 2.2 7.5110
-8
 3.3 
4 2.8610
-7
 2.8 2.3110
-8
 8.1 
Average RSD 6.6 
Significant improvement was observed in the signal to background (S/B) of the 
integrated biosensor used without prior modification. This may be due to the 
smaller and more stable background currents as demonstrated in the control 
experiments, while the current signal for 4 mM HDL-C was almost the same using 
either modified or unmodified biosensors. The reproducibility of the method was 
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also improved which could be attributed to the removal of a variable process step. 
Although the linearity of the method did not change, the LOD went from from 0.5 
mM to 0.25 mM which is important for the calculation of non-HDL-C.  
In summary, an integrated HDL-C biosensor was developed with acceptable assay 
sensitivity of 4.5510-8 and good linearity (r2) of 0.993 with the ability to detect HDL-
C in the range of 0.25 to 4 mM. The average RSD of the method for three 
measurements was calculated to be 6.6% (1.90-11.9%). This results were 
comparable with those reported in Chapter 5 using externally mixed assay reagents 
(slope=3.3210-8, r2=0.999, RSD=9.5 %; n=5) with a slight improvement in 
sensitivity and reproducibility. However, the linearity and S/B were found to be 
slightly better when assay reagents were mixed externally. Although the integrated 
HDL-C biosensor showed good linearity as well as acceptable sensitivity, the 
method precision was still outside those set by NECP guidelines (5.0%) (Bishop, 
Fody and Schoeff, 2013). However, this target could be achieved by the 
implementation of tight engineering controls in large scale manufacture. 
 Although there are many reports of the amperometric measurement of cholesterol 
(TC or FC) using various immobilisation techniques (Arya, Datta and Malhotra, 
2008; Ruecha, Siangproh and Chailapakul, 2011; Ruecha et al., 2014; Shin and 
Kameoka, 2012; Türkarslan, Kayahan and Toppare, 2009), there are few reports of 
their application to the measurement of cholesterol in serum (Dey and Raj, 2014; 
Fang, 2011; Foster, Cassidy and O'Donoghue, 2000; Hooda et al., 2009; 
Manjunatha et al., 2012; Ruecha et al., 2014; Urmila et al., 2011).  
Foster et al., (2000), reported a diagnostic device for HDL-C (0.76 – 2.3 mM) and 
TC (2.81-13.0 mM) based on the electrochemical measurement of H2O2 released 
after enzymatic reaction of cholesterol leading to peroxidase oxidation of potassium 
ferrocyanide. The device had a detection zone containing the reagent necessary for 
enzymatic reaction and ferrocyanide as an electrochemical mediator allowing 
electron transfer between the H2O2 and the electrode. Potassium ferrocyanide was 
oxidised in the presence of H2O2 followed by its reduction at the electrode and 
producing current. The detection zone was in contact with electrodes and received 
the cholesterol sample from one end by capillary action. A 20-fold dilution of serum 
sample was required for effective measurement using the device and the current 
was measured at -0.2 V (vs Ag/AgCl) at 3.5 min following 7.5 min incubation time 
(total measurement time of 11 min). The method also required sample pre-
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treatment for HDL-C measurement including a precipitation step using PTA and 
MgCl2 followed by 10 min centrifugation at 10,000 rpm or filtering before 
introduction of the supernatant to the device. A comparison between the method 
development in this research and that reported by Foster et al., (2000) 
demonstrates that the method developed in this research might be more suitable to 
be used as diagnostic device as there is no need for any sample dilution or pre-
treatment before introducing the serum sample to the device (Foster, Cassidy and 
O'Donoghue, 2000). However, challenges remain due to the variability of screen 
printed electrodes which has also been reported by Foster et al., (2000). 
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6.3 Development of an integrated TC biosensor 
As was mentioned in Chapter 1, use of non-HDL-C for decision-making in 
treatment of atherosclerotic cardiovascular risk in adults (ACRAD) was introduced 
by NCEP (Adult Treatment Panel III (ATP III), 2002; Boekholdt et al., 2012; Stone 
et al., 2014). While non-HDL-C is calculated by subtraction of the HDL-C value 
from the TC value, to develop a diagnostic device capable of measuring non-HDL-
C, it was important to also develop an integrated TC biosensor using the equivalent 
platform as that developed in Chapter 5. It was shown in Chapter 5 that a modified 
silver electrode using Triton X-100/PBS was capable of measuring TC (0 to 10 mM) 
using external reagent addition. The next step was to then develop an integrated 
TC biosensor through the inkjet-print deposition of a TC assay reagent.  
6.3.1 Effect of PVP and PDA on the amperometric measurement of TC using 
externally addition of assay reagent     
As was mentioned in Section  6.2, an ink formulation was developed containing 
PVP and PDA (0.2% (w/v)) which was suitable for the fabrication of the HDL-C 
integrated biosensor. The same ink formulation as mentioned in Section 6.2.3 was 
again prepared, but this time in 0.5% (v/v) Triton X-100/PBS instead of Emulgen B-
66/PBS. The effect of PDA and PVP on the amperometric measurement of TC was 
first investigated using external reagent addition before moving to the fabrication of 
the integrated biosensor. Fig.  6.21 illustrates the amperometric responses of Triton 
X-100/PBS modified electrodes to TC. 20 µL of assay reagent containing final 
concentrations of 60 U/mL ChOx and 156 U/mL ChEs prepared in 0.5% (v/v) Triton 
X-100/PBS/0.2% (w/v) (PVP and PDA) was mixed with 20 µL TC as substrate. 
Assay reagent  was used immediately following preparation (1st repeat) or for a 
minimum of one hour (2nd-4th repeats) (Fig. 6.22 and Table 6.11). 
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Fig. ‎6.21. Biosensor response to TC in delipidated serum at -0.1 V (vs 
Ag/AgCl) after 420 s using ChOx (60 U/mL) and ChEs (156 U/mL) prepared in 
0.5% (v/v) Triton X-100/PBS containing 0.2% (w/v) PVP and PDA which was 
externally added and incubated for 240 s; A: 1st repeat performed immediately 
following assay reagent preparation; 2nd-4th repeats performed one hour after 
preparation. Slope=2.0410-8 , r2=0.992 and RSD=12.1%, n=4; B: three repeats 
measurement (slope=2.2510-8 , r2=0.994 and RSD=7.0%, n=3).   
 
Table ‎6.11. Detailed analytical data of amperometric measurement (-0.1 V vs 
Ag/AgCl) of TC using Triton/PBS modified electrode by external addition of 
assay reagents. 
 N=4 N=3 
TC/mM 
I/A 
(average 
at 420 s) 
SD 
RSD 
(%) 
I/A 
(average 
at 420 s) 
SD 
RSD 
(%) 
0 3.89E-08 4.1010
-9
 10.5 3.8910
-8
 4.1010
-9
 10.5 
1 7.46E-08 2.7910
-8
 3.7 7.5310
-8
 3.0410
-9
 4.0 
3 1.09E-07 1.5010
-8
 13.8 1.1210
-7
 1.6010
-8
 14.3 
5 1.52E-07 1.9210
-8
 12.6 1.6210
-7
 1.7310
-9
 1.1 
7 1.96E-07 2.8410
-8
 14.5 2.0910
-7
 1.3110
-8
 6.3 
9 2.24E-07 3.9110
-8
 17.5 2.4310
-7
 1.4210
-8
 5.8 
 Average RSD 12.1 Average RSD 7.0 
As can be seen in Fig.  6.21 A, the results using the first set of modified electrodes 
which were obtained immediately following preparation of assay reagent showed 
significant deviation from the later repeats, which might be due to the fact that the 
enzymes may need some time to stabilise and settle their activity following the 
addition of PDA and PVP. This was also observed in Section  6.2.3 following the 
immediate deposition of stabilised enzymes. The calibration curve using all four 
sets of measurement showed a slope of 2.0410-8 A/mM, linearity (r2) of 0.992 and 
RSD of 12.1% (Fig.  6.21 B). However, by removing the first set of replicates, the 
modified electrodes showed a sensitivity 2.2510-8 A/mM, linearity (r2) of 0.994 and 
RSD of 7.0% showing a slight increase in sensitivity of the method and a significant 
improvement in method reproducibility (Table  6.11).      
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A comparison of the amperometric measurement of TC with and without PDA and 
PVP following external reagent addition is shown in Fig.  6.22, taking data from 
Chapter 5 (Section 5.3.2.1). 
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Fig. ‎6.22. Biosensor response to TC in delipidated serum at -0.1 V (vs 
Ag/AgCl) after 420 s using externally addition of assay reagent a) (triangles) 
in the absence of PVP and PDA (slope=2.2410-8 A/mM, r2 = 0.984 and 
RSD=10.8%; n=3) b) (circles) in the presence of stabilizers (slope=2.2510-8 
A/mM, r2 = 0.994 and RSD=7.0%; n=3). 
A sensitivity of 2.2510-8 A/mM was observed following the addition of stabilizers 
which was very similar to that observed previously in their absence (2.2410-8 
A/mM) confirming that no significant effect was observed on the modified electrode 
response in the presence of stabilizers which was also shown previously in Section 
 6.2.3. Linearity was slightly improved (0.994 vs 0.984) with significant improvement 
in reproducibility of the method for three repeat measurements following the 
addition of stabilizers with RSDs of 7.0% and 10.8%, respectively. 
6.3.2 Inkjet-print deposition of TC assay reagent on modified silver 
electrodes 
As was shown previously in Section  6.2, due to the effects of the deposition and 
immobilisation methods on the analytical performance of the integrated HDL-C 
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biosensor which caused issues such as enzyme activity, stability, reagent solubility, 
assay homogeneity, etc, the integrated biosensor required optimisation of its 
reagent formulation to minimise these effects. In the previous section, the effect of 
stabilizers on the amperometric measurement of TC using the encapsulated 
modified electrodes was evaluated using externally added reagents demonstrating 
improved reproducibility and linearity. In this section, the effect of inkjet-print 
deposition of assay reagent on the amperometric measurement of TC was 
assessed. Therefore, ChOx (329.8 U) and ChEs (913.5 U) in 1.5 mL 0.25% (v/v) 
Triton X-100/PBS containing 0.2% (w/v) PVP and PDA was prepared. Two or four 
layers of the formulation was inkjet-printed on the electrodes which had previously 
been modified with Triton X-100/PBS according to Section 6.2.3. The integrated 
biosensors were stored in a sealed container at 2-8 °C for 24 h and used for the 
amperometric measurement of TC. The inter-relationships between enzyme 
concentration, incubation time and print layers on the assay response were 
evaluated. A concentration of 0.25% (v/v) Triton X-100 was chosen as 
concentrations above 0.5% have been shown to have a negative effect on 
enzymatic reaction of cholesterol which was demonstrated in Chapter 3. 
Measurement of TC using the integrated biosensors using two and four printed 
layers is shown in Fig.  6.23. Measurements using two print layers were performed 
with 240 s and 420 s incubation in order to assess the effect of incubation time 
which may be limiting the response due to enzyme activity and other kinetic 
processes. Increasing the incubation time was shown to increase both the 
sensitivity and linearity of the method, confirming such limiting conditions. At four 
printe layers with 240 s incubation, this gave a sensitivity of 2.13910-8 A/mM and 
linearity (r2) of 0.819, which was 1.6-fold greater than that observed for two layers 
after 240 s incubation (slope of 1.3110-8 A/mM and (r2) of 0.772). Since increasing 
either incubation time or layer number led to better sensitivity and linearity, the next 
step was to increase the enzymes concentrations to twice the initial concentrations 
and evaluate the effect. This was done to prevent enzymes from limiting the 
enzymatic reaction. 
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Fig. ‎6.23. Amperometric measurement of TC using the integrated biosensor (-
0.1V vs Ag/AgCl) at 420 s using: two printed reagent layers a) after 240 s 
incubation (slope=1.3110-8 A/mM and r2=0.772) and c) after 420 s incubation 
(slope=1.7310-8 A/mM and r2=0.864) and also b) using four reagent layers 
after 240 s incubation (slope=2.13910-8 A/mM and r2=0.864). 
Therefore, four layers of assay reagent containing ChEs (1566 U) and ChOx (582 
U) prepared in 1.5 mL of 0.25% (v/v) Triton X-100 containing 0.2% (w/v) PVP and 
PDA inkjet-printed onto modified electrodes.  As can be seen in Fig.  6.24, the 
integrated biosensor showed a sensitivity of 1.4210-8 A/mM with linearity (r2) of 
0.949 and RSD=11.6% (n=3), the sensitivity of which was 1.6-fold lower than that 
observed for externally added reagent in the presence of stabilizers, while the 
imprecision was similar (slope=2.2410-8 A/mM, r2=0.984 and RSD=10.8%; n=3). 
These differences may again be due to some variability in screen printed 
electrodes as well as the enzymatic reaction characteristic especially at higher 
concentrations. To sum up, four layers of higher enzymes concentrations was 
considered optimal and was used for any further investigations.   
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Fig. ‎6.24. Amperometric measurement of TC (-0.1 V vs Ag/AgCl) using the 
integrated biosensor containing ChEs (1566 U) and ChOx (582 U) in 1.5 mL of 
0.25% (v/v) Triton X-100 containing 0.2% (w/v) PVP and PDA after 240 s 
incubation at 420 s (slope=1.41510-8 A/mM and r2=0.949, RSD=11.6% n=3). 
 
Table ‎6.12. Detailed analytical data of amperometric measurement of TC 
using integrated biosensor previously modified using 0.5% Triton X-100/PBS 
(n=3). 
TC/
mM 
I/A             
Average at 
420 s 
SD 
RSD 
(%) 
0.5 1.7610
-7 
2.8010
-8
 16.0 
1 2.0910
-7
 2.2010
-8
 10.6 
3 2.4010
-7
 2.6510
-8
 11.1 
5 2.5710
-7
 3.3110
-8
 12.9 
7 2.9110
-7
 4.1410
-8
 14.2 
9 3.0510
-7
 1.5010
-8
 4.9 
Average RSD 11.6 
6.3.3 Assessment of TC biosensor performance in the absence of electrode 
modification 
Having evaluated the impact of enzyme concentration, print layer number and 
incubation time on the response of the integrated TC biosensor, it was then 
assessed whether it was possible to remove the electrode modification step in a 
manner analogous to that demonstrated for HDL-C (Section  6.2.4). As is shown in 
Fig.  6.25, huge variability was observed at 0.5 and 1 mM TC which may be due to 
the reliability of the fabrication process. However, in general better linearity and 
reproducibility (r2=0.982 and RSD=9.5%) were observed for integrated biosensors 
using the unmodified electrodes which is believed to be due to the elimination of a 
fabrication step. On the other hand, the sensitivity decreased by 1.4-fold compared 
to modified electrodes, which might also be expected as there may be a trade off 
between the magnitude and reproducibility of the catalytic modification.  
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Fig. ‎6.25. Measurement of TC using unmodified silver paste electrodes 
(slope=9.3810-9A/mM and r2 of 0.982, RSD=9.5%; n=3). 
 
Table ‎6.13. Detailed analytical data of amperometric measurement of TC 
using unmodified silver paste electrodes (n=3). 
TC/mM 
I/A             
Average 
at 420 s 
S/B SD 
RSD 
(%) 
0 1.3410
-7
 - - - 
0.5 1.6010
-7
 1.19 2.0610
-8
 12.9 
1 1.6210
-7
 1.20 3.7210
-8
 22.9 
3 1.7410
-7
 1.30 1.9810
-8
 11.4 
5 1.9610
-7
 1.46 9.7110
-9
 4.9 
7 2.1310
-7
 1.59 3.5110
-9
 1.6 
9 2.4110
-7
 1.80 7.0210
-9
 2.9 
Average RSD 9.5 
The integrated TC biosensor was further optimised with respect to the 
amperometric measurement time. In order to improve the S/B and consequently 
sensitivity of the biosensors, the benefit of measurement as soon as current had 
reached a steady state response (approx. 200 s) was assessed. A comparison 
between the calibration curves obtained at 200 s and 420 s (Fig.  6.26) reveals that 
the current sensitivity was 1.4-fold greater when measured at 200 s compared to 
that measured at 420 s, also with better linearity. It has been reported that the 
onset of a steady state current can be achieved more rapidly by limiting the 
expansion of diffusion layers using working and auxiliary electrode in close 
opposition. Using thinner cells may also help to achieve steady state as well as 
better sensitivity (Foster, Cassidy and O'Donoghue, 2000).   
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Fig. ‎6.26. Amperometric measurement of TC using integrated biosensors with 
unmodified silver paste electrodes (-0.1 V vs Ag/AgCl) at a) 200 s 
(slope=1.3410-8, r2=0.99 and RSD=10% (n=3)) and b) 420 s (slope=9.3810-
9A/mM and r2 of 0.982, RSD=9.5%; n=3). 
While better sensitivity and linearity was observed at 200 s, the integrated 
biosensor failed to provide a precision of less than the 3%, as required for TC 
measurement as per NECP guidelines (Bishop, Fody and Schoeff, 2013). Further 
investigation would be required to improve the sensitivity of the integrated TC 
biosensor by optimising the concentrations of surfactant in a way that does not 
interfere with enzymatic reaction as well as finding a way to provide less variable 
screen printed electrodes. Once again, implementation of rigorous engineering 
controls would also improve sensor reproducibility. 
Recently, a disposable TC biosensor was fabricated using a screen printed three 
electrode configuration (Fang, 2011). The reagent ink containing ChEs and 
cholesterol dehydrogenase, combined with nicotinamide adenine dinucleotide 
(NAD) as coenzyme, and 1,10-phenanthroline-5,6-dione (PD) as the electron 
transfer mediator in the presence of buffer, binder, filler and enzyme stabilizers was 
also screen printed onto the surface of the working and reference electrodes to 
form an integrated reagent layer. The integrated biosensors were then used for 
amperometric measurement of 1.3 to 13 mM cholesteryl acetate prepared in Triton 
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X-100/PBS. The current was measured after 38 s at a fixed potential of 300 mV vs 
Ag/AgCl. The biosensor was stable for up to 100 days and was reported to 
satisfactorily measure blood TC. However, no detailed analytical data was reported  
Manjunatha, et al., (2012) reported the use of functionalized graphene (FG) 
modified graphite electrodes with good electrocatalytic activity towards H2O2 as a 
platform for the amperometric measurement of TC (0.05-0.3 mM) and FC (0.05-
0.35 mM). ChEs and ChOx enzymes were covalently co-immobilised onto the 
modified electrode and cholesterol palmitate was used as a substrate for ChEs. 
The integrated biosensor was applied to the amperometric measurement of TC in 
serum which required a minimum 15-fold dilution to allow its concentration fall 
within the linear range of the sensor (0.05-0.3 mM), which is not ideal for point of 
care testing.  
Hooda, et al., (2009) reported the fabrication of a cholesterol biosensor based on 
the incorporation of HRP into a carbon paste screen printed electrode and 
immobilised ChEs and ChOx using glutaraldehyde onto the surface of a polyvinyl 
chloride (PVC) 15 mL container to form an electrochemical cell while HRP was 
added into the carbon paste working electrode. Although the system showed good 
correlation (r=0.9916) when compared with Bayer's  Enzo Kit at 45°, such a system 
using 15 mL and minimum 200 µL serum sample would not be suitable for 
development of disposable diagnostic device. However, the experiment showed 
suitability of using PVC as platform for enzymes immobilisation which might be 
suitable for future development of biosensors.   
6.4 Conclusions 
Integrated biosensors for the measurement of HDL-C and TC were developed and 
optimised and showed an acceptable linear regression of 0.993 (0.25 to 4 mM) and 
0.982 (0.5 to 9 mM), respectively which were in agreement with the recommended 
method linear regression (r2) reported by the NCEP working group for both HDL-C 
and TC analyses which is more than 0.975 within their clinical range.  
The final HDL-C integrated biosensor showed an acceptable sensitivity of 4.5510-8 
A/mM with an average RSD of 6.6% (n=3). These results showed good agreement 
with the results obtained by the biosensors using external addition of assay 
reagents (Section 5.2.2; slope=3.3210-8, RSD=9.5%, n=5). Although better 
precision was observed using the integrated biosensor, this was still greater than 
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the precision expected as per NECP criteria for HDL-C measurement which is less 
than 5%.  
The final TC integrated biosensor yielded a sensitivity of 9.3810-9A/mM with an 
average RSD of 9.5% (n=3). These results also showed good agreement with the 
results obtained by using external reagent addition (Section 5.2.2; slope=2.2410-8 
A/mM, and average RSD=10.8%; n=3). However, the TC integrated biosensor also 
failed to provide acceptable precision of less than 3% as per NECP guidelines for 
TC measurement. The integrated biosensors were stable for twenty days when 
stored at 2-8 °C. 
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7.1 Overall conclusions  
7.1.1 Suitability of using surfactant/salt modified electrodes as a platform 
for the amperometric measurement of H2O2, HDL-C and TC 
This study has shown that sensors capable of the direct reduction of H2O2 were 
suitable for employment as a platform for cholesterol measurement with the 
eradication of one of the enzymatic steps in classical cholesterol determination. 
Screen-printed, silver paste electrodes modified with a lyotropic layer of DBSA/KCl 
were successfully employed in the measurement of H2O2 generated after the 
enzymatic reaction of cholesterol with ChOx and ChEs. 
The application of a homogeneous HDL-C assay in combination with this 
electrocatalytic enhancement was assessed. Despite some negative effects caused 
by some of the assay reagents such as ChOx and components of the sample 
matrix, the sensor showed acceptable linearity from 0 to 10 mM H2O2 with a 
sensitivity of 3.710-8 and linearity (r2) of 0.99 and RSD of 7.2%, which made it 
suitable for application to the direct determination of HDL-C in serum, based on the 
end point enzyme assay protocol developed in Chapter 3. The application of other 
surfactant/salt combinations such as Emulgen B-66/PBS and Triton X-100/PBS for 
HDL-C and TC measurement, respectively, was then evaluated and all showed 
comparable sensitivity and linearity for cholesterol measurement using the silver 
paste electrode platform (Chapter 5). However, the presence of the electrode 
modification step was found to contribute to the total variability of the resulting 
biosensors. The modification step could be effectively removed due to the presence 
of surfactant and salt in the assay reagent mixture, which improved reproducibility 
at the expense of sensitivity.  
7.1.2 Selective measurement of HDL-C and TC 
An assay methodology was developed for the differential measurement of both 
HDL-C and TC at room temperature using a single step homogeneous assay 
approach and based on the generation of H2O2 as the end product of the enzymatic 
catalysis of cholesterol and cholesterol esters. The assay methodology was initially 
based on a spectrophotometric measurement approach to allow convenient assay 
development, but was then adapted to the measurement of HDL-C and TC using 
an electrochemical transduction methodology. Other key features of the assay was 
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the minimisation of the sample dilution requirements, so as to ultimately facilitate 
direct measurement using the electrochemical sensor, and the use of assay 
reagents that were compatible with the electrochemical sensing principle which was 
based on the electrocatalytic reduction of H2O2 using a modified silver-based 
screen printed electrode. The spectrophotometric assay developed employed a 
four-fold sample dilution step and was capable of measuring cholesteryl acetate up 
to 4 mM. It was found that 6% (w/v) Emulgen B-66 was suitable for the selective 
measurement of HDL-C over LDL-C through its selective behaviour towards 
lipoproteins. Triton X-100 (0.5% (w/v)) was successfully used to measure TC in all 
the lipoproteins regardless of their type. The modified electrodes were capable of 
measuring both HDL-C (up to 4 mM) and TC (up to 10 mM) by externally addition 
of assay reagents. The assay reagents were also able to contribute to the 
electrocatalysis in a manner analogous to the electrode modification layer, which 
was later employed to simplify the biosensor fabrication approach.    
7.1.3 Clinical measurement of HDL-C and TC using HDL-C and TC 
biosensors 
Biosensors for HDL-C and TC were successfully used to measure HDL-C and TC 
prepared in delipidated serum when the sample was first mixed with the assay 
reagents before their application to the electrode and which required a two-fold 
sample dilution. The biosensors were also applied to the measurement of sets of 
clinical samples. Further improvement in the performance of the biosensor and 
accompanying assay are required to bring them into sufficient agreement with 
standard methods. Such lack of agreement may have been mainly due to the effect 
of the sample matrices on the amperometric measurement methodology using the 
modified electrodes, as well as the sensitivity of assay methodology itself in the 
presence of higher concentrations of other assay components such as TG or 
bilirubin etc (Iizuka et al., 2012; Miller et al., 2010).  
7.1.4 Fabrication of integrated HDL-C and TC biosensors     
Although the biosensors based on the modified electrodes were capable of 
measuring HDL-C and TC in delipidated serum with external addition of the assay 
reagents, fabrication of analogous integrated biosensors capable of measuring 
small sample volumes presented many additional challenges including the 
development of the deposition and immobilisation of the assay reagents to result in 
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stable and reproducible sensors, as well as optimisation of fabrication parameters 
such as reagent concentration, deposition process parameters, storage conditions 
and assay methodology. Another key consideration was optimising the assay to 
allow direct measurement without the requirement for sample dilution.   
As was shown in Chapter 6, even a direct deposition, can bring about alterations in 
enzyme behaviour, and the kinetics of many processes such as concentration/time 
profiles of assay reagents and substrates and products across and throughout the 
sample chamber during the measurement process. Additionally, processes such as 
reagent re-solubilisation and the speed and reproducibility of sample filling will all 
impact on the analytical performance of the resulting assay. Any changes in 
enzyme structure may lead to changes in the catalytic activity of the enzymes by 
either reducing accessibility of the substrate to the enzymes active site or losing the 
enzymes dynamic properties. Taking into account these factors, development of an 
integrated HDL-C biosensor was achieved using inkjet-print deposition of an assay 
reagent formulation containing ChOx and ChEs in 6% (w/v) Emulgen B-66/PBS 
and 0.2% (w/v) PVP and PDA in order to improve the kinetic of reaction, diffusion 
rate, reproducibility, sensitivity and linearity as well as stability of the integrated 
biosensor. However, to improve the linearity of the method, higher concentrations 
of enzymes were required. Although the final integrated biosensor HDL-C which 
was fabricated using unmodified electrodes showed comparable sensitivity, 
linearity and reproducibility with those based on external addition of the reagents, 
the method still failed to provide acceptable reproducibility and sensitivity to be 
applied as a diagnostic test device. 0.25% (v/v) Triton X-100 was used instead of 
Emulgen B-66 for fabrication of integrated TC biosensor as well as greater enzyms 
concentrations.   This sensitivity and reproducibility was found to be poorer for the 
integrated TC integrated biosensor compared to the sensor based on external 
reagent addition. ChEs (1,044 U/L) and ChOx (388 U/L) were used for the 
fabrication of TC integrated biosensor and ChOx (218 U/L) and ChEs (633 U/L) 
were employed fore for the fabrication of integrated HDL-C biosensor.  
To summarise, electrochemical biosensors were developed that were capable of 
the selective measurement of HDL-C and TC across the analytical range for 
application in point of care cholesterol screening. Measurements in clinical samples 
using external addition of assay reagents showed that further imporovement in the 
measurement approach was required to bring it within acceptable agreement with 
standard methods and which may be due to as yet unidentified interactions 
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between the sensor and interfering sample matrix components. In addition, 
integrated biosensor configurations were also demonstrated for HDL-C and TC 
measurement in spiked serum samples. While overall reproducibility still lies 
outside acceptable standards, it is believed that this could be achieved through 
further biosensor development and production optimisation. 
7.2 Future work 
7.2.1 Selection and development of an optimal electrochemical sensing 
platform 
Despite the fact that the silver paste electrode platform was capable of the 
measurement of cholesterol-derived H2O2, the signal to background and 
reproducibility of the modified electrodes were not found to be reach the 
performance standards required for the clinical measurement of cholesterol due to 
the variability in and interference of the electrocatalytic process. Employment of a 
more sensitive and reproducible H2O2 sensor which is less prone to sample matrix 
interference as the measurement platform would be required to achieve this. 
Recently, a H2O2 sensor has been reported based on carbon screen printed 
electrodes modified using inkjet-print deposition of Prussian blue nanoparticles 
(PBNPs). The modified electrodes showed an excellent limit of detection of 210-7 
with a linear range of up to 4.5 mM and sensitivity of 7.6410-4 A/mM.cm2 with 
excellent reproducibility (RSD) of less than 5% (Cinti et al., 2014). Such analytical 
characteristics may make this a good platform to be employed for cholesterol 
measurement, in particular HDL-C measurement due to its excellent sensitivity and 
limit of detection which is essential for HDL-C measurement which has a narrow 
clinical range. The application of the PBNPs carbon paste platform could be applied 
to the selective assay measurement methodologies developed here, as well as for 
the amperometric measurement H2O2 released after enzymatic reaction of LDL-C 
(Nauck, Warnick and Rifai, 2002) and TG (Fossati and Prencipe, 1982). LDL-C is 
the main lipoprotein carrying the most blood cholesterol and is known as a primary 
risk factor for CHD. H2O2 released after enzymatic reaction of LDL-C in the 
presence of its selective surfactant and ChEs and ChOx may be measured using 
the same strategy considering the effect of its surfactant on modified electrode 
catalytic activity. Although the Friedewald calculation method is currently the most 
convenient method which effectively eliminates the need for LDL-C measurement, 
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fabrication of an integrated LDL-C biosensor could also be considered. Direct 
measurement may also be more accurate than subtraction for non-HDL-C.   
7.2.2  Detailed assessment of the selectivity of the method towards HDL-C 
subfractions vs non-HDL-C and further study on the mechanism of 
selectivity   
As was discussed in Chapter 1, large HDL2 and small HDL3 are the two main 
fractions of HDL (Kurosaki and Ogawa, 2009; Okada et al., 2001). Okada et al., 
(2009) reported the recovery of only 76% HDL2 and 95% of HDL3 in the presence 
of 0.9% Emulgen B-66 compared to the standard heparin-MnCl2 method. Only the 
addition of MgCl2 at 11 mM raised the selectivity towards HDL3 resulting in a HDL-C 
concentration similar to the heparin-MnCl2 standard method, confirming the apo E-
rich dependency of direct methods as compared to the standard method. 
Comparison of eight homogeneous assay kits for HDL-C measurement in clinical 
samples using selective detergents (Kyowa Medex, Sysmex, Kainos and Serotec) 
and the elimination method (Denaka, Sekisui, Toyobo and Wako) also showed a 
partial reaction with apo E-rich HDL-C (Iizuka et al., 2012) in most of the methods. 
Kuroskai and Ogawa (2009) investigated the characteristics of polyoxyethylene 
derivatives (POED) such as Emulgen B-66 towards HDL-C showing that Emulgen 
B-66 binds selectively to apolipoprotein-rich HDL-C. This was performed using 
0.8% (w/v) Emulgen B-66 showing two separated peaks using gel filtration column 
with front peak containing more cholesterol than the latter peak.  
Despite the fact that there is not yet a clear understanding of which HDL-C 
subfractions plays the most important role in CAD, recently there have been some 
reports on the direct measurement of HDL-C subfractions (Ashmaig et al., 2013; Ito 
et al., 2014). In this study, the evaluation was performed on HDL-C isolated from 
human serum which yielded similar responses in the presence of specific and non-
specific surfactants, while the addition of MgCl2 did not result in any significant 
difference. However, further investigation into the measurement of HDL-C 
subfractions may be necessary for any future clinical measurement of HDL-C. In 
addition, in this study the selectivity was assessed in the presence of LDL-C which 
represented the most significant source of non-HDL in the circulation. However, 
VLDL-C also carries some cholesterol, 25% of which may dissolve in 0.9% 
Emulgen B-66 (Okada et al., 2001). This also needs further investigation for any 
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future measurement of clinical samples as this may give false positive results in 
HDL-C measurement. 
Further study on the exact mechanism of surfactant action on selective 
solubilisation of a specific lipoprotein should be performed and the possibility of 
using LDL-C specific surfactants for the selective measurement of LDL-C should be 
evaluated.    
7.2.3 Clinical measurement of HDL-C and TC 
While further clinical studies would be performed to evaluate an alternative H2O2 
platform which was less sensitive to interferences and variability an extensive study 
should also be performed using more clinical samples with more detailed 
information capable of dividing the samples into different groups to provide better 
understanding of the biosensor functionality in different clinical sample matrices as 
well as uncertainty estimation of the method as a standard requirement (Eurolab, 
2007). 
7.2.4 Development of improved integrated HDL-C and TC biosensors 
Despite the fact that other researchers have used diffusional barriers such as 
membranes to effectively dilute the sample, in this research, the direct 
measurement of cholesterol was chosen in a way that the sample was required to 
re-solubilise the deposited reagent before commencing the enzymatic reaction. No 
membranes or other harsh immobilisation techniques were used since the silver 
modified electrode itself was the basis of H2O2 detection, and any small changes in 
its surface modification may have affected its sensitivity toward H2O2. It is believed 
that using a thinner electrochemical cell with working, counter and reference 
electrodes closer together may improve the linearity and sensitivity of the method 
developed in this study (Foster, Cassidy and O'Donoghue, 2000). However by 
replacing the platform with the PBNP system mentioned earlier, the possibility of 
using an inkjet-printable membrane to laminate enzyme and stop them from leaking 
might be greater. To manipulate the permeability of the substrate to the electrode 
surface, an outer polymeric  membrane could be chosen to fabricate a HDL-C or 
TC sensor based on the sensitivity and linearity required (Maines, Ashworth and 
Vadgama, 1996; Maines et al., 1996; Maines et al., 2000; Vadgama and Mandler, 
2013; Vadgama and Mandler, 2013). Since inkjet-printing gives the possibility of 
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layer by layer deposition of the reagent, for the fabrication of the integrated 
biosensor, a detection layer containing PBNPs could be printed first, followed by 
inkjet-printing of the reagent layers containing ChEs, ChOx and surfactant. The 
final layer would be an inkjet-printable water-resistant semi-permeable membrane 
as an outer layer to encapsulate the reagent and manipulate the permeability of the 
substrate depending on the required linear range. Dip-coated cellulose acetate 
membranes have been reported to be used to encapsulate biosensors fabricated 
using inkjet-printing (Setti et al., 2005; Setti et al., 2007; Yun et al., 2011).  
Further investigation on improving the stabilisation of enzymes in solution should 
also be performed considering hydrophilic-hydrophobic interactions of the enzymes 
with the carrier which can affect on the enzymes dynamic properties as well as its 
structure using spectrophotometric techniques should be useful (Cantone et al., 
2013; Secundo, 2013). Since enzyme stabilisation is an important step in the 
improvement of integrated biosensor functionality, looking at different modes of 
enzyme stabilisation such as medium engineering (optimising the formulation) 
(Bommarius and Payeb, 2013; Cantone et al., 2013) is important. The medium 
engineering technique is based on stabilisation of proteins relies on formulating 
suitable buffer conditions which is based on the importance of salt type and its 
concentration as well as the final solution ionic strength. Bommarius and Paye 
(2013) in their report ranked some of the most common anions and cations, based 
on their ability to stabilize or destabilize the enzymes. Among them, phosphate and 
Mg2+ are categorised as strong stabilising ions which can preserve enzymes activity 
upon the addition. 0.1 M phosphate buffer at pH 6.8 was used for preparation of 
assay reagent in this report. Some optimisation of buffer concentrations may help 
to improve sensitivity and linearity of integrated biosensors. 
Closing remarks 
This thesis has shown that fabrication techniques such as screen printing and inkjet 
printing can be effectively combined with other processes such as electrocatalysis, 
selective biochemistries for analysis of cholesterol subfractions and enzymatic 
assay strategies to create low cost, disposable enzyme-based sensor suitable for 
the point of care measurement of cholesterols such as HDL-C, TC and non-HDL-C 
(LDL-C). While these biosensors developed here require further development to 
make them viable for clinical analysis, significant proof of concept has been 
demonstrated and routes to its effective implementation have been identified. The 
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low cost, disposable and printed nature of the sensors also makes them highly 
compatible with the emerging printed electronics industry, a very important part of 
which is the development of sensors and diagnostic devices. The printed devices 
developed here could be effectively integrated with such systems to create new 
and disruptive healthcare technologies. 
 
 
   
 
 224 
 
References  
Ashmaig, M.E., Gupta, S., McConnell, J.P. and Warnick, G.R. (2013) Validation of 
a novel homogeneous assay for of HDL3-C measurement. Clinica Chimica Acta. 
425 (0), pp. 37-41.  
Bommarius, A.S. and Payeb, M.F. (2013) Stabilizing biocatalysts. Chemical Society 
Review. 42, pp. 6534-6565.  
Cantone, C., Ferrario, V., Corici, L., Ebert, C., Fattor, D., Spizzo, P. and Gardossi, 
L. (2013) Efficient immobilisation of industrial biocatalysts:criteria and constraints 
for the selection of organic polymeric carriers and immobilisation methods. 
Chemical Society Review. 42, pp. 6262-6276.  
Cinti, , Arduini, F., Moscone, D., Palleschi, G. and Killard, A.J. (2014) Development 
of a Hydrogen Peroxide Sensor Based on Screen-Printed Electrodes Modified with 
Inkjet-Printed Prussian Blue Nanoparticles. Sensors, 14 (8), pp. 14222-14234.  
Eurolab, (2007) Measurement Uncertainty Revisited: Alternative Approaches to 
Uncertainty Evaluation  . Report number: 1/2007.Paris/France: Eurolab.  
Fossati, P. and Prencipe, L. (1982) Serum Triglycerides determined colorimetrically 
with an enzyme that produces Hydrogen Peroxide. Clinical Chemistry. 28 (10), pp. 
2077-2080.  
Foster, R., Cassidy, J. and O'Donoghue, E. (2000) Electrochemical Diagnostic Strip 
Device for Total Cholesterol and Its Subfractions. Electroanalysis . 12 (9), pp. 716-
721.  
Iizuka, Y., Ishijima, M., Kato, T., Nanmoku, T., Kuwa, K., Kawakami, Y. and Isobe, 
K. (2012) Clinical sample comparison of eight homogeneous assay kits for high 
density lipoprotein cholesterol and low density lipoprotein cholesterol. J Anal Bio-
Science. 35, pp. 168-178.  
Ito, Y., Satoh, N., Ishii, T., Kumakura, J. and Hirano, T. (2014) Development of a 
homogeneous assay for measurement of high-density lipoprotein-subclass 
cholesterol. Clinica Chimica Acta. 427 (0), pp. 86-93.  
Kurosaki, Y. and Ogawa, Z. (2009) Reactivity of a detergent, polyoxyethylene 
derivative, with high density lipoprotein subclass. Journal of Analytical Bio-Science. 
32, pp. 434-439.  
Maines, A., Ashworth, D. and Vadgama, P. (1996) Diffusion restricting outer 
membranes for greatly extended linearity measurements with glucose oxidase 
enzyme electrodes. Analytica Chimica Acta. 333 (3), pp. 223-231.  
Maines, A., Cambiaso, A., Delfino, L., Verreschi, G., Christie, I. and Vadgama, P. 
(1996) Use of surfactant-modified cellulose acetate for a high-linearity and pH-
resistant glucose electrode. Analytical Communications. 33 (1), pp. 27-30.  
Maines, A., Prodromidis, M.I., Tzouwara-Karayanni, S.M., Karayannis, M.I., 
Ashworth, D. and Vadgama, P. (2000) An enzyme electrode for extended linearity 
 225 
 
citrate measurements based on modified polymeric membranes. Electroanalysis. 
12 (14), pp. 1118-1123.  
Miller, W.G., Myers, G.L., Sakurabayashi, I., Bachmann, L.M., Caudill, S.P., 
Dziekonski, A., Selvin, E., Kimberly, M., Korzun, W.J., Leary, E.T., Nakajima, K., 
Nakamura, M., Nilsson, G., Shamburek, R.D., Vetrovec, G.W., Warnick, G.R. and 
Remaley, A.T. (2010) Seven Direct Methods for Measuring HDL and LDL 
Cholesterol Compared with Ultracentrifugation Reference Measurement 
Procedures. Clinical Chemistry. 56 (6), pp. 977-986.  
Nauck, M., Warnick, G.R. and Rifai, N. (2002) Methods for Measurement of LDL-
Cholesterol: A Critical Assessment of Direct Measurement by Homogeneous 
Assays versus Calculation. Clinical Chemistry. 45 (2), pp. 236-254.  
Okada, M., Matsui, H., Ito, Y. and Fujiwara, A. (2001) Direct measurement of HDL 
cholesterol:Method eliminating apolipoprotein E-rich particles. Journal of Clinical 
Laboratory Analysis. 15 (4), pp. 223-229.  
Secundo, F. (2013) Conformational changes of enzymes upon immobilisation. 
Chemical Society Review. 42 (15), pp. 6250-6261.  
Setti, L., Fraleoni-Morgera, A., Ballarin, B., Filippini, A., Frascaro, D. and Piana, C. 
(2005) An amperometric glucose biosensor prototype fabricated by thermal inkjet 
printing. Biosensors & Bioelectronics. 20 (10), pp. 2019-2026.  
Setti, L., Fraleoni-Morgera, A., Mencarelli, I., Filippini, A., Ballarin, B. and Di Biase, 
M. (2007) An HRP-based amperometric biosensor fabricated by thermal inkjet 
printing. Sensors and Actuators B-Chemical. 126 (1), pp. 252-257.  
Vadgama, P. and Mandler, D. (2013) Characterization of thin films and 
membranes. Analytical and Bioanalytical Chemistry. 405 (5), pp. 1433-1434.  
Yun, Y.H., Lee, B.K., Choi, J.S., Kim, S., Yoo, B., Kim, Y.S., Park, K. and Cho, 
Y.W. (2011) A Glucose Sensor Fabricated by Piezoelectric Inkjet Printing of 
Conducting Polymers and Bienzymes. Analytical Sciences. 27 (4), pp. 375-379.  
 226 
 
List of Publications and Presentations 
 T. Ahmadraji, L. Gonzalez-macia and T.J Killard, A biosensor for the 
determination of high density lipoprotein cholesterol employing combined 
surfactant-derived selectivity and sensitivity enhancements, Anal. Methods, 
2014,6, 3975-3981. 
 T. Ahmadraji and T.J. Killard, The evolution of selective analyses of HDL 
and LDL cholesterol in clinical and point of care testing, Anal. Methods, 
2013,5, 3612-3625. 
 IOP Institute of Physics (Advanced printing for medical and health 
application), Development of a printed biosensor for HDL-cholesterol, 
Swansea University, UK, 24 Apr 2012 
 Great Western Electrochemistry Meeting,  Development of a biosensor for 
HDL-cholesterol based on a novel electrocatalyst for hydrogen peroxide 
reduction, Bath, UK, 18 June 2012.. 
 Electrochem 2012 (Poster), Development of a biosensor for HDL-
Cholesterol based on a novel electrocatalyst for hydrogen peroxide 
reduction, Trinity College Dublin, Ireland, 2-4 Sep 2012. 
 IOP Students conference 2012 (Oral presentation), Development of a 
printed biosensor for HDL-cholesterol, Institute of Physics, London, UK, 8 
Dec 2013. 
 CRIB Annual Meeting 2013 (Poster), Development of a biosensor for HDL-
cholesterol based on a novel electrocatalyst for hydrogen peroxide 
reduction, UWE, Bristol, UK, 11 Jan 2013. 
 3rd International Conference on Bio-Sensing Technology (Poster), Printed 
biosensors for the selective determination of HDL-C, Sitges (near 
Barcelona), Spain, 12-15 May 2013. 
 Great Western Electrochemistry Meeting (Oral presentation), Development 
of a printed HDL-cholesterol biosensor based on a novel electrocatalyst for 
hydrogen peroxide reduction, Bath, UK, 3 Jun 2013. 
 227 
 
 HLS Postgraduate Research Conference (winner of the best Poster 
presentation prize), Printed biosensors for the selective determination of 
HDL-C, UWE, Bristol, UK, 28 Jun 2013. 
 Analytical research forum 2013 (Oral presentation), Development of a 
printed biosensor for selective determination High Density Lipoprotein 
Cholesterol (HDL-C), GlaxoSmithKline & the University of Hertfordshire, UK, 
8 - 10 July 2013. 
 Electrochem 2013 (Pster presentation), Amperometric dtermination of high 
density lipoprotein and total cholesterol in serum using a printed biosensor, 
University of Southampton, UK, 1-3 September 2013. 
 CRIB Annual Meeting 2014 (winner of the best Poster presentation prize), 
Development of an electrochemical sensor for high density lipoprotein 
cholesterol and total cholesterol using modified silver screen printed 
electrodes, UWE, Bristol, UK, 10 Jan 2014. 
 Sensors in medicine 2014 (Poster presentation), A biosensor for the 
amperometric determination of high density lipoprotein cholesterol based on 
a printed lyotropic surfactant layer, Royal Geographic Society, London, 25 - 
26 Mar 2014. 
 Biosensor 2014 (Poster presentation), Amperometric determination of 
serum high density lipoprotein cholesterol and total cholesterol using a 
printed surfactant lyotropic layer , Melbourne, Australia, May 2014. 
 ESEAC 2014 (winner of the best Poster presentation prize), A biosensor for 
the amperometric determination of high density lipoprotein cholesterol 
based on a printed lyotropic surfactant layer, Switzerland,  Jun 2014. 
 HLS Postgraduate Research Conference (Oral presentation), A biosensor 
for the amperometric determination of HDL-cholesterol based on a printed 
lyotropic surfactant layer, UWE, Bristol, UK, 27 Jun 2014. 
 
